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Synopsis 
Die Aufklärung von Proteinstrukturen liefert wertolle Einblicke in die vielfältigen 
Funktionen zellularer Prozesse. Jedoch müssen bestimmten Herausforderungen gemeistert 
werden um Proteine Struckturbiologisch analysieren zu können. Die Produktion von 
adequaten Mengen an kristallisierbarem Protein stellt sich vor allem für komplexe 
Zielproteine aus Säugetieren als mühsam dar. In solchen Fällen ist die Verwendung von 
Säugetierzelllinien von Vorteil. Mechanismen für die korrekte Faltung von Proteinen und 
die Fähigkeit posttranslationale Modifikationen durchzuführen sind in Säugetierzelllinien 
gegeben. Die Herstellung von stabilen Zelllinien für die rekombinante Proteinproduktion 
ermöglicht die robuste Expression in einer Reihe von Set-ups: vom kleinen Maßstab in 
Batch-Kultur bis hin zu größeren Maßstäben in Bioreaktoren. Stabile Zellliniengenerierung 
ist jedoch ein sehr zeitaufwendiger Prozess. Sie erfordert eine extensive Analyse und 
Charakterisierung von hochproduzierenden Zellklonen nach der zufälligen Integartion 
eines Transgenes in die Wirtszelllinie. Darüber hinaus stellen komplexe heterogene 
Glycanstrukturen auf der Proteinoberfläche die nächste Herausforderung dar. Diese 
beeinträchtigen Proteinkristallisation und Diffraktion. Mutante Zelllinien wie z.B. 
CHO Lec3.2.8.1 ermöglichen die Expression von Proteinen mit einer homogene 
GlcNAc2Man5 Glycanstruktur. Um die lösliche Expression von rekombinanten Proteinen 
zu fördern können verschiedene Strategien angewandt werden. Beispielsweise die 
Expression verkürzter oder chimerer Konstrukte alswohl die Co-expression von 
Multiproteinkomplexen oder molekularer Chaperone. 
In dieser Arbeit wurde die glykosylierungsdefizente Zelllinie CHO Lec3.2.8.1 genutzt um 
ein schnelles und flexibles System für die Herstellung von stabilen Zelllinien zu etablieren, 
welche die Co-expression von Zielproteinen in bereits charakterisierten chromosomalen 
Loci ermöglicht. Dieses binäre System enthält stabil integrierte Austauschkassetten  welche 
die zielgerichtete Integration von Transgenen ermöglichen. Hiermit wird die zügige 
Herstellung von Produktionszelllinen mit vorhersehbaren Expressionseigenschaften 
gewährleistet.  
Dieses binäre System wurde genutzt um Produktionszelllinien für die Co-expression von 
Toll-like Rezeptor Ectodomainen in Kombination mit Chaperonen zu generieren. 
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Synopsis 
The elucidation of protein structures provides a valuable insight into the diverse functions 
of cellular processes. However the field of structural biology faces some major bottlenecks. 
The production of adequate amounts of high quality protein, particularly for complex 
mammalian targets can be a demanding process. In such cases the use of mammalian 
expression hosts is favourable to the widely used prokaryotic systems due to their 
capability to process the most genuine post-translational modifications and employ proper 
protein folding mechanisms. The generation of stable mammalian cell lines for recombinant 
protein production enables the robust expression in various settings from small scale batch 
cultures to large scale bioreactors. Stable cell line development however is a very 
time-intensive process that requires extensive screening for high producer clones after 
random integration of the gene of interest into the host genome. Another challenge 
structural biologists are confronted with are complex heterogeneous glycosylation pattern 
on the protein surface. These interfere in proper crystal formation and thus diffraction 
analysis. The use of glycosylation mutant cell lines such as CHO Lec3.2.8.1, that express a 
uniform glycosylation profile of the high mannose type (GlcNAc2Man5), address this 
problem. To improve the soluble expression of recombinant proteins various strategies can 
be pursuit. This includes the expression of truncated and chimeric constructs as well as the 
co-expression of multi-protein complexes and molecular chaperones. 
In this work the glycosylation deficient cell line CHO Lec3.2.8.1 was used to create a fast 
method to generate stable producer cell lines that co-express target genes at 
pre-characterized chromosomal loci. Binary CHO Lec3.2.8.1 master cell lines, stably tagged 
with two different exchange cassettes comprising fluorescent marker genes, were 
established during this work. Targeted integration of recombinant genes into these 
pre-defined genomic loci using recombinase mediated cassette exchange (RMCE), based on 
the Flp/FRT system, enables the fast generation of stable producer cell lines with 
predictable expression properties. 
This binary system was used to generate producer cell lines for the expression of Toll-like 
receptor ectodomains in combination with molecular chaperones. 
    INTRODUCTION 
 3  
1 Introduction 
1.1 Recombinant protein expression 
The importance of protein function in biological systems is evident by their diverse roles in 
all cellular processes. Proteins do not only provide a structural matrix but are also directly 
or indirectly involved in catalytic processes, cellular signalling, transport and storage as 
well as the immune defence and cell-cell interactions (Alberts, 2008). Protein aberrations 
due to genetic mutations can lead to malfunctioning of one or more cellular processes 
resulting in a multitude of phenotypes with different levels of severity e.g. haemoglobin 
disorders (Weatherall, 2004), neurodegenerative diseases (Chiti et al., 2006) and cancer 
(Frank, 2004). Therefore, the elucidation of protein structure and function is essential for 
the understanding of biological processes which will aid in the development of 
therapeutical coping strategies. 
The historically important protein insulin was not only the first protein to be sequenced 
(Sanger, 1949) but also the first recombinant drug brought onto the market after its 
successful recombinant expression in Escherichia coli (Goeddel et al., 1979). This eliminated 
the need for cumbersome extraction from natural sources and met the increasing demands 
with a qualitatively superior product. Since its initial use (Cohen et al., 1973) recombinant 
deoxyribonucleic acid (DNA) technology evolved to a diverse tool for researchers as well 
as for the life science industry.  Recombinant proteins can now be manipulated to display 
specific properties such as improved solubility, expressibility and affinity to 
chromatographic resins using fusion-tags (Malhotra, 2009). Single domains, truncated and 
chimeric proteins can be generated (Hudson et al., 2003, Jin et al., 2008) as well as completely 
engineered proteins which do not occur naturally such as bispecific antibodies (Hudson et 
al., 2003). Codon optimisation can be used to aid expressibility in different hosts (Angov et 
al., 2008) and posttranslational modifications (PTM) can be optimized to influence a variety 
of functions including plasma-half life, system clearance and protection from immunogenic 
reactions (Walsh et al., 2006).  
As specified before, the elucidation of protein structures is important. Since the first protein 
structures were obtained for myoglobin (Kendrew et al., 1958) and haemoglobin (Muirhead 
INTRODUCTION 
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et al., 1963), over 100,000 more entries were deposited in the Protein Data Bank (PDB) to 
date.  The continued development of new and improved expression systems, recombinant 
engineering and technical tools results in the constant release of new structures that 
contribute to a more holistic picture of cellular mechanisms. Nonetheless, recombinant 
protein expression for structural biology applications is confronted with major bottlenecks. 
For one, the soluble expressibility of protein is limited particularly for complex protein 
structures. Moreover, heterogeneity resulting from complex glycosylation patterns makes 
it difficult to obtain well diffracting crystals. Properties that influence protein expression 
and crystallization are strongly impacted by the choice of expression system used for 
heterologous protein production. So far bacterial expression hosts like E. coli are most 
commonly used due to their inexpensive and uncomplicated technical and cultivation 
requirements which makes them easy to handle. However, prokaryotes lack the secretory 
pathway present in eukaryotes and thus the machinery necessary for PTMs. This results 
often in incorrectly folded non-functional protein that accumulates in inclusion bodies. 
Even though refolding procedures can be attempted, these are not always successful. Thus 
the limit of bacterial expression systems is reached at this point for many protein targets. 
Therefore the use of eukaryotic expression systems becomes more and more widespread. 
While heterologous expression in yeast is still considered as relatively inexpensive the costs 
of insect and mammalian systems are elevated due to complex media requirements. In 
comparison to bacterial systems insect and mammalian systems are time-consuming 
particularly when generating stable cell lines (Villaverde et al., 2003, Aricescu et al., 2006, 
Nettleship et al., 2010, Aricescu et al., 2013). 
1.2 Glycosylation – friend or foe 
In this work the focus lies on the production of difficult to express protein targets for 
structural biology. The importance and drawbacks of glycosylation for structural biology 
as well as approaches that deal with protein glycosylation are described in this chapter. 
Roughly 50 % of proteins found in humans are glycosylated which highlights the central 
role of glycosylation for biological function. Deficiencies in the glycosylation pathway are 
associated with medical condition such as congenital disorders of glycosylation (CDG) 
including mucolipidosis II or Walker-Warburg syndrome (Freeze, 2006). However, at the 
same time glycoform variations can be used as disease markers for the diagnostic 
determination of medical conditions (Walsh et al., 2006). Protein glycosylation regulates 
    INTRODUCTION 
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structural stability, proper folding, endosomal trafficking, proteolytic processing and 
protein solubility.  Glycan patterns also influence protein-protein interactions and in vivo 
protein functions such as signal transduction, functional activity, immunogenicity, 
bioavailability, biodistribution and pharmacokinetics. Glycosylation patterns are divided 
into N-linked and O-linked glycans which are either connected to nitrogen atoms of 
asparagine residues comprising an Asn-X-Ser/Thr motif or hydroxyl groups of serine or 
threonine residues respectively. N-linked glycosylation is initiated through the attachment 
of branched glycan precursors in the endoplasmic reticulum (ER) which are further 
modified when passing the Golgi apparatus whereas O-linked glycosylation takes place 
through the sequential attachment of single N-Acetylgalactosamine (GalNAc) 
monosaccharaides. While O-linked glycosylation sites are less problematic for structural 
biology applications as they are mostly found in extended, unfolded serine-, threonine- and 
proline-rich regions of proteins. N-linked glycosylation poses a problem as it interferes with 
protein crystallization and diffraction. However, N-linked glycosylation sites are known to 
be relevant for glycan-protein interactions and the protection of hydrophobic regions and 
thus cannot be dismissed as easily (Walsh et al., 2006, Chang et al., 2007, Croset et al., 2012). 
Therefore glycosylation deficient cell lines such as CHO Lec3.2.8.1 or HEK293-GNTI- cells 
which only express truncated glycan patterns (Stanley, 1989, Reeves et al., 2002) as well as 
glycosylation inhibitors are employed. N-glycosylation can be inhibited by the presence of 
kifunensine which inhibits mannosidase I (Elbein et al., 1990) or swainsonine which inhibits 
lysosomal α-mannosidase (Elbein et al., 1981) or N-butyl-deoxynojirimycin (NB-DNJ) 
which inhibits α-glucosidase during expression. The truncated glycan chains attain a 
sensitivity for enzymes including endoglycosidase (endo) H or endo F1 leaving a single 
N-Acetylglucosamine (GlcNAc) residue. Butters et al., (1999) demonstrated that the 
combined use of CHO Lec3.2.8.1 cells with ND-DNJ improved the deglycosylation 
efficiency of glycoproteins with endoH from 12 % to almost 100 %. Finally, if all N-linked 
glycans shall be removed peptide-N-glycosidase F (PNGase F) will do so. However 
PNGase F will also convert the asparagine side chain-residue to aspartate which might 
negatively affect protein interactions and thus often results in the aggregation of the protein 








cells of  the paucimannose  type and hyper‐mannosylated yeast  cells.  (Right) Truncated N‐glycosylation profiles are 




Mammalian expression systems become more popular as an alternative to bacterial 
expression hosts as well as other eukaryotic systems including insect and yeast platforms. 
This is due to their ability to process the most genuine glycosylation pattern and the 
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availability of the cellular folding machinery necessary for complex human target proteins. 
Those advantages ease the approval of biopharmaceuticals by regulatory agencies as well 
as the soluble expression and proper folding of proteins for structural biology applications. 
However, complex glycan structures need to be removed before crystallization. 
Alternatively, mutant cell lines with truncated glycosylation profiles for structural biology 
can be employed. Therefore, the glycosylation mutant cell line CHO Lec3.2.8.1 was used to 
generate stable master and producer cell lines for the co-expression of demanding target 
proteins during this work.  For the transient screening of constructs and small scale test 
expressions HEK293-6E cells were utilized.  
Transient and stable protein expression in mammalian cell lines was optimized in the last 
years as described in the following chapters (Durocher et al., 2002, Aricescu et al., 2006, 
Nettleship et al., 2010). Transient expression in Human embryonic kidney (HEK) cells is 
commonly used for construct screening in small scale formats. Chinese hamster ovary 
(CHO) cells on the other hand are generally used for the generation of stable producer cell 
lines which enables rapid scale-up in bioreactors and repeatable protein production. 
Detailed information on HEK and CHO cells used for transient and stable protein 
expression are given in the following chapters. 
1.3.1 Transient protein expression in HEK293 cell lines 
HEK293 cell lines are most commonly used for the transient expression of proteins. In our 
lab the transient expression in HEK293-6E cells, described below, is established and 
routinely used. HEK293 cells were originally derived from HEK cells transformed with 
sheared adenovirus type 5 DNA (Graham et al., 1977). HEK293 derivative cell lines 
followed, including HEK293T cells expressing the simian virus 40 (SV40) large T-antigen 
(Lebkowski et al., 1985) and HEK293-EBNA cells expressing the Epstein-Barr virus (EBV) 
Epstein-Barr nuclear antigen 1 (EBNA-1) (Young et al., 1988). These allow episomal 
amplification of plasmids containing the viral SV40 or EBV origins of replication SV40 ori 
and oriP respectively. As a result, a larger copy number of plasmid is retained within the 
cell during expression which improves protein yields (Schlaeger et al., 1999, Aricescu et al., 
2006). Yates et al., (2000) demonstrated more specifically that the components DS (dyad 
symmetry) and FR (family of repeats) within oriP comprise several EBNA-1 binding sites 
which function as replicator and retain plasmids during cell division respectively after 
binding of EBNA-1. Furthermore it was shown that the replicator DS only requires two 
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EBNA-1 binding sites for proper functioning (Yates et al., 2000). HEK293-6E is a 
HEK293-EBNA cell line which expresses a truncated version of the EBNA-1 protein 
(Durocher et al., 2002). HEK293-6E cells were used in this work for the transient expression 
and screening of protein targets before the generation of stable glycosylation mutant 
CHO Lec3.2.8.1 cell lines since HEK293-6E cells are already routinely used in our 
laboratory. However, glycosylation mutant HEK293-GnTI- cells unable to synthesise 
complex N-linked glycans due to the lack of N-acetylglucosaminyltransferase are also 
available and only express homogenous Man5GlcNAc2 residues on the glycoprotein surface 
(Reeves et al., 2002, Chaudhary et al., 2012). 
Transient expression protocols for HEK293 cell lines were optimized over the years as an 
alternative to laborious stable cell line generation. The improvement of protein yields, 
downstream processing and transient scalability as well as the reduction of cultivation 
related costs for adherent culture methods and the setup of high-throughput (HTP) 
applications were addressed. The use of inexpensive transfection reagents such as calcium 
phosphate (CaPi) or polycationic linear and branched polyethylenimine (PEI) were 
explored and improved over the years. In this work suspension adapted HEK293-6E cells 
were used for transient test expressions in batch culture before the generation of stable 
CHO Lec3.2.8.1 production cell lines. The HEK293-6E cells were cultivated under serum 
free conditions (Meissner et al., 2001) and transfected with 25 kDa liner PEI with prior 
DNA:PEI complex formation (Schlaeger et al., 1999, Durocher et al., 2002). Nonetheless, it 
was demonstrated that the use of high cell densities (20x106 cells/mL) during transfection 
without prior complex formation (Backliwal et al., 2008) can yield equally high results. Even 
though CaPi co-precipitation is an equally efficient method for the transient transfection of 
HEK cells compared to PEI, the presence of foetal calf serum (FCS) during transfection is a 
major drawback for large scale applications as it requires the removal of serum through 
complete medium exchange (Baldi et al., 2005). Furthermore, the supplementation with 
valproic acid five days after transfection was used to improve transient protein expression 
during this work. It was shown that supplementation with valproic acid a histone 
deacetylase inhibitor was used to obtain volumetric yields up to 1 g/L of recombinant 
antibody (Backliwal et al., 2008). The inhibition of histone deacetylases increases the level 
of histone acetylation and thus endorses a relaxed conformation in the chromatin structure. 
This results in higher transcription levels and thus increased protein yields (Kazantsev et 
al., 2008).  
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Transient transfection in various suspension adapted HEK293 cell lines is now used for 
HTP screening of protein constructs in small scale multiwell formats with subsequent 
purification (Davies et al., 2005) and crystallisation (Lee et al., 2009) as well as large scale 
expression in WaveTM bioreactors (Geisse et al., 2005, Chaudhary et al., 2012). Nevertheless 
the use of adherent HEK293T and HEK293-GNTI- cells for transient transfection was also 
optimized for economic construct screening in T-flasks and consequent expansion into 
roller-bottles for protein production. Through the adaption to affordable culture media 
(Dulbecco’s Modified Eagle’s Medium, Sigma), costs were reduced significantly and are 
extensively used until today for medium scale applications (Aricescu et al., 2006). Moreover, 
automated sterile systems, such as the CompacT SelecT cell culture robot, enable the 
transient transfection in adherent HEK293T and HEK293-GnTI-. Thus, user-specific 
variations during the time-consuming manual handling and transfection steps are 
eliminated and allow the continuous cultivation of backup cells and transient protein 
production (Zhao et al., 2011).  
1.3.2 Stable protein expression in CHO cell lines 
Since the first clinical approval of a recombinant biopharmaceutical produced in CHO, 
namely human tissue-type plasminogen activator (Kaufman et al., 1985),  CHO cells became 
the most commonly used cell line for stable protein production in the biopharmaceutical 
industry in which 70 % of protein targets are expressed. Cellular processes in CHO cells 
were genetically engineered over the years to exhibit specific properties such as improved 
glycosylation pattern, proper gene amplification, reduced lactate production, resistance 
against apoptosis and the adaptation to suspension culture. Methodological developments 
including expression vector design, advanced cloning procedures, codon optimization, 
superior transfection protocols, improvement of stable integration and clonal selection 
methods as well as process improvements such as the optimization of media formulations, 
feeds, additives,  pH, temperature and bioreactor design were brought forward to enhance 
growth and expression properties (Datta et al., 2013). Recent advances in the deciphering of 
the CHO and CHO-K1 genomic sequence (Wurm et al., 2011, Xu et al., 2011, Lewis et al., 
2013) as well as proteome, secretome (Baycin-Hizal et al., 2012), transcriptome (Becker et al., 
2011), glycome (North et al., 2010, Tep et al., 2012) and metabolome (Dietmair et al., 2012) 
open new doors for metabolic and proteomic engineering. 
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CHO cells were originally isolated by Puck et al., (1958) as an alternative to the malignant 
tissues derived cell lines available at that time. The low chromosome number of Chinese 
hamsters 2n=22 made them an attractive choice for genetic studies (Puck et al., 1958). 
Several CHO derived cell lines are currently employed for protein production. For example 
subclone CHO-K1 (Kao et al., 1968) and CHO DHFR-deficient cells (dhfr-) that lack 
dihydrofolate reductase (DHFR) activity that usually converts dihydrofolate to 
tetrahydrofolate which is required for the de novo synthesis of purines (Urlaub et al., 1980). 
CHO-dhfr- cells are used in combination with methotrexate (MTX) a DHFR antagonist 
which blocks residual DHFR activity to select cells that regain DHFR activity through 
co-amplification of the dhfr gene supplied on the expression vector (Kim et al., 1998).  
To produce demanding protein targets for structural biology applications CHO Lec3.2.8.1 
cells were used for the generation of stable master and producer cell lines in this work. 
Glycosylation deficient CHO Lec3.2.8.1 cells are used when glycoproteins are desired with 
a minimum of heterogeneity in there glycosylation pattern. Stanley, (1989) isolated the 
CHO Lec3.2.8.1 cell line through sequential screening against several plant lectins from the 
Pro-Lec3.6B mutant cell line derived from the CHO cell line Pro-5. Resistance against a 
number of plant lectins, which were the consequence of reduced cell surface binding of 
those lectins, accounted for several glycosylation deficient phenotypes with a cumulative 
effect thus resulting in highly truncated and uniform glycosylation patterns.  The lectin 
resistant mutation Lec1 accounts for a lack in N-acetylglucosaminyltransferase-1 activity, 
whereas the Lec2 and Lec3 phenotypes exhibit reduced transport of CMP-sialic acid into 
the Golgi lumen. Similarly the Lec8 phenotype shows reduced transport of UDP-galactose 
into the Golgi lumen (Stanley, 1989).  
The generation of stable cell lines (Figure 1-2) follows a specific order; random integration 
of the gene of interest (GOI) into the host chromosome is followed by a selection method of 
choice. Popular selection methods include the use of the DHFR system described 
previously which is based on the rescue of a defective nucleotide metabolism through the 
over-expression of the enzyme DHFR (Urlaub et al., 1980, Kim et al., 1998) or the glutamine 
synthase (GS) system which similarly compensates for the lack of glutamine in culture 
media through the over-expression of GS thus strengthening the glutamine synthase 
pathway.  Methionine sulfoximine (MSX) a GS inhibitor is used to increase selection 
stringency (Cockett et al., 1990). Alternatively resistance against antibiotics can be prompted 
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through the integration of bacterial genes such as neo or puro. The puro gene is a codon 
optimized version of Pac with reduced CpG (C-phosphate-G) motives and thus is less 
affected by epigenetic silencing in mammalian cells. These encode neomycin 
phosphotransferase and puromycin N-acetyl transferase respectively rendering the cell line 
resistant to G418 or puromycin (Southern et al., 1982, Vara et al., 1986, InvivoGen, 2014). 
After random chromosomal integration, of a recombinant gene and initial selection 
procedures, several time-consuming rounds of extensive labour-intensive screening are 
required to isolate stable isogenic high producer cell lines. To reduce development costs 
and time in a pipeline that result from clonal screening and isolation, HTP automated 
platforms were established in industrial setups (Shi et al., 2011). This HTP platform 
combines fluorescence-activated cell sorting (FACS) as well as imaging and liquid handling 
systems and thus allows screening of up to 10,000 clones in one run (Shi et al., 2011).  In this 
PhD thesis fluorescent marker genes were used for the isolation of stable CHO Lec3.2.8.1 
master cell lines via FACS whereas the resistance genes neo or puro were used for the 
isolation of stable producer cell lines. 
Following random genomic integration within a transfected population of cells, expression 
level between distinct cells of this population can vary strongly depending on the number 
of transgene integrations and chromosomal integration sites (position effect). While 
chromosomal integration into the loosely packed euchromatin favours protein expression, 
integration into dense inactive heterochromatin does not (Wurm, 2004). Therefore clonal 
isolation of single cell derived or phenotypically homogenous high producer cell lines from 
the initially obtained pool of transfected cells is necessary to obtain isogenic clones with 
constant expression level. However, even after the isolation of producer cell lines, 
inter-clonal variation can be observed within these clonal isolates (Kim et al., 1998, Liu et al., 
2006, Kaufman et al., 2008, Pilbrough et al., 2009). These differences are attributed to genetic 
mosaicism that results from specific cell intrinsic variations as well as gradual termination 
of gene expression due to silencing effects that result from epigenetic downregulation of 
exogenous DNA. To circumvent epigenetic silencing cis-regulatory elements such as 
scaffold/matrix attachment regions (S/MARs) or ubiquitous chromatin opening elements 
can be used to flank the GOI (Wurm, 2004). Furthermore additives such as butyrate (Davie, 
2003) or valproic acid (Backliwal et al., 2008) which block histone deacetylase activity can 
be employed to boost protein expression. Moreover, it was shown that the methodology 
used for the isolation of isogenic clones does play a role in the constancy of homogenous 
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expression. For example Liu et al., (2006) demonstrated that the removal of selective 
pressure after clonal isolation can result in epigenetic silencing which was further 
confirmed by Kaufman et al., (2008) who compared the use of drug-based selection pressure 
to FACS. Thus clonal isolates obtained through cell sorting were shown to exhibit a higher 
degree of uniformity (Kaufman et al., 2008). Nevertheless, the use of FACS for the isolation 
of producer cell lines with a high level of fluorescence can also result in heterogeneity due 
to non-genetic random stochastic fluctuations in expression during clonal isolation.  Thus 
a population of isolated high producers may also contain cells with lower expression 
profiles that were temporary present within the isolated gate. This results in the co-isolation 
of cells with a lower production yield. These low producer subpopulations may outgrow 
the high producers over time. Vice versa when isolating producer cell lines with a low level 
of fluorescence these might be outgrown from high producers (Pilbrough et al., 2009). To 
ease the generation of homogenous high producer cell lines and cut down development 
times, targeted integration approaches for stable cell line development are being pursuit 




and extensive  screening  for high producers before  large  scale production and process optimization.   Adapted  from 
Wurm, (2004). 
1.4 Stable cell line development through targeted integration 
In this work the generation of stable CHO Lec3.2.8.1 producer cell lines is based on targeted 
integration with site-specific recombinases (SSR). Site-specific recombination as well as 
alternative approaches towards targeted integration are described below.   
Site-specific targeted integration methods including nuclease based methods such as the 
zinc-finger nuclease (ZFN) system, the transcription activator-like effector nucleases 
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(TALEN) system and the clustered, regulatory interspaced, short palindromic repeats 
associated (CRISPR/Cas) system were developed to enable efficient genomic alterations as 
an alternative to homologous recombination (HR). While ZFNs and TALENs employ 
linked arrays of proteomic DNA-binding domains which each recognize specific bases of a 
desired DNA sequence to guide their chimeric nuclease to a specific chromosomal location, 
DNA targeting of one or more loci with the CRISPR/Cas system is mediated by RNA using 
base-pairing. Sequence-specific targeting is followed by the introduction of DNA 
double-strand breaks (DSBs) which are repaired by the cellular machinery using either non-
homologous end joining (NHEJ) or homology-directed repair (HDR) which either leads to 
the insertion or deletion of DNA sequences. Particularly ZFNs have been used for in vivo 
gene-knockouts, replacements or repair in gene therapy as an alternative to gene silencing 
(Gaj et al., 2013, Sander et al., 2014). However, neither ZFNs, TALENs nor CRISPR are ideal 
for stable cell line development with the aim of high yield recombinant protein production 
as this would require specific knowledge of genomic loci within an expression host which 
is not yet available. Transposon based methods such as Sleeping Beauty (SB) or piggybac 
similarly to nuclease based methods are used for in vivo modifications of animal models 
and cell culture applications. Chromosomal integration is targeted to naturally occurring 
sites with specific insertion pattern for each transposon. However, even though integration 
is directed it may occur in several transcriptionally active or inactive sites (Ivics et al., 2010). 
Nevertheless the use of piggyBac for protein expression was demonstrated for mixed stable 
populations (Li et al., 2013). To target a GOI at a pre-characterised genomic locus with 
predictable protein expression level, site specific recombinases (SSR) are the method of 
choice for stable cell line development as they do not require previous knowledge of a 
genomic locus but still enable the generation of isogenic cell lines. 
Site-specific recombination systems are commonly found in bacteria, bacteriophages and 
yeast but not in higher eukaryotes. They catalyse DNA integration, excision/resolution or 
inversion through site specific recombination between specific DNA sequences. Depending 
on the residue which catalyses the recombination, SSRs are divided into tyrosine-type or 
serine-type recombinases. While the mechanism of tyrosine-type recombinases includes the 
formation of a holiday junction (HJ) intermediate (Figure 1-3), serine-type recombinases 
cause a 180 ° rotation of the substrate DNAs during recombination. According to the 
directionality of their recombination tyrosine-type recombinases are further subdivided 
into unidirectional tyrosine-type recombinases like λ and HK022 integrases which require 
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non-identical recognition sites (attP and attB) or bidirectional tyrosine-type recombinases 
like Cre and Flp recombinase which require identical recognition sites i.e. loxP or FRT 
respectively. Serine-type integrases on the other hand are subdivided according to their 
protein size into small serine-type recombinases which may act in a unidirectional or 
bidirectional manner (e.g. γδ and Tn3 resolvases or Hin and Gin invertases respectively) or 
large serine-type recombinases like ΦC31 and R4 integrases which act in an unidirectional 
way (Hirano et al., 2011). 
 
Figure 1‐3: Mechanism of tyrosine‐type recombinases. Four tyrosine‐type recombinase monomers (e.g. Cre or Flp) 









Since the early 90’s the tyrosine-type recombinases Flp and Cre were employed in 
mammalian cells (O'Gorman et al., 1991, Fukushige et al., 1992). These were further 
optimized (Buchholz et al., 1998, Raymond et al., 2007) and used for tag-and-target (targeted 
integration) and tag-and-exchange (targeted replacement) strategies in in vitro and in vivo 
applications to tailor mammalian genomes. In this work the tyrosine type recombinase Flp 
is used for a tag-and-exchange approach in CHO Lec3.2.8.1 cells via recombinase mediated 
cassette exchange (described in Section 1.4.2).  
1.4.1 Flp recombinase 
The eukaryotic flippase (Flp) recombinase originates from the 2µM plasmid of 
Saccharomyces cerevisiae. Flp binds to Flp recognition target sites (FRT) comprising two 13 bp 
inverted repeats separated by an 8 bp spacer region. A third 13 bp symmetry element was 
shown to be non-essential (Andrews et al., 1985, McLeod et al., 1986) (Figure 1-4). However 
as a yeast protein Flp is active at 30 °C, to adapt it for use in mammalian systems the 
thermodynamic properties of Flp were improved through directed evolution strategies to 
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be active at 37 °C resulting in the mutant Flpe  (Buchholz et al., 1998). Flpe was further 
enhanced by de novo synthesis of the mouse-codon optimised Flpo variant (Raymond et al., 
2007) which was shown to be 5x more active than Flpe in murine embryonic stem cells 





In 1994 the engineering of mutant FRT sites (FRTmut) for use in tag-and-exchange 
applications began to further expand the Flp/FRT toolbox. Using PCR based mutagenesis  
the 8 bp spacer region was modified to obtain 5 different FRT mutants (FRT1-5) (Schlake et 
al., 1994). This list of FRT mutants was later expanded by Turan et al., (2010) and examined 
for cross-interaction and self-recognition potential (Table 1-1). The FRT sites FRTwt, FRT3, 


















RMCE based targeted integration was used for the generation of stable producer cell lines 
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Random integration of gene targets into chromosomal loci can result in unpredictable gene 
expression as the genomic environment as well as the co-introduction of prokaryotic vector 
sequences may cause epigenetic silencing. The use of SSRs in tag-and-target and 
tag-and-exchange systems enabled the targeted integration into a previously characterized 
genomic locus to obtain suitable expression profiles. Tag-and-target systems based on the 
Flp/FRT system employ one FRT site to integrate a GOI into a tagged locus (Flp-in) 
(O'Gorman et al., 1991). The Flp-in system was also commercialised by Invitrogen which 
now offers an array of cell lines for targeted exchange projects (Invitrogen, 2010). A 
variation of the Flp-in system, the Flp-mediated DNA integration and rearrangement at 
prearranged genomic targets (FLIRT) system was introduced by Huang et al., (1997). The 
FLIRT system employs two tandemly oriented homospecifc FRT sites which can be used to 
flank a marker gene, tag a cell line and remove the marker gene again using a Flp-out 
reaction leaving only one FRT site in the genome. This single FRT site in turn can be used 
for the Flp-in reactions of a transgene into this specific chromosomal locus. However, 
during Flp-in reactions prokaryotic elements are still co-introduced which potentially 
induces epigenetic silencing. As a Flp-in reaction results in the GOI being flanked with two 
unidirectional homospecifc FRT sites, the reverse reaction (Flp-out) will be catalysed if 
recombinase activity should be persistent i.e. through random integration of the 
flippase-vector (Oumard et al., 2006, Turan et al., 2011). Therefore Schlake et al., (1994) 
introduced a tag-and-exchange strategy, RMCE, which utilises a combination of wild type 
FRT and mutant FRT sites flanking a selection marker. The use of heterospecific FRT sites 
enabled the double-reciprocal crossover between a donor vector containing the GOI and a 
genomic exchange cassette with a compatible set of heterospecific FRT sites.  Thus a single 
copy of a GOI without any prokaryotic elements could be integrated into a predefined 
genomic locus. RMCE has been used by several groups for the generation of master cell 
lines in embryonic stem (ES) cells (Seibler et al., 1998), CHO-K1, HEK293 (Nehlsen et al., 
2009), CHO (DUXX-B11) (Mayrhofer et al., 2014), CHO Lec3.2.8.1 (Wilke et al., 2011) and 
Spodoptera frugiperda 9 (Sf9) cells (Fernandes et al., 2012). Industrial applications of the 
Flp/FRT based RMCE system in CHO cells were described (Rehberger et al., 2013). 
Similarly loxP and FRT sites can be used in combination (Froxing) if a non-reversible 
approach is desired (Lauth et al., 2002). A strategy which combines the use of different FRT 
variants in an inverse oriented homospecifc fashion as well as loxP variants is the 
flip-excision (FlEx) system. FlExing introduces an inversely oriented GOI together with a 
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correctly oriented marker gene in the first round of recombination.  In the second round of 
recombination the GOI and the marker gene are turned around thus reversing their 
expressible status (Schnütgen et al., 2003, Schnütgen et al., 2005).  The Flp/FRT system was 
further brought forward by Turan et al., (2010) which generated additional FRT mutants 
and evaluated their capability for self-recognition and level of cross-interaction to enable 
their simultaneous use to the classic FRT3/FRTwt combination. The identification of 
compatible sets of heterospecific FRT sites enabled the use of multiplexing which targets 
two distinct chromosomal exchange cassettes in parallel. To obtain functional FRT mutants 
the three rules listed in Table 1-2  needed to be considered when mutating the 8 bp spacer 
region of a FRT site. Alternative approaches for the integration of two transgenes in distinct 
loci using a combination of the Flp/FRT and the ФC31/attP system were demonstrate in 
HEK293 cells (Waldner et al., 2011). An overview of Flp/FRT based methods is shown in 
Figure 1-5. 
Table 1‐2: Traditional rules determining FRT interaction potential (Turan et al., 2010)  
    Sequence  AT content 
Rule 1  No major interruptions of the 5’‐polypyrimidine‐tracts may occur  5’-TCTAGAAA-3’ 
3’-AGATCTTT-5’ 
75 % 
Rule 2  Bordering base pairs of the spacer sequence must be unchanged  5’-TCTAGAAA-3’ 
3’-AGATCTTT-5’ 
75 % 





homospecific  FRT  sites which  for example are utilized  in  the FlEx  system  (described  in  the  text).  (B) Equi‐oriented 
homospecific  FRT  sites  on  the  other  hand  catalyse  integration  or  excision  reactions.  Insertion  is  prompted  against 
thermodynamic  and  kinetic  hindrances  (Flp‐in) whereas  entropy  driven  excision  (Flp‐out)  reactions  are  favoured  if 
recombinase activity persists. The FLIRT  system  (described  in  the  text)  is based on  the Flp‐in/Flp‐out  system. One 
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1.4.3 The use of FACS for stable cell line development 
In this work RMCE is used for the targeted integration of transgenes. No matter which 
method is chosen for targeted integration, the appropriate isolation of master cell lines 
needs to be put into consideration.  The importance of proper master cell line selection and 
isolation was highlighted by Liu et al., (2006). Not only should cell lines be screened for 
locus integration but also for homogenous unenforced expression to ensure long-term 
stability if selective pressure was used for clonal isolation which may otherwise result in 
heterogeneous expression level as well as epigenetic silencing. Qiao et al., (2009) even 
suggested two rounds of RMCE following FACS. The first after genomic tagging of the 
master cell lines and one after a successful round of RMCE to isolate master cell lines with 
the desired phenotype and reusable high expressible loci. Thus FACS based methods are 
the most suitable for the isolation of master cell lines when avoiding drug selection marker. 
The use of fluorescent marker genes for the FACS based isolation of cell lines was 
demonstrated by several groups. For example Mancia et al., (2004) separated a eGFP marker 
gene with an internal ribosomal entry site (IRES) element from the GOI to avoid direct 
proteomic linkage which would otherwise require eGFP removal after purification. 
Likewise the direct connection of a fluorescent marker gene to the GOI can be circumvented 
when using a modified version of the FLIRT system. If a fluorescent marker gene flanked 
with homospecifc FRT3 sites is followed by the GOI during genomic tagging, the fluorescent 
marker gene can be removed after clonal isolation of a high producer cell line through 
Flp-mediated excision (Kaufman et al., 2008, Wilke et al., 2010). Renschler relies entirely on 
FACS for the isolation of RMCE master cell lines (Master TurboCellsTM) that contain an 
eGFP marker flanked with heterospecific FRT sites as well as on the isolation of producer 
cell line (Producer TurboCellsTM) pools that are 90-99% eGFP negative (Rehberger et al., 
2013). However many groups successfully employ selection traps for the isolation of 
producer cell lines (Nehlsen et al., 2009, Wilke et al., 2011, Fernandes et al., 2012). In this 
work fluorescent marker genes are used for the isolation of CHO Lec3.2.8.1 master cell lines 
after genomic tagging. An introduced selection trap than is used for the isolation of 
producer cell lines after successful RMCE to isolate stable producer cell lines.  
1.4.4 pFlp‐Bac‐to‐Mam exchange vectors 
The multi-host vector pFlp-Bac-to-Mam (pFlpBtM) and its derivative pFlpBtM-II were 
developed in our group to enable the fast screening of protein constructs in several 
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expression hosts (Meyer, 2012, Meyer et al., 2013). In this work pFlpBtM vectors were used 
as exchange vectors for the generation of stable CHO Lec3.2.8.1 producer cell lines and as 
expression vectors in HEK293-6E cells. For the RMCE based generation of stable 
CHO Lec3.2.8.1 producer cell lines pFlpBtM vectors comprise heterospecific FRT sites 
flanking a GOI as well as a phosphoglycerate kinase (PGK) promoter and a start codon 
which activates a selection trap in the previously tagged chromosomal locus upon 
successful integration (Wilke et al., 2011). For the transient expression in HEK293-6E 
(Durocher et al., 2002) pFlpBtM vectors comprise the EBV origin of replication as well as a 
cytomegalovirus (CMV) promoter. All pFlpBtM based vectors can also serve as donor 
vectors for the generation of recombinant bacmids using the MultiBac system. Those 
bacmids can be utilised for baculovirus expression vector system (BEVS) based protein 
production in insect hosts (Berger et al., 2004, Fitzgerald et al., 2007). Detailed information 
on the generation and evaluation of pFlpBtM vectors was described previously (Meyer, 















In this work eGFP (enhanced green fluorescent protein) and tdTomato (tandem dimer 
Tomato) were used as fluorescent markers in the establishment of a binary RMCE system 
in CHO Lec3.2.8.1 cells. Their presence within the stably integrated exchange cassettes for 
one allowed the FACS based isolation of master cell lines. On the other hand successful 
exchange of fluorescent marker genes against target genes enabled the identification of 
producer cell lines using flowcytometry and fluorescence microscopy. As shown in 
Figure 1-7 the emission spectra of eGFP and tdTomato can be distinguished accurately 
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which is important for their differentiation when used in parallel in the same system. 
Moreover, tdTomato was used as a model protein to evaluate the newly established binary 
RMCE system. tdTomato was integrated into “single” RMCE master cell lines (contain only 
exchange locus 1 with eGFP) and binary RMCE master cell lines (contain both loci)  using 
RMCE. The specific expression capabilities of each locus were determined and correlated 
to the binary RMCE system.    
Fluorescent proteins are extensively used in the life sciences community for an array of 
applications in living cells, tissues and imaging. Information about the cellular localization, 
movement and thus function of proteins as well as cell, tissue and nucleic acid labelling can 
be gathered. Green fluorescent protein (GFP) family proteins are approximately 25 kDa in 
size with a length of 220-240 amino acid. They comprise a β-barrel structure and have a 
tendency to oligomerize which prompted the development of monomeric forms 
(Chudakov et al., 2010). The existence of GFP was first reported by Shimomura et al., (1962) 
in the jelly fish Aequorea aequorea. 30 years later Prasher et al., (1992) cloned and determined 
the first sequence of a Aequorea victoria derived gfp gene which laid the basis for its use as a  
fluorescent marker in prokaryotic and eukaryotic cells as shown by Chalfie et al., (1994). 
Mutations within the gfp gene gave rise to GFP variants with increased sensitivity level as 
for enhanced GFP (eGFP) (Cormack et al., 1996) or fluorescent shifts as for cyan and blue 
fluorescent protein (CFP/BFP) (Heim et al., 1994, Heim et al., 1996). Later on the red 
fluorescent GFP homologue from the mushroom coral Discosoma sp. DsRed was isolated 
(Matz et al., 1999) and served as basis for directed evolution to obtain monomeric red 
fluorescent protein-1 (mRFP1) (Campbell et al., 2002). Further directed evolution efforts of 
mRFP1 gave rise to an array of fluorescent proteins including mCherry, mHoneydew, 
mBanana, mOrange, mTangerine and mStrawberry (Shaner et al., 2004), whereas directed 
evolution of the faster maturing DsRed.T1 variant (Bevis et al., 2002) gave rise to dimer 
(d)Tomato which was further modified to avoid aggregation by fusing two copies together 
to obtain tandem dimer (td)Tomato (Shaner et al., 2004).  
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The binary RMCE system in CHO Lec3.2.8.1 cells, established during this work, enables the 
co-expression of integrated transgenes at pre-characterized genomic loci. It is expected that 
the co-expression of difficult to express proteins with their molecular chaperones will 
improve the expression of demanding targets. The difficult to express target proteins 
chosen for this work are TLR1, TLR2 and TLR5 (detailed description in Section 1.5.4 and 
Section 1.5.5).  
TLRs received their name due to their conserved homology to the Drosophila melanogaster 
receptor Toll. They are type-I integral membrane glycoproteins and belong to the 
Toll/interleukin-1 (IL-I) receptor (TIR) superfamily. TLRs are usually found in sentinel cells 
including B-cells, macrophages, monocytes, neutrophils or dendritic cells but also in 
non-immune cells like epithelial and endothelial cells. As patter recognition receptors 
(PRRs) TLRs respond to pathogen associated molecular pattern (PAMP) such as pathogen 
derived carbohydrate, peptide and nucleic acid structures and therefore play an important 
role within the innate immune response in the defence against bacterial, fungal, protozoal 
and viral pathogens. Nonetheless, it becomes evident that TLRs also have a purpose in the 
initiation of the adaptive immune response as they regulate T-helper (TH) cell profiles 
through differential binding of their ligands. Furthermore TLRs also recognize 
damage-associated molecular pattern (DAMP), cell-derived non-microbial components 
which are released upon non-programmed cell death.  So far 13 TLRs were identified in 
mammals, 10 of those are present in humans. Depending on their ligand specificity TLRs 
are either located on the cell membrane (TLR1, 2, 4, 5, 6 and 10) or within endosomal 
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compartments (TLR3, 7, 8, 9, 11, 12 and 13). Malfunctioning of the TLR system is associated 
with several clinical pictures; including allergies, cancer and inflammatory diseases as well 
as neurodegenerative and autoimmune disorders. This makes the elucidation of TLR 
signalling pathways, mechanisms and consequently their specific role in innate and 
adaptive immunity essential for translational medical applications (Agrawal et al., 2003, 
Ishii et al., 2005, Barton et al., 2009, Hidmark et al., 2012, Tang et al., 2012, Raetz et al., 2013). 
TLRs are divided into three domains an N-terminal ectodomain (ECD), a single spanning 
transmembrane domain and an intracellular TIR domain responsible for downstream 
signal transduction. The N-terminal ECD adapts a horseshoe-like structure involved in 
ligand recognition. It is composed of 16-28 leucine rich repeat (LRR) modules each 
comprising 24 amino acid residues with conserved “LxxLxLxxN” motives (Figure 1-8). The 
hydrophobic LRR domain is capped with C- and N-terminal disulphide-bonded caps 
(LRR-CT and LRR-NT) which do not comprise any LRR motives and thus protect the 
hydrophobic core from solvent and aid domain stabilisation (Jin et al., 2008).  
TLR signalling follows two different paths; either the myeloid differentiation 
primary-response protein 88 (MyD88)-dependent pathway triggering a nuclear factor 
kappa-light-chain-enhancer of activated B cells (NF-κB) response followed by the 
transcription of inflammatory cytokines or the MyD88-independent pathway triggering 
either a NF-κB response as well as an interferon (IFN) regulatory factor (IRF3) response 
followed by the transcription of IFN-β. Ligand binding initiates the dimerization of TLRs 
accompanied by conformational changes which activate a downstream cascade. In the 
MyD88-dependent pathway the adaptor molecule MyD88 is directly recruited to the TIR 
domains of TLR5, 7, 8, 9 and 11 upon receptor dimerization through homodimerization of 
its own C-terminal TIR domain. The association of MyD88 with TLR2 and TLR4 is bridged 
through the adaptor molecule TIRAP (TIR-domain-containing adaptor protein also known 
as MyD88-adaptor-like protein, MAL). In addition to the MyD88-dependent pathway TLR4 
also employs the MyD88-independent pathway through the adaptor molecules TRIF 
(TIR-domain containing adaptor protein inducing IFN-β) and TRAM (TRIF related adaptor 
molecule). In contrast TLR3 employs only the adaptor molecule TRIF (Akira et al., 2004, 
Liew et al., 2005, O'Neill et al., 2007, Trinchieri et al., 2007). A schematic overview of TLR 
structure and signalling is given in Figure 1-8. 
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To improve the expression of demanding protein targets for structural biology applications 
a binary RMCE system was established in glycosylation deficient CHO Lec3.2.8.1 cells. The 
co-expression of molecular chaperones shall improve the expression of TLR targets. To 
further improve the soluble expression and crystallization properties of TLRs the “hybrid 
LRR technique”, described below, was used in this work. 
To date crystal structqures for TLR ECDs alone or in complex with agonistic or antagonistic 
ligands were solved for TLR1, TLR2, TLR3, TLR4, TLR5, TLR6 and TLR8 (References listed 
in Table 1-3). The soluble expression and crystallization of TLRs however is a major hurdle. 
To tackle this problem Kim et al., (2007) developed the “hybrid LRR technique” to improve 
the soluble expression of TLRs and their protein crystallization properties. The hybrid LRR 
technique uses variable lymphocyte receptor (VLR) fragments attached to one or both 
termini of a TLR ECD construct at conserved “LxxLxLxxN” motives (Figure 1-9).  
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VLRs belong to the LRR family of proteins. They are found in jawless fish (Pancer et al., 
2004) where an abundant array of VLR variants derived from germline genes VLR-A, VLR-B 
(Pancer et al., 2005) and VLR-C (Kasamatsu et al., 2010) regulate adaptive immune 
responses. Crystal structures for inshore hagfish Eptatretus burger VLR-A and VLR-B 
variants were described by Kim et al., (2007). VLRs are “typical” LRR family proteins 
displaying a horseshoe-like structure. Their shape results from conserved asparagine 
ladder and phenylalanine spine structures of the LRR module backbone. This hydrophobic 
core is flanked by protective caps (LRR-NT and LRR-CT respectively). Sequence variations 
are limited to the concave surface where ligand binding occurs (Kim et al., 2007). The hybrid 
LRR technique employs the conserved “LxxLxLxxNxL” motive common to all LRR family 
proteins. Residues annotated with “x” are exchangeable hydrophilic amino acids which are 
exposed at the concave surface of the horseshoe-like structure whereas conserved residues 
are responsible for the structural network (Jin et al., 2008). The hybrid LRR technique was 
shown to maintain the structural integrity of fusion partners and thus enabled the 
truncation of TLR constructs without loss of their protective LRR-NT or LRR-CT caps as 
those were replaced by matching hybrid VLR fragments (Kim et al., 2007).  
The hybrid LRR technique was used to solve crystal structures for TLR4 (Kim et al., 2007), 
TLR1, TLR2, TLR6 (Jin et al., 2007, Kang et al., 2009) and TLR5 (Yoon et al., 2012). TLRs 
interact with protein and non-protein ligands using their concave, lateral or convex surface 
which induces the dimerization of TLR homo- or heterodimers forming a typical “m”-shape 
demonstrated by several crystallographic studies (Jin et al., 2007, Liu et al., 2008, Kang et al., 
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2009, Park et al., 2009, Yoon et al., 2012, Tanji et al., 2013) (Figure 1-10). A list of currently 
available TLR ECD structures with or without bound agonistic or antagonistic ligands is 







Organism  TLR/Complex  PBD ID  VLR Hybrid  Reference 
Human  TLR1‐TLR2‐Pam3CSK4  2Z7X  Yes  (Jin et al., 2007) 
Mouse  TLR2‐mTLR6‐Pam2CSK4  3A79  Yes  (Kang et al., 2009) 
Mouse  TLR2‐lipoteichoic acid  3A7B  Yes  (Kang et al., 2009) 
Mouse  TLR2‐PE‐DTPA  3A7C  Yes  (Kang et al., 2009) 
Human  TLR3  2A0Z  No  (Bell et al., 2005) 
Human  TLR3  1ZIW  No  (Choe et al., 2005) 
Mouse  TLR3/dsRNA  3CIY  No  (Liu et al., 2008) 
Human  TLR3/mAB1068/mAB12/mAb15  3ULV, 3ULU  No  (Luo et al., 2012) 
Mouse  TLR4/MD‐2 complex  2Z64  No  (Kim et al., 2007) 
Human  TLR4  2Z63, 2Z62, 2Z66  Yes  (Kim et al., 2007) 
Human  TLR4/MD‐2/Eritoran  2Z65  Yes  (Kim et al., 2007) 
Human  TLR4‐MD‐2‐LPS dimer  3FXI  No  (Park et al., 2009) 
Mouse  TLR4/MD‐2/Re‐LPS  3VQ2  No  (Ohto et al., 2012) 
Mouse  TLR4/MD‐2/lipid IVa  3VQ1  No  (Ohto et al., 2012) 
Human  TLR4 (D299G/T399I)‐MD‐2‐LPS  4G84  No  (Ohto et al., 2012) 
Zebrafish  TLR5  3V44  Yes  (Yoon et al., 2012) 
Zebrafish  TLR5/FliC  3V47  Yes  (Yoon et al., 2012) 
Human  TLR8/TLR8  3W3G  No  (Tanji et al., 2013) 
Human  TLR8/TLR8/CL097  3W3J, 3W3N   No  (Tanji et al., 2013) 
Human  TLR8/TLR8/CL075  3W3K  No  (Tanji et al., 2013) 
Human  TLR8/TLR8/R848  3W3L, 3W3M  No  (Tanji et al., 2013) 
Human  TLR8/Ds‐877  3WN4  No  (Kokatla et al., 2014) 
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1.5.4 TLR1 and TLR2 
For the co-expression in the binary RMCE system established during this work ECD 
constructs for mTLR1 and mTLR2 were selected. The co-expression with their molecular 
chaperones (described in Section 1.5.6) was predicted to improve the soluble expression for 
both. While crystal structures for TLR1 and TLR2 are already available in complex with 
di- or tri-acylated lipopeptides (Jin et al., 2007, Kang et al., 2009) no structure for TLR1 or 
TLR2 is yet available in complex with a protein ligand. The elucidation of TLR1 and TLR2 
structures in complex with curli fibrils was of interest for collaboration partners and thus 
was selected for the expression in the binary RMCE system.   
TLR1 was first identified by Nomura et al., (1994) as KIAA0012, later on by Taguchi et al., 
(1996) as Toll/Interleukin-1-receptor-Like (TIL) and finally by Rock et al., (1998) as TLR1. 
TLR2 was first identified by Chaudhary et al., (1998) as Toll/Interleukin-1-receptor-Like-4 
(TIL-4) when searching for human Toll homologues and rediscovered together with other 
TLRs by Rock et al., (1998). TLR1 and TLR2 are located on the cell surface of leukocytes, 
dendritic cells (DCs), lymphatic endothelial cells and epithelial cells (Muzio et al., 2000, 
Furrie et al., 2005, Pegu et al., 2008). TLR2, with TLR1 or TLR6 as co-receptor, recognizes 
non-protein ligands including tri-acylated or di-acylated lipopeptides, LPS, lipoteichoic 
acids and zymosan (Jin et al., 2007, Kang et al., 2009). Nonetheless a protein-ligand, CsgA, 
the main component of amyloid-like curli fibrils expressed in a small subset of 
Enterobacteriaceae including Salmonella enterica serotype Typhimurium (S. Typhimurium) 
and E.coli was shown to be a TLR2 agonist (Tükel et al., 2005, Tükel et al., 2009, Oppong et 
al., 2013). In cooperation with TLR1, TLR2 mediates a ligand induced immune response 
upon CsgA recognition (Tükel et al., 2010). A stronger NF-κB response was observed when 
CD14, serving as an accessory protein, binds to curli fibres before TLR2-TLR1 activation 
(Rapsinski et al., 2013). Amyloid formation in bacteria is of biological importance as part of 
the extracellular biofilm matrix. In humans however amyloid formation can cause 
neurodegenerative disorders including Alzheimer’s and Huntington’s disease. These 
phenotypes result from inflammation-mediated tissue damage from amyloid formation 
and deposition (Tükel et al., 2009, Tükel et al., 2010). Interactions of TLR2 with fibrillar 
β-amyloid plaques (fAβ) a component of plaques in Alzheimer’s disease (Jana et al., 2008, 
Udan et al., 2008, Reed-Geaghan et al., 2009, Liu et al., 2012) and serum amyloid A (SAA) 
(Cheng et al., 2008, He et al., 2009) were demonstrated. 
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1.5.5 TLR5 
To begin of this work no crystal structure for TLR5 was yet available. Thus the hTLR5 ECD 
was chosen as a target for the expression in the binary RMCE system. Meanwhile the crystal 
structure for dsTLR5 became available (Yoon et al., 2012). However the expression of human 
TLR5 ECDs was shown to be a real challenge (Hong et al., 2012, Yoon et al., 2012) and thus 
remained a worthwhile target.  
TLR5 was first identified by Chaudhary et al., (1998) as Toll/Interleukin-1-receptor-Like-3 
(TIL-3) when searching for human Toll homologues and rediscovered together with other 
TLRs by (Rock et al., 1998). TLR5 is located on the cell surface of leukocytes, DCs, lymphatic 
endothelial cells and epithelial cells (Chaudhary et al., 1998, Muzio et al., 2000, Miller et al., 
2005, Pegu et al., 2008). So far TLR5 is unique compared to other TLRs as it was shown to 
recognize protein-ligands only, namely bacterial flagellin (Hayashi et al., 2001). However 
only flagellin monomers are recognized by TLR5 as the 13 amino acid binding site of 
flagellin is located within the flagellar filament. Each flagellin monomer comprises 4 
domains (D0, D1, D2 and D3). D1, one of the most conserved domains interacts with TLR5 
(Smith et al., 2003). This was further confirmed through mutation studies within the D1 
domain which eliminated flagellin-TLR5 interactions (Andersen-Nissen et al., 2005) as well 
as the flagellin-dsTLR5 crystal structure (Yoon et al., 2012). The flagellin binding site on 
TLR5 was studied by several groups using truncation, mutation as well as in silico studies 
(Jacchieri et al., 2003, Mizel et al., 2003, Andersen-Nissen et al., 2007). An in silico prediction 
which postulated residues 552-561 as potential TLR5 binding site (Jacchieri et al., 2003) 
could not be confirmed by in vivo studies which narrowed the TLR5 binding site down to 
residues 386-407  including an accessory function of residues 408-425 (Mizel et al., 2003) and 
residues 174-401 (Andersen-Nissen et al., 2007) respectively. The flagellin-dsTLR5 crystal 
structure revealed two primary binding interfaces of dsTLR5 (Yoon et al., 2012) one within 
the experimentally postulated binding sites as well as one located downstream. Moreover 
it was revealed that TLR5 binding affinities within different species vary and thus each 
species recognises and binds a certain set of bacterial flagellins more or less efficiently 
(Andersen-Nissen et al., 2007, Keestra et al., 2008, Metcalfe et al., 2014). Besides its role in 
innate and adaptive immunity in which TLR5 supports MHC class-II presentation of 
flagellin fragments to CD4 T cells (Letran et al., 2011), the therapeutic relevance of TLR5 is 
indicated by its increased presence on breast cancer carcinoma which are highly receptive 
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to TLR5 mediated signal-transduction. Cai et al., (2011) demonstrated that flagellin can 
induce anti-carcinogenic effects as a TLR5 agonist by inhibiting proliferation of 
carcinogenic cells. Nonetheless TLR and cell-type specific differences have been observed 
in tumorigenesis (Cai et al., 2011). 
1.5.6 Accessory proteins – GRP94 and PRAT4A 
The eukaryotic ER chaperone glucose-regulated protein 94 (GRP94) (alias: heat shock 
protein 90b1 (HSP90b1), HSPC4, glycoprotein 96 (gp96), endoplasmin and ERp99) an ER 
paralogue to the cytosolic HSP90 and the chaperone-like ER resident protein, protein 
associated with toll-like receptor 4A (PRAT4A) (alias: canopy FGF signalling regulator 3 
(CNPY3)) were shown to chaperone serval TLRs as described below. In this work mGRP94 
and mPRAT4A were used for the co-expression of mTLR1, mTLR2 and hTLR5 ECDs in the 
binary CHO Lec3.2.8.1 RMCE system. It was anticipated that the co-expression of TLRs 
with molecular chaperones will improve their soluble expression. 
GRP94 is divided into three domains. An N-terminal adenosintriphosphate (ATP)ase 
domain with intrinsic ATPase activity which binds and hydrolyses ATP is separated by a 
non-conserved highly charged intermediate domain from a C-terminal homodimerization 
domain which influences enzymatic activity of the ATPase domain. GRP94 is expressed in 
most cell types and is induced under stress conditions following the accumulation of 
misfolded proteins. (Randow et al., 2001, Liu et al., 2010). The structural basis of GRP94 was 
elucidated by Dollins et al., (2007) for canine (cl)GRP94 (73-754Δ287-327) in complex with 
adenosine diphosphate (ADP) and the non-hydrolysable ATP analogue 
adenylyl-imidodiphosphate (AMPPNP). GRP94 shows a left handed helical twist 
(twisted V) conformation which allows C-terminal domain homodimerization but prevents 
N-terminal homodimerization. A C-terminal client binding site was suggested and later 
confirmed by Wu et al., (2012) which identified a C-terminal loop structure formed by 
amino acid residues 652-678 (Figure 1-11). In contrary to GRP94, PRAT4A shows no 
intrinsic ATPase activity nor does it influence ATPase activity of GRP94 as co-chaperone 
(Liu et al., 2010). Mutation studies demonstrated that PRAT4A interacts differently with 
different TLR clients (Kiyokawa et al., 2008). 
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The use of immune co-precipitation and knockdown studies typically in HEK cells, B-cells 
or macrophages demonstrated that the conformational maturation of TLRs is dependent on 
the ER chaperones GRP94 and PRAT4A which regulate TLR cell surface display or 
trafficking to lysosomes. Randow et al., (2001) demonstrated that GRP94 is not required for 
cell survival even though it represents one of the most abundant ER proteins in a cell. 
However GRP94 was shown to be essential for the regulation of innate immunity as it 
controls cell surface trafficking of TLR1, TLR2 and TLR4. It was observed that the GRP94 
deficient mutant cell line E4.126 derived from murine pre-B-cells (70Z/3) retained expressed 
TLRs within the ER and thus inhibited the response to bacterial toxins including LPS 
(lipopolysaccharide), LTA (lipoteichoic acid) and PGN (peptidoglycan). A few years later 
Yang et al., (2006) demonstrated that the response to TLR ligands is dependent on GRP94 
expression for cell surface TLRs (TLR2, TLR4, TLR5) as well as endosomal TLRs (TLR7 and 
TLR9) using macrophage-specific GRP94-deficient mice.  
The same year Wakabayashi et al., (2006) described another protein which regulates cell 
surface expression of TLRs. PRAT4A associates with the immature hypoglycosylated form 
of TLR4, but not MD-2 or TLR2, thus regulating trafficking of TLR4 in HEK293, B-cells 
and/or DCs. A similar protein which also associates with TLR4, PRAT4B, was identified 
through database analysis as it shares 54 % amino acid sequence with PRAT4A (Konno et 
al., 2006). In contrary to PRAT4A, PRAT4B was shown to be a negative regulator for TLR 
trafficking (Hart et al., 2012). The importance of PRAT4A for innate and adaptive immunity 
was demonstrated by the same group as gene-silencing of PRAT4A inhibits not only the 
trafficking of TLR4 but also TLR1 to the cell surface as well as TLR9 trafficking to the 
    INTRODUCTION 
 31  
lysosome. In contrary to their previous results cell surface trafficking of TLR2 trafficking is 
also down-regulated but not inhibited (Takahashi et al., 2007). Functional loss of TLR4 and 
TLR9 was confirmed by Liu et al., (2010) after PRAT4A knockdown. Furthermore, knock 
down studies of PRAT4A added TLR2 and TLR7 to the list of PRAT4A clients (Liu et al., 
2010) as well as TLR5 (Shibata et al., 2012). 
It was suggested that GRP94, in contrary to common expectations, does require PRAT4A 
as a co-chaperone for TLR trafficking. This was supported by co-localization studies of 
PRAT4A and GRP94 in the ER as well as the demonstration of adenosine nucleotide 
sensitive chaperone interactions between both. Moreover, it was shown that TLR9 requires 
both PRAT4A and GRP94  in a tri-molecular complex for maturation (Liu et al., 2010). 
To improve the soluble expression of TLR ECDs in this work the molecular chaperones 
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2 Aim of this work 
Stable cell line development is a time-consuming process. The generation of homogenous 
high producer cell lines does require extensive screening and needs to be repeated for each 
individual target (Wurm, 2004). Targeted integration via RMCE however does cut the 
timelines for stable cell line development significantly as the integrated gene is 
incorporated into a previously tagged chromosomal locus (Wilke et al., 2011). The use of 
stable cell lines for protein production does enable the convenient scale up into bioreactors 
which is particularly useful for difficult to express protein targets with low volumetric 
yields. Nevertheless, the expression of demanding protein targets can also be aided through 
the co-expression of protein subunits or accessory molecules (Neuhaus et al., 2006, 
Bieniossek et al., 2008). The level of protein production however is not the only bottleneck 
that needs to be faced for structural biology applications. Heterogeneous glycosylation 
patterns do interfere during crystal formation and thus need to be removed a priori or 
glycosylation deficient cell lines such as CHO Lec3.2.8.1 need to be employed (Stanley, 1989, 
Aricescu et al., 2006).  
The aim of this work focuses on the stable co-expression of difficult to express protein 
targets with accessory molecules for structural biology applications. This requires the 
establishment of a binary master cell line in glycosylation deficient CHO Lec3.2.8.1 which 
will enable the targeted integration of genes at two pre-defined genomic loci via RMCE. 
RMCE will ease the generation of homogenous high producer cell lines by reducing 
development times for their generation.  
The binary RMCE system will be evaluated with the model protein tdTomato. Targeted 
integration via RMCE of tdTomato into “single” RMCE master cell lines (with only one 
exchange locus) and binary RMCE master cell lines (with both exchange loci) will enable 
the determination of specific expression capabilities for each locus and its correlation to the 
binary RMCE system. Moreover, the reproducibility of tdTomato expression for each locus 
will be determined.  
Producer cell lines co-expressing Toll-like receptors in combination with their chaperones 
GRP94 or PRAT4A will be generated to improve volumetric yields of soluble protein 
production.  
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3 Materials and Methods 
3.1 Instruments 
Instruments used for this work are listed in Table A.1-1 in the appendix. 
3.2 Chemicals, kits and reagents 
If not specified otherwise, all chemicals were obtained from Bayer, Becton Dickinson (BD), 
GE Healthcare, InvivoGen, Invitrogen, Life Technologies, Lonza, Macherey-Nagel, Merck, 
Millipore, New England Biolabs (NEB), Novagen, Qiagen, Promega, Roche, Roth, 
Sigma-Aldrich or Thermo Scientific. 
3.2.1 Enzymes and molecular weight standards 
Restriction endonucleases, enzymes and molecular weight standards commonly used in 














































PageRuler Plus prestained  SDS‐PAGE  SM1811/ 26620  Fermentas / Thermo Scientific 











Culture media for bacteria (Table 3-4) were prepared in purified water (MilliQ) and 
autoclaved at 121 °C before additional compounds were added after being sterile filtered 
(0.2 µm). Antibiotics are listed in Table 3-5. Cell culture media and supplements for 
mammalian cells are listed in Table 3-6 and Table 3-7; those were either obtained as 
ready-to-use solutions or prepared from powdered formulations in MilliQ. Prepared media 
were sterilized by a custom made filtration line containing the component Sealkleen 
(ZLK702G23LHKH4, Pall) in which the medium is run through two nylon filters with 
decreasing pore size (1 µm and 0.2 µm). 
Table 3‐4: Media for bacterial cultures 
























Medium    Antibiotics  Cat#  Supplier 
E. coli FAST‐Media TB Liquid Blas  100 µg/ mL blasticidin  fas‐bl‐l  InvivoGen 
E. coli FastMedia BLAS AGAR   100 µg/ mL blasticidin  fas‐bl‐s  InvivoGen 
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Table 3‐5: Antibiotics and reagents for bacterial cultures 
Medium  Final concentration  Cat#  Supplier 
Ampicillin (Amp)  100 µg/mL  A9518‐100G  Sigma‐Aldrich 
Kanamycin (Kan)  50 µg/mL  T832.3  Roth 
Table 3‐6: Cell culture media 
Medium  Used for cell line  Cat#  Supplier  Supplements 
ProCHO5 
 
CHO Lec3.2.8.1  BE12‐766Q  Lonza  7.5 mM L‐glutamine (and 
11 mg/mL phenol red) 
CD Hybridoma   CHO Lec3.2.8.1  11279‐023  Invitrogen  8 mM L‐glutamine, 5 % FBS 
F17  HEK293‐6E  05‐0092DK  Invitrogen  7.5 mM L‐glutamine, 
0.1 % pluronic, 25 µg/mL G418 
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3.2.3 Transfection reagents 
Transfection of recombinant plasmid DNA into CHO cell lines was done using 
electroporation based nucleofection (Lonza). A cationic lipofection technique on the other 
hand was used for transfection in HEK cells (Table 3-8). 
Table 3‐8: Transfection reagents 




Nucleofection solution  CHO Lec3.2.8.1  VCV‐1003  Lonza 
3.3 Oligonucleotides and plasmids 
Plasmids used in this work are listed and explained in Table 3-9. Oligonucleotides are listed 
in Table 3-10; these were purchased from MWG Eurofines Operon in HPLC purified quality 


















Tagging  vector  originally  used  for  genomic  integration  of  an  eGFP  expressing  exchange  locus 




neomycin  selection  trap.  Tagging  vector  pEF‐FS‐eGFP‐dpuro  was  used  for  cloning  of  the  tagging  vector 
pEF‐FS‐tdTomato‐dpuro described in this work. 
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pEF‐FS‐tdTomato‐dpuro 
Tagging  vector  used  for  genomic  integration  of  an  tdTomato  expressing  exchange  locus 




Vector  containing  synthesized  FRT13  and  FRT14  sites  for  cloning  of  tagging  vector  pEF‐FS‐tdTomato‐dpuro 
(Life Sciences). 
11AAYGFC_F13‐F14_pFlpBtM_II_pMK‐RQ 




















Exchange  vector  comprising  the  full  length  tdTomato  sequence with  a  C‐terminal His‐tag  derived  from  vector 
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pFlpBtM‐II(beta)‐sshTLR5‐1‐391‐VLR‐TEV‐STrEP‐H8 
Exchange vector comprising a human TLR5 ectodomain sequence (amino acids 1‐391) with its genuine signal peptide, 
derived  from  vector pFlpBtM‐II‐sshTLR5 wt‐c‐QC_R387Q_(Klon3) (Steffen Meyer,HZI). The  sshTLR5  construct  is 
C‐terminally fused to a VLR fragment (amino acids 133‐200). The C‐terminal twin‐Strep‐tag and His‐tag are separated 






























pUNO1‐mGRP94  (InvivoGen).  Vector  was  used  for  transient  expression  of  mGRP94  in  HEK293‐6E  and  stable 
integration into the binary RMCE cell line TE3‐B4‐H1. 
pFlpBtM_II_F13_mPRAT4A_F14 
Exchange vector comprising  the  full  length murine PRAT4A  sequence with a C‐terminal FLAG‐tag, derived  from 





























amplified  from  pDUO_mTLR1_mTLR2  vector  and 
cloned  into  pFlpBtM‐II  or  pFlpBtM‐II(beta)  vector 






construct  which  was  amplified  from 






construct  which  was  amplified  from 






construct  which  was  amplified  from 
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TLR5_1‐391NheRev  AGGAGCTAGCGAGATCCAAGGTC
TGTAATTTTTCCAG 
Antisense  primer  for  a  sshTLR5_1‐391  amino  acid 
ECD construct which was amplified from pFlpBtM‐II‐






Sense primer  for  a  sshTLR5_1‐391  amino  acid ECD 
construct  which  was  amplified  from  pFlpBtM‐II‐
sshTLR5 wt‐c‐QC_R387Q_(Klon3) (introduces BamHI 






Sense  primer  for  mPRAT4A  construct  with 







Sense  primer  for  mPRAT4A  construct  with 
C‐terminal  FLAG  tag.  For  amplification  from 






Antisense  primer  mPRAT4A  construct  with 
C‐terminal  FLAG  tag.  For  amplification  from 
pUNO1‐mPRAT4A  vector.  Cloned  into 








Antisense  primer  for  mPRAT4A  construct  with 
N‐terminal  FLAG  tag.  For  amplification  from 
pUNO1‐mPRAT4A vector. Includes a MluI restriction 
site. When cloned into pFlpBtM‐II_F13/F14 it removes 
the  Strep‐tag, His‐tag  and  the  original  stop  codon 







tag  (red).  For  amplification  from  pUNO1‐mGRP94 
vector.  Introduces a MluI  restriction  site  for cloning 
into  pFlpBtM‐II_F13/F14  which  removes  the  Strep‐
tag,  His‐tag  and  the  original  Stop  codon  from 
pFlpBtM‐II_F13/F14  vector.    Instead  a  FLAG‐tag  is 







Introduces  MluI  restriction  site  for  cloning  into 
pFlpBtM‐II_F13/F14  which  removes  the  Strep‐tag, 
His‐tag  and  the  original  Stop  codon  from 
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For  amplification  from  pUNO1‐mGRP94  vector. 
Primer contains a ClaI site as the NcoI site cannot be 
used  for  cloning  as  it  is  present  within  mGRP94. 
Instead the BstBI site within pFlpBtM‐II_F13/F14 will 
be used  for  cloning, however as  the PCR  fragment 
cannot be cut with BstBI either, the compatible ClaI 
site will be  introduced which will destroy  the BstBI 
site  after  cloning  into  pFlpBtM‐II_F13/F14. 
Furthermore  the Shine Dalgarno sequence  (orange) 
needs to be reintroduced as it will be cut out using the 
BstBI  cloning  site  in  pFlpBtM‐II.  Furthermore  a N‐







For  amplification  from  pUNO1‐mGRP94  vector. 
Primer contains a ClaI site as the NcoI site cannot be 




























































The electrocompetent E.coli strains One Shot® TOP10 or XL1 blue were used for cloning and 
plasmid amplification (Table 3-11). 
Table 3‐11: E.coli strains 


















Later  on  the  subclone HEK293‐6E  (NRC  Canada) was  generated  by Durocher  et  al.,  (2002) which  comprised  a 
truncated version of the Epstein‐Barr nuclear antigen 1 (EBNA 1). 
3.5 Molecular biological methods 
Protocols used for molecular biological methods were adapted from standard collections 
such as Sambrook et al., (2001) or established in our laboratory. Sequence analysis of 
plasmid DNA was done by the genome analysis department at the HZI. 
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3.5.1 Polymerase chain reaction (PCR) 
PCR kits and reagents used in his work are listed in Table 3-13. PCR was used to amplify 
fragments for molecular cloning or analyse the genetic background of chromosomal DNA 
via genomic PCR. PCR for molecular cloning was used to amplify full length or truncated 
constructs from template vectors and insert restriction sites for cloning or affinity-tags for 
purification. PCR reactions were set up in volumes from 25 µL - 50 µL (Table 3-14) and 
amplified using either a thermocycler or a gradient thermocycler). Correct amplification 
was analysed by agarose gel electrophoresis (Section 3.5.2). If required PCR amplifications 
were extracted from a preparative agarose gel (Section 3.5.3) before further use. For 
genomic PCR amplification PCR reactions were set up in 50 µL volumes according to 
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 Table 3‐16: (Gradient) Thermocycler conditions for molecular cloning 
Program Steps  Temperature  Time  Cycles 
Initial denaturation  98 °C  1 min   





Extension  72 °C  1 min   
Final extension  72 °C  10 min   
Pause  10 °C  For ever   
Table 3‐17: (Gradient) Thermocycler conditions for genomic PCR 
Program Steps  Temperature  Time  Cycles 
Initial denaturation  94 °C  5 min   
Denaturation  94 °C  1 sec   
Annealing  72 °C  1 min   x 35 cycles 
Extension  68 °C  4 min   
Final extension  68 °C  10 min   
Pause  10 °C  For ever   
3.5.2 Agarose gel electrophoresis 
DNA samples obtained from PCR amplifications (Section 3.5.1) or restriction digests 
(Section 3.5.4) were analysed using agarose gel electrophoresis. 0.8 % (w/v) agarose in TAE 
buffer was boiled in a microwave and cooled down to approximately 60 °C before the 
addition of 5-10 µL ethidium bromide. Well number and sizes were adjusted with the 
appropriate combs.  DNA samples were mixed with 6x DNA loading buffer, applied to the 
wells and run at 70 V - 100 V. The gels were documented under UV illumination at 254 nm. 







Buffer  Composition  Cat#  Supplier 
TAE buffer   35.4 mM Trizma® base  T1503‐1KG  Sigma 
  0.1 % acetic acid  3738.5  Roth 
  1 mM EDTA  A1103.1000  AppliChem 
  pH 8.5     
6 x DNA loading buffer   0.4 % (w/v) glycerol p.A.  1.04092.1000  Merck 
  10 % (v/v) 100x bromphenol blue  A512.1  Roth 
  0.03 M EDTA  A1103.1000  AppliChem 
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3.5.3 DNA extraction 
The NucleoSpin® Extract II kit (MN, Cat# 740609.150) was used for the extraction of 
linearized plasmids, DNA fragments and PCR products. The DNA extraction was done 
according to the manufacturer’s protocol. 
3.5.4 Digestion of DNA with restriction endonuclease 
Restriction digests were generally set up in a 40 µL reaction volume with 5 µg – 10 µg 
plasmid DNA in an appropriate NEBuffer, 0.5 U/µL – 1.0  U/µL of the required restriction 
endonucleases and 1x BSA (bovine serum albumin)  if required. The reaction mixtures were 
incubated for 2 h – 3.5 h at the temperature instructed from the manufacturer and heat-
inactivated afterwards if possible. If required the digests were done sequentially with either 
adding a second enzyme after the first digest directly to the reaction mixture and adjusting 
the temperature or isolating the required fragment from an preparative 0.8 % agarose gel 
(Sections 3.5.2) and setting up a new restriction digest. Plasmid backbones were 
dephosphorylated to avoid religation by adding 10 U antarctic phosphatase (NEB, Cat# 
M0289S) and NEBuffer for antarctic phosphatase to the restriction digest and incubating it 
for 20 min at 37 °C. All digests were stored at -20 °C for storage. Restriction digests made 
for testing plasmid construct integrity were typically made with 500 ng plasmid DNA in a 
30 µL reaction volume. 
3.5.5 Ligation of DNA fragments 
To prepare a ligation as well as controls for re-ligation and no ligation, a ligation master 
mix was prepared containing the ligation buffer (Roche, Cat# 14028100), 20 ng/µL 
linearized vector DNA. For the ligation the insert DNA in a 1:3 molar ration and 1 U T4 
DNA ligase (Roche, Cat# 14295420) were added to 20 µL ligation master mix, only 1 U T4 
DNA ligase into the re-ligation control and neither T4 DNA ligase nor insert DNA into the 
negative control. The samples were ligated for 16 h at 12 °C in a Thermocycler. 
3.5.6 Preparation of electrocompetent cells 
For the preparation of electrocompetent cells glycerol stocks of E.coli One Shot® TOP10 or 
XL1 blue were stroke out on non-selective LB-agar plates and incubated overnight at 37 °C. 
An isolated colony was used to inoculate a 40 mL pre-culture at 37 °C overnight shaking at 
130-160 rpm. The pre-culture was used in a 1:100 or 1:50 dilution to inoculate the main 
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culture (500 mL – 2 L of bacterial culture) and grown at 37 °C and 130-160 rpm until an 
optical density (OD)600 between 0.5-1.0 was reached. Sterile centrifuge tubes were used to 
chill the cell suspension on ice for at least 30 min and mixed occasionally to avoid a 
temperature gradient. Centrifugation of the chilled bacterial suspension for 10 min at 4 °C 
and 3000 rpm was followed by a washing step with sterile ice-cold HEPES-glycerol wash 
buffer (1 mM HEPES, 10 % (v/v) glycerol, pH 7.0). For each pellet obtained from 1 L of 
bacterial culture 500 mL of sterile ice-cold HEPES-glycerol wash buffer were used. The 
centrifugation and washing step was repeated after pooling the cell pellets if required in 
250 mL HEPES-glycerol wash buffer. The newly obtained pellet was resuspended in 20 mL 
ice-cold 10 % glycerol and transferred to sterile Oak Ridge SS34 centrifuge tubes and 
centrifuged again at 3000 rpm for 10 min. The harvested pellet was take up in 1 mL – 3 mL 
ice-cold sterile 10 % glycerol and aliquoted in sterile Eppendorf tubes, shock frozen in liquid 
nitrogen and stored at -80 °C. 
3.5.7 Transformation of competent bacteria 
Before electroporation the Gene Pulser® Cuvette (Cat# 165-2086, Bio-Rad) was chilled on 
ice. 2 µL (~4 ng) of plasmid DNA were mixed with 50 µL – 60 µL of electrocompetent cells 
and incubated on ice for 1 min. The Bio-Rad Gene PulseTM was set to a capacitance of 25 µFD 
and 2.5 kV. The Bio-Rad Controller was set to 200 Ω and the Bio-Rad capacity extender to 
126 µFD. The dried cuvette was placed in the chamber slide and a pulse applied once. After 
addition of 1 mL LB-medium the cells were incubated between 30 min – 60 min at 37 °C 
and 300 rpm.  20 µL – 200 µL of bacterial suspension were plated on selective LB-agar plates 
and incubated overnight at 37 °C. 
3.5.8 Bacterial pre‐cultures 
Bacterial pre-cultures were prepare by inoculation of 3 mL – 4 mL LB medium containing 
the appropriate antibiotics with a colony picked from an LB agar plate or a 1:1000 dilution 
of an existing bacterial culture. The pre-cultures were grown at 37 °C and 130 rpm overnight 
and can be used for the inoculation of larger volumes of LB medium for the preparation of 
glycerol stocks or plasmid preparations. 
3.5.9 Glycerol stock 
To enable the quick preparation of new plasmids, 8 % glycerol stocks were prepared and 
stored at -80 °C.  To do so 50 mL LB medium with the appropriate antibiotics were 
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inoculated 1:1000 or 1:500 with a pre-culture and grown at 37 °C and 130 rpm until an OD600 
between 0.5 – 0.8 was reached. 900 µL of cell suspension were mixed together with 100 µL 
sterile 80 % glycerol (8 % glycerol end-concentration) in cryogenic vials and stored at -80 °C. 
3.5.10 Plasmid preparation 
Pre-cultures were used to inoculate appropriate volumes of LB medium containing the 
appropriate amount of antibiotics. Plasmid preparations were done according to the 










AquaGenomicTM Solution [MoBiTec, Cat# 2030MT] was used for the isolation of genomic 
DNA. 1-2 x106 CHO cells were harvested at 12.000 xg and stored at -20 °C. To lyse the cells 
100 µL AquaGenomicTM Solution were added to the frozen pellet and vortexed for 1 min 
(or until the pellet was thoroughly resuspended). Following an incubation time of 4 min 
the lysate was pelleted at 13.000 xg for 2 min. The clear lysate was transferred to a new 
reaction tube and the DNA precipitated with 90 µL isopropanol. The precipitated DNA was 
pelleted at 13.000 xg for 2 min, the supernatant removed and the DNA pellet washed twice 
with 70 % ethanol. The air dried DNA pellet was dissolved in autoclaved MilliQ water or 
in Nuclease-Free Water (Promega, Cat# P119C). Insoluble material was pelleted at 13.000 xg 
for 1 min and the supernatant transferred to a new Eppendorf. Genomic DNA was stored 
at -20 °C.  
3.5.12 Photometric quantification of DNA and protein concentrations 
NanoDrop ND-1000 and NanoDrop ND-2000 spectrophotometer were used to quantify 
DNA concentrations at 260 nm and protein concentrations at 280 nm. The measurements 
were carried out with 2 µL sample volume after calibration with a corresponding buffer. In 
DNA read outs the A260nm/A280nm ratio was used to determine protein contaminations. 
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Ratios of 1.8 -2.0 were considered pure. In protein read outs the Beer-Lambert law (equation 
below) had to be considered and the acquired absorbance values needed to be divided 
through the molar extension coefficient (ε) of each target protein to obtain the correct 
protein concentration. The molar extinction coefficients for each protein target were 











Cell culture consumables are listed in Table A.1-2 in the appendix. 
3.6.2 Maintaining cells in culture  
Cell lines were maintained as suspension cultures in flat bottom shake flasks on orbital 
shakers. Media and supplements were used according to Table 3-6 and Table 3-7. 
CHO Lec3.2.8.1 cells were cultivated at 37 °C and 110 rpm in a humidified atmosphere with 
5 % CO2. Adherent CHO Lec3.2.8.1 cells were incubated at 37 °C at 8 % CO2. Cells were 
routinely split every 3-4 days with a seeding cell density of 2-3 x105 cells/mL to maintain 
an exponential growth phase. Adherent cells were expanded to larger multi-well plates or 
transferred to suspension culture when reaching a confluency of approximately 80 %. 
Expansion of adherent cells was done as follows; the culture medium was removed and the 
cell layer trypsinized with 50 µL – 1 mL 1x trypsin/EDTA. The cells were pelleted at 180 xg 
for 4 min and resuspended in culture medium. 
HEK293-6E were cultivated at 37 °C and 110 rpm in a humidified atmosphere with 5 % CO2. 
Cells were routinely split every 3-4 days with a seeding cell density of 3 x105 cells/mL to 
maintain an exponential growth phase. 
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3.6.3 Determination of cell number and viability 
Determination of cell number and cell viability was done by the trypan blue dye exclusion 
method with a Neubauer hemocytometer or flowcytometry after propidium iodide 
staining. If cells contained mCherry or tdTomato cassettes no propidium iodide staining 
was used and thus only a measure of cell density but no measure of cell viability was 
performed in such cases. Both dyes can only permeate the cell membranes of dead cells and 
thus cause staining (blue and red respectively). 
Using the trypan blue exclusion method cell suspensions were mixed 1:1 with 0.5 % trypan 
blue, transferred to one chamber of the Neubauer hemocytometer and viable (white) and 
non-viable (blue) cells were counted in 2 or 4 big squares under the light microscope. Cell 
density and viability were calculated according to the equations below. 
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݊݋. ݋݂	ݏݍݑܽݎ݁ݏ 																															ݒܾ݈݅ܽ݅݅ݐݕ	ሾ%ሿ ൌ
ݒܾ݈݅ܽ݁	݈݈ܿ݁ݏ	 ൈ 	100
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Using the flow cytometer (Guava EasyCyteTM) cell suspensions were mixed 1:10 with 
1x PBS (phosphate buffer saline) if cell viability was also determined a final concentration 
of 50 µg/mL propidium iodide was added. (Section 3.6.10). 
3.6.4 Cryopreservation 
For long term storage cell banks were kept in vapour phase over liquid nitrogen. Cells were 
harvested from suspension culture by centrifugation at 180 xg for 4 min. The pellets were 
resuspended in freezing medium (80 % culture medium, 10 % dimethylsulfoxid (DMSO, 
Sigma, Cat# D2650) and 0.01 % methylcellulose) at a cell density of 0.5 x107 cells/mL. 
Cryogenic vials were filled with 1.8 mL cell suspension and transferred to a special freezing 
container in isopropanol which constantly decreases the temperature for -1 °C/min. 
Freezing container were stored at -70 °C for 24 h before transferring the cryogenic vials to 
the nitrogen tank. 
3.6.5 Revitalisation 
Cells were thawed and washed with 10 mL of culture medium, mixed and centrifuged 
again at 180 xg for 4 min. The pellet was resuspended in 30 mL culture medium. 
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3.6.6 Transfection of eukaryotic cells  
An electroporation based method was used to deliver substrates into the cytoplasm and the 
nucleus of mammalian cells for either protein production or genomic tagging. Since it is a 




















To generate binary CHO Lec3.2.8.1 RMCE cell lines which allow the integration of gene 
targets at two defined loci the introduction of a second exchange cassette into the RMCE 
cell lines SWI3_26 and SMT_dneo(2)_24 was required. To do so the tagging vector 
pEF-FS-tdTomato-dpuro was linearized with the restriction endonuclease SalI and the 
RMCE master cell lines SWI3_26 and SMT_dneo(2)_24 were transfected with the linearized 
tagging vector using the Amaxa Nucleofector system (Section 3.6.6). The cells were 
cultivated in suspension culture and ~ 1x107 cells were sorted as a pool for double positive 
clones (containing eGFP and tdTomato) with the highest 4 % tdTomato fluorescence using 
FACS (Section 3.6.10). The sorted cells were plated adherently in 96-well plates and 
expanded stepwise (Section 3.6.2). If required the sorted cells were serially diluted (Section 
3.6.9) or send for a second round of FACS sorting to obtain binary RMCE master cell lines. 
The stability of the binary RMCE master cell lines was observed for at least 11 weeks using 
flowcytometry (Section 3.6.10) 
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3.6.8 Generation of producer cell lines by RMCE 
RMCE master cell lines were cultivated in ProCHO5 medium. Three days before 
transfection the cells were split to 2x105 cells/mL to ensure an exponential growth phase. 
Transfection of the RMCE master cell lines was done with the Amaxa nucleofector kit V 
(Section 3.6.6). The next day the cells were pelleted at 180 xg for 4 min, resuspended in 
10 mL CD Hybridoma medium and transferred to a 100 mm cell culture dish to grow 
adherently. The Corning dish was cultivated at 37 °C and 8 % CO2. The CD Hybridoma 
medium was exchanged every 2-3 days. From day 5 after transfection antibiotic pressure 
was applied through the addition of 2 mg/mL G418 to the CD Hybridoma medium during 
medium exchange. 1-2 weeks after application of antibiotic pressure the colonies were 
picked from the Corning dish and transferred to 96-well plates containing CD Hybridoma 
medium with G418 and left to grow at 37 °C and 8 % CO2 . At a cell density of approximately 
50 % - 80 % positive cell clones were isolated using serial dilutions (Section 3.6.9) in 96-well 
plates with CD Hybridoma medium. To obtain clonal isolates this step was repeated as 
often as required. Alternatively cells were directly picked semi-sterile under the microscope 
and transferred to 96-well plates after florescence analysis. After clonal isolation the cells 
were stepwise expanded to 6-well plates. To transfer the cells to suspension culture the cells 
were trypsinized, pelleted at 180 xg for 4 min and resuspended in ProCHO5 medium with 
0.01 U/mL heparin to avoid clumping but antibiotic pressure was removed. Flowcytometry 
was used to confirm the successful cassette exchange as this resulted in the loss of the stably 
integrated fluorescent marker gene. 
Binary RMCE cell lines (Section 3.6.7) were produced similarly. However, the cassettes 
were exchanged sequentially as the simultaneous exchange of both loci against a GOI did 
not yield enough positive clones to enable their isolation (data not shown). Thus locus 2 
(FRT13-tdTomato-FRT14-Δpuro) was generally exchanged first as the puromycin selection 
trap is more selective than the neomycin selection trap. Thus the isolation of positive clones 
was completed quicker. For the same reason selective pressure with 150 µg/mL puromycin 
was applied 7 days after transfection instead of 5 days. The isolated cell lines were than 
used for a second round of RMCE to exchange the other locus. 
3.6.9 Single cell cloning by serial dilution 
To obtain isolated clones serial dilutions in 96-well plates were used. To do so 100 µL 
CD Hybridoma medium with the required antibiotics was aliquoted into a 96-well plate 
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and incubated at 37 °C and 8 % CO2 for 15 min. The 100 µL medium from well A1 was 
removed again. The cells from a 96-well plate grown to approximately 50 % - 80 % 
confluency were transferred to well A1 (~ 200 µL) and diluted 1:2 down the column from 
well A1 to well H1. With a multichannel pipette 100 µL CD Hybridoma medium with 
antibiotics was added to the wells A1 – H1 and diluted 1:2 across the rows of the plate. 
100 µL CD Hybridoma medium was added to the wells to obtain a total volume of 200 µL 
in each well. The 96-well plates were incubated for about a week at 37 °C at 8 % CO2 before 
the next round of clonal isolation or expansion. 
3.6.10 Flow cytometry and preparative cell sorting 
The Guava EasyCyteTM Mini System is a flowcytometer which uses a 488 nm diode laser 
for the excitation of samples and 3 fluorescence detectors (525 nm (green), 583 nm (yellow) 
and 680 nm (red)) to measure emission signals. The Guava EasyCyteTM was used to analyse 
the fluorescent level of eukaryotic cells after transient transfection or stable integration of 
gene targets. Cells were diluted 1:10 with 1x PBS; non-florescent cells could also be stained 
with 50 µg/mL propidumiodid to determine cell viability and exclude dead cells from the 
analysis. 
Preparative cell sorting was done with the MoFlo XDP, Aria-II or Vantage SE by Lothar 
Gröbe research group experimental immunology (EXIM) at the HZI or Maria Höxter 
research group gen regulation and differentiation (RDIF) at the HZI. To obtain binary 
RMCE cell lines 1x107 tdTomato tagged cells (Section 3.6.7) were sorted for tdTomato 
positive cells and/or the highest 4 % fluorescence for tdTomato as a pool in 1-2 mL 
ProCHO5 medium using a 100 µm tip. 
3.6.11 Resistance of SWI3_26 (CHO Lec3.2.8.1) cell line to antibiotics 
Objective was to determine the antibiotic concentration which causes total cell death of the 
CHO Lec3.2.8.1 RMCE master cell line SWI3_26. To determine the resistance of the 
CHO Lec3.2.8.1 RMCE master cell line SWI3_26 against antibiotics; 2x104 cells were seeded 
in 24-well plates (BD Falcon) and cultivated at 37 °C at 8 % CO2. After one day antibiotic 
pressure was applied according to Table 3-21. Every 3-4 days the antibiotic containing 
CD-Hybridoma medium (Lonza) was exchanged. The change in cell density was observed 
under the light microscope (Olympus CKX41) over 17 days and estimated visually as the 
percentage of density. 
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Table 3‐21: Antibiotic pressure applied to SWI3_26 (CHO Lec3.2.8.1) 
G418 [µg/µL]  Hygromycin B [µg/µL]  Zeocin [µg/µL]  Phleomycin [µg/µL]  Puromycin [µg/µL] 
0  0  0  0  0 
150  50  50  2.5  1 
300  100  100  5  2 
450  150  150  7.5  3 
600  200  200  10  4 
900  300  300  15  5 
1200  400  400  20  6 
1500  500  500  25  8 
1800  600  600  30  10 
2100  700  700  40  12 
2400  800  800  50  15 
2700  900  900  100  20 
3.7 Protein production and purification 
3.7.1 Transient protein expression in HEK293‐6E 
Transient expression in HEK293-6E cells was used for the screening of constructs as well as 
for test expressions in batch culture.  Transfections of HEK293-6E cells were carried out 
according to Section 3.6.6. The transfection efficiency was monitored daily using 
flowcytometry (Section 3.6.10) as well as cell number and viability (Section 3.6.3). The 
starting culture volume used during transfection was expanded 48 h post transfection by 
adding the same amount of fresh F17 medium to the culture. Furthermore the culture was 
supplemented with tryptone (TN1) to a final concentration of 0.5 %.  Supplementations 
with a final concentration of 4.5 g/L glucose at 72 hpt to avoid nutrient depletion and 
3.75 mmol/L valproic acid at 96 hpt to boost expression rates in the stationary phase 
(Backliwal et al., 2008). Cells were typically harvested at 4.000 rpm in a bench top centrifuge 
using 50 mL Falcon tubes, if necessary the culture supernatants were pooled and 
supplemented with 0.1 % sodium acid for storage at 4 °C. If the cell pellets were needed 
those were washed with 1x PBS pooled in one Falcon tube and centrifuged again. The 
supernatant was removed and stored at -20 °C. 
3.7.2 Protein production in stable CHO Lec3.2.8.1 cell lines 
For small scale protein production producer cell lines generated in Section 3.6.8 were 
expanded to a volume of 150 mL - 1.5 L and cultivated for 3-5 days in shaker flasks. Culture 
supernatants or cell pellets were typically harvested at 7330 rcf for 30 min or at 4.000 rpm 
in a bench top centrifuge using 50 mL Falcon tubes. Cell pellets were further washed with 
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1x PBS transferred to a 50 mL Falcon tube and centrifuged again at 4.000 rpm. Culture 
supernatants were supplemented with 0.1 % sodium acid and stored at 4 °C. Cell Pellets 
were stored at -20 °C. 
For large scale protein production, in a 2.5 L – 40 L scale, producer cell lines were cultivated 
in an autoclavable stirred tank bioreactor by Nadine Konisch in batch (2.5 L) or perfusion 
mode (> 2.5 L). A double membrane stirrer within the 2.5 L bioreactor was equipped with 
two types of membrane tubing (Accurel®  S6/2, Membrana); one for bubble-free aeration 
via 8 meters of hydrophobic polypropylene membrane tubing and one that enables 
perfusion with internal cell retention via 8 meters of hydrophilized, micropourous 
membrane tubing (Lehmann et al., 1987, Blasey et al., 1991). Figure 3-1 shows a flow diagram 
for the process. Producer cell lines were cultivated in a 1:1 blend of ProCHO5 and ZKT-I 
medium at 37 °C with a stirring speed of 45 rpm and a dissolved oxygen concentration of 
40 % air saturation at pH 7.4. If cell densities exceeded 107 cells/mL during the production 
phase the temperature was reduced to 32 °C. Perfusion rates were adjusted according to 
the metabolic consumption of glucose preventing a drop below 2.5 g/L. Samples of 2 mL 
were drawn daily for in-process control. Harvested culture supernatants were concentrated 
and diafiltrated against an exchange buffer (50 mM Tris-HCl, 500 mM NaCl, pH 8.0) with 
the ProFlux® tangential flow system (Millipore) equipped with two Pellicon 2 cassettes 
(MWCO 10kD, Cat# P2C010C05, Millipore). The diafiltrated sample was supplemented 
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3.7.3 Trichloroacetic acid (TCA) precipitation 
To preliminary test protein expression using small volumes of culture supernatant or total 
cell lysate, TCA precipitation is used to concentrate the protein for Western blot analysis. 
To do so 1 mL of culture supernatant or total cell lysate are mixed with 100 µL 100 % TCA 
and incubated on ice for 30 min.  The precipitated protein is centrifuged down at 13.000 rpm 
for 15 min. the protein pellet is washed with 1 mL ice-cold 70 % ethanol and pelleted again 
for 5 min at 13.000 rpm. The protein pellet is dissolved in 50 µL water and 50 µL 2x Laemmli 
buffer. 
3.7.4 Cell lysis 
To lyse mammalian cell pellets 10 mL - 50 mL lysis buffer together with one Roche complete 
EDTA-free protease inhibitor cocktail tablet and 2 µg – 5 µg DNase I (Table 3-22) were 
added to a frozen cell pellet in a Falcon tube and vortexed.  The tube was left on ice for 
approximately 40 min – 60 min and the content centrifuged at 30.000 xg for 20 min - 60 min 
and eventually filtered with a 0.45 µm syringe filter. Small cell pellets in Eppendorf tubes 
were lysed with 50 µL – 700 µL lysis buffer, kept on ice for 15 min and centrifuged at 

















The VIVAflow 200 system or the KrosFlow® research IIi TFF system were set up according 
Figure 3-2 or Figure 3-3 respectively. The 10 % storage ethanol was removed from the 
VIVAflow 200 cartridge or MidiKros column and the system cleaned with at least 500 mL 
MilliQ water to remove residual ethanol. The MilliQ water was drained from the system 
and approximately 200 mL of the cell culture supernatant were placed into the concentrate 
reservoir. The remaining cell culture supernatant was connected as feed reservoir to the 
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concentrate reservoir. The sample was concentrated down to approximately 50 mL - 100 mL 
by re-circulation through the system. After concentration of the sample the exchange buffer 
(50 mM Tris-HCl, 500 mM NaCl, pH 8.0) was connected to the feed reservoir and the 
concentrated sample was diafiltrated through re-circulation through the system with at 
least 500 mL exchange buffer. The concentrated and diafiltrated sample was recovered, the 







Vivaspin concentrators with a polyethersulfon (PES) membranes (Table 3-23) were used to 
concentrate smaller volumes of protein solutions and/or use them for buffer exchange. 
Protein solutions were centrifuged at up to 5000 xg in Vivaspin 20 concentrators or up to 
4000 xg in Vivaspin 6 concentrators until the desired volume was reached. If the buffer 
should be exchanged after concentration this was added and centrifuged again as 
necessary. 
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Table 3‐23: Vivaspin concentrators 
3.7.7 Small scale purification of tagged proteins with magnetic beads 
Small scale purifications of cell extracts or cell culture supernatants were done using 
magnetic beads. All fractions were collected and analysed by SDS-PAGE and Western blot 
(Sections 3.8.1 and 3.8.2). 
Table 3‐24: Small scale purification methods 
MagneHisTM Ni‐Particles (Promega, Cat# V8560) 















Purifications of cell extracts or cell culture supernatants were done using commercially 
available or stacked columns. Fractions were collected and analysed by SDS-PAGE and 
Western blot (Sections 3.8.1 and 3.8.2).   
  
Concentrator  MWCO (kDa)  Cat#   Supplier 
Vivaspin 20  30.000   VS2022  Vivascience /Satorius 
Vivaspin 20  10.000   VS2002  Vivascience /Satorius 
Vivaspin 20  5.000   VS2012  Vivascience /Satorius 
Vivaspin 20  3.000  VS2092  Vivascience /Satorius 
Vivaspin 6  30.000  VS0622  Vivascience /Satorius 
Vivaspin 6  10.000  VS0602  Vivascience /Satorius 
Vivaspin 6  5.000  VS0612  Vivascience /Satorius 
Vivaspin 6  3.000  VS0692  Vivascience /Satorius 
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(50 mM Na2HPO4, 300 mM NaCl, 250 mM  imidazole, pH 8.0). As  the column was overloaded a  second  round of 
purification was necessary, so  the  resin was equilibrated again with 10 CV of binding buffer and  the  flowthrough 












































To analyse protein purity and yield as well as expression kinetics SDS-PAGE (sodium 
dodecyl sulphate polyacrylamide gel electrophoresis) was used under denaturing 
conditions (Laemmli et al., 1970). 12 % or 10 % gels were either made according to Table 3-28 
or precast gels from Bio-Rad were used. Samples were mixed with 8x SDS loading buffer 
and boiled for 5 min at 90 °C before applying them to a SDS-gel. Typically 10 µL - 15 µL of 
sample were loaded to 15-well SDS-gels and 15 µL - 20 µL to 10-well SDS-gels. 
Mini-Protean® TGXTM were loaded with 15 µL or 30 µL sample (15-well and 10-well 
respectively). The gels were pre-focused under constant voltage of 120 V for 5 min and run 
at 160 V until the dye front reached the end of the gel. To remove the SDS the gel was 
washed in water and then stained with either Instant blue or coomassie staining solution. 
The buffers used for SDS-PAGE are listed in Table 3-29. The molecular weight standards 
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Table 3‐28: SDS‐Gel composition (for 8 gels) 
Solution   Resolving gel  Stacking gel 
  12 %  10 %  5 %  3 % 
Acrylamide/bisacrylamide 30 % (v/v)  12 mL  10 mL  1.5 mL  1 mL 
4x lower buffer  7.5 mL  7.5 mL  ‐  ‐ 
4x upper buffer  ‐  ‐  2.5 mL  2.5 mL 
10 % SDS  0.3 mL  0.3 mL  ‐  ‐ 
H2O  10.1 mL  12.4 mL  5.9 mL  6.4 mL 
TEMED  40 µL  40 µL  30 µL  30 µL 





























Native PAGE was used to analyse proteins in there non-denatured globular state.  Pre-cast 
NativePAGE Novex 4-1 % Bis-Tris gels (Invitrogen, Cat# BN1004BOX) were used 
according to the manufacturer’s protocol in combination with the XCell SureLock® system. 
Gels were run for 105 min at 150 V and stained with coomassie staining solution 
(Section 3.8.1). Samples were mixed with 4x sample buffer before loading 10 µL of the 
















Western blots were made for the specific detection of proteins. Protein samples were 
separated using SDS-PAGE (Section 3.8.1) and then transferred to a polyvinylidene fluoride 
(PVDF) membrane with the Trans-blot SH semi-dry transfer cell (Bio-Rad) or the Trans-blot 
Turbo Transfer System (Bio-Rad) by a semi-dry blotting procedure (Kyhse-Andersen, 1984) 
before immunostaining. The SDS-gels as well as two pieces of blotting paper were 
equilibrated in transfer buffer. The PVDF membrane was first activated shortly in 100 % 
methanol before equilibration in transfer buffer. For the protein transfer the 
PVDF-membrane was placed bubble-free below the SDS-gel and sandwiched between two 
pieces of blotting paper on the anode of a blotting apparatus. The blot was run for 
30 min - 35 min at 12 V when using the Trans-blot SH semi-dry transfer cell (Bio-Rad) or 
for 7 min – 10 min when using the Trans-blot Turbo Transfer System (Bio-Rad). After the 
transfer the PVDF-membrane was blocked in 5 % skim milk powder in 1x PBS or Tris 
buffered saline with Tween-20 (TBS-T).  The membrane was washed 3x for 5 min in TBS-T 
and the primary antibody diluted in TBS-T (+ 3 % milk for FLAG antibody) applied to the 
membrane. The primary antibody was incubated overnight on a shaking platform and then 
removed by washing the membrane again 3x for 5 min with TBS-T. The secondary antibody 
(if required) was applied to the membrane diluted in TBS-T and incubated for at least 
2 hours. The membrane was washed again as described before and 1x for 5 min in alkaline 
phosphatase (AP) buffer. AP-conjugated antibodies bound to the protein of interest were 
detected with a 5-Bromo-4-chloro-3-indoxyl phosphate (BCIP) / nitro blue tetrazolium 
chloride (NBT) colour development substrate mixture diluted in AP buffer.  The Materials, 
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Table 3‐31: Materials, antibodies and reagents for Western blotting 
Materials  Model  Cat#  Supplier 
PVDF membrane  ImmobilonTM‐P, PVDF, pore size 0.45   IPVH00010  Millipore 
Blotting paper  GB 004 Gel‐Blotting Paper  426994  Schleicher und 
schuller 























Reagents  Concentration  Cat#  Supplier 
BCIP  50 mg/mL in 100 % dimethylformamide  S381C  Promega 







Cell extracts or purified protein eluates obtained from cell lines expressing the fluorescent 
protein tdTomato were analysed with the Tecan MD 1000 plate reader on Nuncleon Delta 
Surface plates (Thermo Scientific/Nunc, Cat# 137101). Purified tdTomato was used to 
generate a suitable standard curve diluted in either cell extract obtained from cell lines not 
expressing tdTomato or buffer corresponding to the one present in purified eluates. 
Samples and standards were analysed in two sets of triplicates on two separate plates using 
100 µL volume. Settings used during the measurements are listed in Table 3-32. 
Concentrations for tdTomato expression were calculated according to the calibration curve 
obtained during the same measurement. 
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To identify protein samples after separation with SDS-PAGE MALDI-TOF (Matrix Assisted 
Laser Desorption Ionisation – Time-of-Flight) mass spectrometry (MS) was used. Tryptic 
digestion of the isolated protein sample was followed by the co-crystallization with organic 
acids. A UV laser mediated the desorption of protein fragments and was than ionized by 
protonation of the peptide fragments.  Thus the mass-to-charge ratios were derived from 
the TOF measurements. This data was compared with the MASCOT database to identify 
the analysed proteins. The analyses were done by the research group Cellular Proteome 
Research at the HZI. 
3.9 Statistical methods 
3.9.1 Standard deviation 
The standard deviation (SD) for repeated measurements or values of one population were 
calculated according to the formula below which corresponds to the STDEV.P function in 
Microsoft Excel. 
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3.9.2 Analysis of variance – ANOVA 
To determine if there is a significant difference between mean protein yields obtained from 
triplicate batch cultures or different harvesting timepoints, a two-factor ANOVA without 
replication was used.  
First null-hypothesis (H0A): No significant difference in expression between batch cultures 
(µ = average yield, r = number of batch). 
ܪ଴஺ ൌ μଵ ൌ μଶ ൌ ⋯ ൌ μ௥          
Second null-hypothesis (H0B): No significant difference in expression between different 
harvesting time points. (µ = average yield, c = number of harvesting time point). 
ܪ଴஻ ൌ ߣଵ ൌ ߣଶ ൌ ⋯ ൌ ߣ௖ 
To confirm these null-hypothesises the F-ratio needed to be calculated for each by dividing 
the mean sum of squares (MS) of an analysed group through the MS of the within group 
variation.  A and B refer to the analysed groups (batch and harvesting time point) and E to 
the within group variation or random error. 
ܨ஺ ൌ ெௌಲெௌಶ                   ܨ஻ ൌ
ெௌಳ
ெௌಶ 
If an observed F-ratios was lower than the critical F value (F<Fcrit) and the p-value 
(probability) was larger than the set significance level α (p > α) the null-hypothesis could 
be accepted. All calculations were done using the two-factor ANOVA without replication 
function in Microsoft Excel. The significance level α was set to 0.05 to obtain a 95% 
confidence level. The formulas below show the different components required for the 
calculation of the F-ratio (SS = Sum of squares, df = degrees of freedom, x = measured 
values, ̅ݔ = total average of all measured values). 
ܵ ஺ܵ ൌ ܿ෍ሺݔ௜ െ ̅ݔሻଶ
௝
 ݀ ஺݂ ൌ ݎ െ 1 ܯ ஺ܵ ൌ ܵ ஺ܵ݀ ஺݂ 
ܵܵ஻ ൌ ݎ෍ሺݔ௝ െ ̅ݔሻଶ
௝
 ݀ ஺݂ ൌ ܿ െ 1 ܯܵ஻ ൌ ܵܵ஻݀ ஻݂  
ܵܵா ൌ෍	
௜
෍ሺ̅ݔ௜௝ െ ̅ݔ௜ െ	 ̅ݔ௝ െ ̅ݔሻଶ
௝
 ݀ ா݂ ൌ ሺݎ െ 1ሻሺܿ െ 1ሻ ܯܵா ൌ ܵܵா݀ ா݂  
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4 Results 
4.1 Establishment of binary RMCE master cell lines 
To enable the stable co-expression of difficult to express proteins with accessory molecules 
at pre-defined genomic loci a binary RMCE system was established during this work. The 
RMCE master cell lines SWI3_26 (Wilke et al., 2011) and SMT_dneo(2)_24 (Konrad Büssow, 
HZI) previously created in our group already contain the first exchange locus 
(PEF-FRT3-eGFP-FRTwt-Δneo) and were used for the stable integration of a second exchange 
cassette. In this section the steps for the generation of binary CHO Lec3.2.8.1 RMCE master 
cell lines for the targeted integration of transgenes at two distinct genomic loci are 
described. 
The groundwork required for the preparation of a second exchange cassette included the 
screening for antibiotic sensitivity in SWI3_26 cells to determine a suitable resistance 
marker for its selection trap (Section 4.1.1). Furthermore, the analysis of the fluorescent 
marker tdTomato (Section 4.1.2) ensured the compatibility with the existing eGFP marker 
in a binary system. To enable the site-specific integration into different loci heterospecific 
FRT sites (FRT13 and FRT14) which do not cross-interact with the existing ones (FRT3 and 
FRTwt) (Turan et al., 2010) were chosen for the second exchange locus. The chosen 
components were cloned into a tagging vector (Section 4.1.3) and used for genomic tagging 
of the SWI3_26 and SMT_dneo(2)_24 RMCE master cell lines followed by FACS and clonal 
isolation to obtain a new set of binary RMCE master cell lines (Section 4.1.4). To confirm the 
full integration of the exchange cassettes genomic PCR (Section 4.1.5) was used to 
determine RMCE master cell line integrity. Finally, to enable the integration of target genes 
into the second exchange locus a new donor vector was cloned (Section 4.1.6) comprising 
the new set of heterospecific FRT sites (FRT13 and FRT14). The binary RMCE system was 
used for the co-expression of TLRs with molecular chaperones as described in Section 4.4. 
4.1.1 Resistance of the CHO Lec3.2.8.1 cell line SWI3_26 to antibiotics 
To isolate cells that successfully integrated a GOI during RMCE, the second exchange locus 
in the binary RMCE system requires a different selection marker in its selection trap than 
exchange locus one. To select a resistance marker the resistance of the CHO Lec3.2.8.1 
RMCE master cell line SWI3_26 (Wilke et al., 2011) against the antibiotics geneticin (G418), 
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puromycin, phleomycin, zeocin and hygromycin B was tested according to Section 3.6.11. 
The decrease in cell density stagnated at a confluency of 20-30 % (visual observation) with 
all tested antibiotics. At this point no cell proliferation took place anymore indicating total 
cell death. Total cell death was observed at a concentration of 2100 µg/mL for G418, 
15 µg/mL for puromycin and phleomycin, 400 µg/mL for zeocin and 500 µg/mL for 
hygromycin B (Figure 4-1). The highest sensitivity was observed for puromycin and 
phleomycin which were equally suitable as potential selection traps for the second 
exchange locus. As a Δpuro selection trap was already available in our group, on the vector 
pEF-FS-eGFP-dpuro (Konrad Büssow, HZI), puromycin was used as antibiotic marker for 
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4.1.2 Suitability of tdTomato as fluorescent marker 
For the generation of binary RMCE cell lines a second fluorescent marker was required for 
simultaneous use with the eGFP marker already present in the first integration site of the 
RMCE master cell lines SWI3_26 and SMT_dneo(2)_24. To determine the suitability of 
tdTomato as a fluorescent marker in this setup a tdTomato producer cell line was derived 
from the master cell line SWI3_26 using the pFlpBtM-II_(beta)_tdTomato exchange vector 
for RMCE (Section 3.6.8).  
Flowcytometric analysis of this tdTomato producer cell line BBA10-tdTomato-C1 with the 
Guava easyCyte showed that tdTomato does not interfere with the green channel 
(BP 525/30 nm) which is used to determine the efficient exchange of the eGFP locus. 
However, the yellow channel (BP 583/26 nm) in which tdTomato is detected most 
efficiently as it is close to its emission maximum at 581 nm also detects eGFP (emission 
maximum 510 nm) and thus is not suitable for the detection of neither in a binary RMCE 
setup. Nonetheless, as tdTomato is also detected in the red channel (BP 680/ 30 nm) in 
which eGFP does not interfere significantly this one can be used for the analysis of 
tdTomato in a binary RMCE cell line (Figure 4-2). Similar testing was done to exclude any 
cross-interference with the Axiovert 100 fluorescence microscope using filter set 43 
(BP 605/70 nm), filter set 9 (LP 515 nm), filter set 44 (BP 530/50 nm) and filter set 25 (TBP 
460 + 530 + 625 nm). The most suitable combination was filter set 44 for eGFP with filter set 
43 for tdTomato (data not shown). In conclusion, tdTomato is a suitable second fluorescent 
marker and can be used in simultaneously to the eGFP fluorescent marker in a binary 
RMCE system.  
 
Figure 4‐2: Flowcytometric analysis of the BBA10‐tdTomato‐C1 producer cell line and SWI3_26 RMCE master cell 
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4.1.3 Cloning of tagging vector pEF‐FS‐tdTomato‐dpuro  
For the integration of an additional exchange cassette into the RMCE master cell lines 
SMT_dneo(2)_24 and SWI3_26 (Section 4.1.4) it was necessary to prepare a new tagging 
vector. This new tagging vector required a different set of heterospecific FRT sites (FRT13 
and FRT14) which does not cross-interact with the existing set of FRT sites (FRT3 and FRTwt) 
(Turan et al., 2010). Furthermore, a second fluorescent selection marker (tdTomato) which 
emits at a distinct wavelength to the already introduced eGFP marker in the first exchange 
cassette was needed for analytic purposes (Section 4.1.2). Lastly, a Δpuro selection trap 
(Section 4.1.1) was chosen as an additional selection system to the existing Δneo selection 
trap.  
The vector pEF-FS-eGFP-dpuro (Konrad Büssow, HZI) a variant of the vector 
pEF-FS-eGFP-dneo (Wilke et al., 2011), which was used for genomic tagging of 
CHO Lec3.2.8.1 cells to integrated the first exchange locus of the RMCE master cell lines 
SMT_dneo(2)_24 and SWI3_26, already contains a Δpuro selection trap. To introduce the 
new set of heterospecific FRT sites (FRT13 and FRT14) into the tagging vector 
pEF-FS-eGFP-dpuro a fragment containing the new set of FRT sites and the required 
restriction sites for cloning was synthesised by Life Technologies (Figure 4-3) and delivered 
in the vector 11AAYGEC_F13-F14_dpuro_pMA-RQ.  
 




site to assure that upon RMCE the  inserted start codon for the selection trap  is  in frame with the downstream Δpuro 
selection trap (not shown). 
 
Cloning of the pEF-FS-tdTomato-dpuro tagging vector was done in two steps.  First the 
tdTomato fluorescent marker together with its SV40pA signal were retrieved from the 
vector pFlpBtM-II(beta)_tdTomato (Steffen Meyer, HZI) with the restriction endonucleases 
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BstBI and BsaBI. The 1718 bp tdTomato_SV40pA fragment was ligated into the 2478 bp 
11AAYGEC_F13-F14_dpuro_pMA-RQ vector backbone (cut with BstBI and SnaBI) in 
between the FRT sites FRT13 and FRT14 thus destroying the SnaBI site. The resulting 
intermediate vector 11AAYGEC_F13-tdTomato_SV40pA-F14_dpuro-pMA-RQ containing 
the tdTomato selection marker with its SV40pA signal flanked by the heterospecific FRT 
sites FRT13 and FRT14 was used in the second cloning step. From this intermediate vector 
the FRT13-tdTomato_SV40pA-FRT14 fragment (1831 bp) was recovered through digestion 
with the endonucleases HF-HindIII and HF-EcoRI. The vector pEF-FS-eGFP-dpuro was also 
digested with the endonucleases HF-HindIII and HF-EcoRI to remove the eGFP marker 
gene and the old FRT sites FRT3 and FRTwt to obtain a backbone (4253 bp) for the new 
tagging vector which still contains the Δpuro selection trap. Thus the pEF-FS-dpuro 
backbone was ligated with the FRT13-tdTomato_SV40pA-FRT14 fragment to obtain the final 
tagging vector pEF-FS-tdTomato-dpuro (Figure 4-4). All plasmids used in this work are 












“FRT3‐eGFP‐FRTwt”  cassette  (red  line)  in  the  vector  pEF‐FS‐eGFP‐dpuro.  (E)  New  tagging  vector 
pEF‐FS‐tdTomato‐dpuro. 
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4.1.4 Generation of binary RMCE master cell lines 
The tagging vector pEF-FS-tdTomato-dpuro (Section 4.1.3) was used for genomic 
integration of a second exchange cassette (PEF-FRT13-tdTomato-FRT14-Δpuro) into the RMCE 
master cell lines SWI3_26 and SMT_dneo(2)_24 already comprising the first exchange 
cassette (PEF-FRT3-eGFP-FRTwt-Δneo). These two cell lines differ in their level of eGFP 
fluorescence as shown in Figure 4-5. SMT_dneo(2)_2 shows a higher level of fluorescence 
for eGFP indicating that the PEF-FRT3-eGFP-FRTwt-Δneo exchange cassette was integrated at 
a locus with better expression capabilities. The tagged cell lines were subjected to 1 or 2 
rounds of FACS followed by clonal isolation as required to isolate binary RMCE master cell 
lines. 
 
Figure  4‐5:  Flowcytometric  analysis  of RMCE master  cell  lines  SWI3_26  and  SMT_dneo(2)_24  before  genomic 
tagging with pEF‐FS‐tdTomato_dpuro. Histogram overlays obtained with the Guava easyCyte flowcytometer show 
the  level of green fluorescence (left) and the  level of red fluorescence (right) for the RMCE master cell  lines SWI3_26 




Terminology of the cell lines changed after sorting of the tagged cells and was further 
distinguished after clonal isolation. The first part of the name refers to a transfection 
experiment (TE) with a specific cell line designated with the number 1 for SWI3_26 derived 
cell lines and number 3 for SMT_dneo(2) derived cell lines during which the cells were 
genomically tagged. The second part of the name refers to the batch (B) of this transfection 
experiment that was done and send for the first round of FACS. Thus the SWI3_26 derived 
binary RMCE cell lines were named TE1-B1 (transfection experiment 1 batch 1) after the 
first round of FACS followed by a suffix after clonal isolation TE1-B1-[Clone ID]. The 
SMT_dneo(2)_24 derived binary RMCE cell lines were named TE3-B4 (transfection 
experiment 3 batch 4) after the first round of FACS followed by a suffix referring to the 
RESULTS 
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method of sorting in the second round of FACS (high or low tdTomato fluorescence) and a 
clonal number TE3-B4-[Clone ID].  
As seen in Figure 4-6 one round of FACS alone was not sufficient to isolate uniform 
tdTomato positive clones for neither TE1-B1 nor TE3-B4. Clonal isolation of TE1-B1 cells 
was done manually using limiting dilution according to Section 3.6.9 resulting in the 
isolation of 18 uniform tdTomato positive clones. Stable integration of the tdTomato 
exchange cassette was verified for four TE1-B1 clones by tracking their flowcytometry 
profiles over 11 weeks with the Guava easyCyte. Figure 4-7 shows flowcytometric data 
obtained for the binary RMCE master cell line TE1-B1-C2. In contrast, TE3-B4 cells were 
subjected to a second round of FACS which sorted the cells for “high” and “low” 
fluorescent tdTomato positive cells which resulted in the “high” tdTomato fluorescent 
clone TE3-B4-H1 as well as the “low” tdTomato fluorescent clones TE3-B4-L1.1 and 
TE3-B4-L1.2 which were derived from the same pool (Figure 4-8). Stable genomic 
integration of the tdTomato exchange cassette was verified for the binary RMCE master cell 
lines TE3-B4-H1 and TE3-B4-L1.1 by tracking their flowcytometry profiles over 11 weeks 
(Figure 4-9). 
The binary RMCE master cell lines TE3-B4-H1 and TE3-B4-L1.1 were further used to 
generate several producer cell lines as higher yields for locus 1 (PEF-FRT3-eGFP-FRTwt-Δneo) 






























4.1.5 Determination  of  exchange  cassette  integrity  in  binary  RMCE 
master cell lines via genomic PCR 
To confirm the full integration of the exchange cassettes PEF-FRT3-eGFP-FRTwt-Δneo and 
PEF-FRT13-tdTomato-FRT14-Δpuro genomic DNA was extracted from the binary RMCE 
master cell lines TE3-B4-H1 and TE3-B4-L1.1 as described in Section 3.5.3. Forward 
oligonucleotide Cassette-pEF-S was combined with the reverse oligonucleotides 
Cassette-neo-AS or Cassette-puro-AS to amplify the entire exchange cassettes for both loci 
(Figure 4-10).  PCR amplifications of the size 3130 bp for locus 1 (PEF-FRT3-eGFP-FRTwt-Δneo) 
and 3651 bp for locus 2 (PEF-FRT13-tdTomato-FRT14-Δpuro) confirmed the full integration of 
both loci as show in Figure 4-12.  
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In addition to the expected 3651 bp band during the genomic amplification of exchange 
locus 2 (PEF-FRT13-tdTomato-FRT14-Δpuro) with the oligonucleotide pair 
Cassette-pEF-S/Cassette-puro-AS a strong 900 bp band was observed. To determine its 
origin the producer cell line BBA10-tdTomato-C1 (Section 4.2) which only contains locus 1 
with an integrated tdTomato gene (PEF-FRT3-tdTomato-PPGK-ATG-FRTwt-Δneo) was analysed 
(Figure 4-11). Even though the forward oligonucleotide Cassette-pEF-S also binds to the PEF 
promoter of this locus the reverse oligonucleotide Cassette-puro-AS has no binding site in 
locus 1. While no amplification was expected for this oligonucleotide combination, the 
900 bp amplicon was detected (Figure 4-12) which demonstrates that amplification is not 
dependent on the presence of the Δpuro binding site for oligonucleotide Cassette-puro-AS. 
The cell line TE3-B4-L1.1-tdTomato/tdTomato-C1 (Section 4.2) was used as positive control 
as it contains both loci with a tdTomato gene (Figure 4-11). As expected this cell line also 
displayed the 900 bp background band (Figure 4-12). The use of individual 
oligonucleotides, either Cassette-pEF-S or Cassette-puro-AS, in the binary master cell line 
TE3-B4-H1 demonstrated that both oligonucleotides are required for the amplification of 
the 900 bp band (Figure 4-12). All FRT sites as well as tdTomato do contain repetitive 
sequences which theoretically might result in artefacts, however none would result in the 
observed 900 bp amplicon. Potential binding sites of the Cassette-puro-AS oligonuclotide 
within the tdTomato gene which would explain the observed background band could not 
be detected through alignment (similarity down to 55%). Thus this strong background band 
at 900 bp appears to result from a chromosomal binding site not associated with either 
exchange locus. 
       
Figure  4‐11:  Genomic  PCR  amplification  of  producer  cell  lines  BBA10‐tdTomato‐C1  and 
TE3‐B4‐L1.1‐tdTomato/tdTomato‐C1.  (Left)  Genomic  PCR  amplification  of  locus  1 
(PEF‐FRT3‐tdTomato‐PPGK‐ATG‐FRTwt‐Δneo) with the oligonucleotides Cassette‐pEF‐S and Cassette‐puro‐AS present in 
both cell lines serves only one binding site in the exchange cassette. Therefore no amplicon is expected. (Right) Genomic 
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TE3‐B4‐H1  and  TE3‐B4‐L1.1  and  two  tdTomato  producer  cell  lines:  Full  integration  of  exchange  locus  1 
(PEF‐FRT3‐eGFP‐FRTwt‐Δneo) at 3130 bp (left) and exchange locus 2 (PEF‐FRT13‐tdTomato‐FRT14‐Δpuro) at 3651 bp (right) 
were demonstrated for both binary RMCE master cell lines (Lane 2 and 3 ‐ yellow box). Moreover it was shown that the 




BBA10‐tdTomato‐C1  only  contains  locus  1  with  an  integrated  tdTomato  gene 
(PEF‐FRT3‐tdTomato‐PPGK‐ATG‐FRTwt‐Δneo). Thus only the forward oligonucleotide which anneals to the PEF promoter 




To enable the integration of a GOI into the PEF-FRT13-tdTomato-FRT14-Δpuro locus of a binary 
RMCE cell line the new set of FRT sites (FRT13 and FRT14) needed to be introduced into the 
exchange vector pFlpBtM-II. To do so a fragment containing FRT13 and FRT14 sites as well 
as the required restriction endonuclease sites for cloning were synthesised by Life 
Technologies (Figure 4-13) and delivered in the vector 
11AAGFC_F13-F14_pFlBtM-II_pMK-RQ. 
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Besides the FRT13 and FRT14 sites the vector 11AAGFC_F13-F14_pFlBtM-II_pMK-RQ also 
comprised an insect promoter, an enhancer and a TMV leader sequence not required for 
this work. These non-relevant vector elements needed to be removed. To remove these 
elements the plasmid was first partially digested with BsaBI. The linearized vector (3537 bp) 
was isolated from an preparative agarose gel and digested in a second step with SnaBI to 
obtain a 2429 bp backbone without the non-relevant sequences which than was religated, 
thus destroying the BsaBI and SnaBI sites. The intermediate vector 
11AAGFC_F13-F14_pFlpBtM-II_pMK-RQ_(no_Insect_Promoter) was than digested with 
the endonucleases HF-KpnI and BstBI to obtain a backbone (2396 bp) for the insertion of the 
“Shine-Dalgarno_MCS_PGK” fragment (1141 bp) extracted from pFlpBtM-II with the 
endonucleases BstBI and KpnI. This ligation results in the next intermediate vector 
11AAYGFC_F13-MCS_PGK-F14_pFlpBtM-II_pMK-RQ containing the 
“Shine-Dalgarno_MCS_PGK” fragment of the pFlpBtM-II vector flanked with the new set 
of heterospecific FRT sites. This fragment “FRT13-Shine-Dalgarno_MCS_PGK-FRT14” 
(1255 bp) was than retrieved with the endonucleases HF-BamHI and AvrII and cloned into 
a pFlpBtM-II vector backbone (5592 bp) which was obtained through the digestion with 
HF-BamHI and AvrII restriction endonucleases, resulting in the new vector 
pFlpBtM-II_F13/F14 (Figure 4-14). 
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Figure  4‐14:  Cloning  of  exchange  vector  pFlpBtM‐II_F13/F14.  (A) Non‐relevant  vector  sequences  (red  line) were 
removed  stepwise  from  the  synthesised  vector  11AAGFC_F13‐F14_pFlBtM‐II_pMK‐RQ  using  BsaBI  and  SnaBI 
endonucleases. (B) The backbone was religated thus destroying the BsaBI and SnaBI sites before digestion with BstBI 
and HF‐KpnI to obtain a vector backbone. (C) The “Shine‐Dalgarno_MCS_PGK” fragment (red line) was retrieved from 
pFlpBtM‐II  with  BstBI  and  HF‐KpnI.  (D)  The  fragment  “Shine‐Dalgarno_MCS_PGK”  was  inserted  into  the 
11AAGFC_F13‐F14_pFlpBtM‐II_pMK‐RQ_(no_Insect_Promoter)  backbone  to  subsequently  retrieve  the  fragment 
“FRT13‐Shine‐Dalgarno_MCS_PGK‐FRT14”  (red  line).  (E)  A  pFlpBtM‐II  vector  backbone  (red  line)  obtained  with 
HF‐BamHI and AvrII  (F) was  ligated with  the  “FRT13‐Shine‐Dalgarno_MCS_PGK‐FRT14”  fragment  to obtain  the new 
exchange vector pFlpBtM‐II_F13/F14.   
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4.2 Evaluation of (binary) RMCE master and producer cell lines 
expressing tdTomato 
As described in Section 4.1 the RMCE master cell lines SWI3_36 and SMT_dneo(2)_24 
comprise one exchange locus (PEF-FRT3-eGFP-FRTwt-Δneo) at different chromosomal 
locations.  The binary RMCE master cell lines TE3-B4-H1 and TE3-B4-L1.1, that were 
derived from SMT_dneo(2)_24, additionally comprise a second exchange locus 
(PEF-FRT13-tdTomato-FRT14-Δpuro). The first exchange locus (PEF-FRT3-eGFP-FRTwt-Δneo) of 
the binary RMCE cell lines is located at the same chromosomal position for both; whereas 
the second exchange locus (PEF-FRT13-tdTomato-FRT14-Δpuro) is located at different 
chromosomal positions. To evaluate position and gene dose effects for these cell lines, 
tdTomato was integrated into the cell lines SWI3_26 and SMT_dneo(2)_24 using RMCE 
thus replacing eGFP in locus 1. Likewise tdTomato was integrated into the first locus of the 
binary RMCE cell lines TE3-B4-H1 and TE3-B4-L1.1, which than expressed tdTomato in 
both exchange loci (Section 4.2.4). Figure 4-15 gives an overview of the analysed cell lines 
and their heritage. 
Genomic PCR (Section 4.2.1) and flowcytometry (Section 4.2.4) were used to demonstrate 
the successful exchange of genomic loci. The binary master cell lines TE3-B4-H1 and 
TE3-B4-L1.1 described in Section 4.1.4 as well as the producer cell lines 
BBA10-tdTomato-C1 and TE3-B4-L1.1-tdTomato/tdTomato-C1 described in Section 4.2.4 
were analysed as follows: Fluorescence based methods including flowcytometry 
(Section 4.2.4) and the quantification with a fluorescent plate reader (Section 4.2.2) were 
used to visualize and quantify the expression level of tdTomato and thus complement and 
support results obtained from protein purification (Section 4.2.3). The producer cell lines 
TE3-B4-H1-tdTomato/tdTomato-C1 and SMT_dneo(2)_24-tdTomato-C1 that were 
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Figure  4‐15:  Overview  of  tdTomato  expressing  RMCE  master  and  producer  cell  lines  and  their  heritage. 
CHO Lec3.2.8.1 cells were genomically tagged with exchange locus 1 (PEF‐FRT3‐eGFP‐FRTwt‐Δneo) from which the master 
cell  lines SWI3_26  (Wilke et al., 2011) and  later on a higher  fluorescent version SMT_dneo(2)_24 were derived. The 
producer cell line BBA10‐tdTomato‐C1 was derived from master cell line SWI3_26 through exchange of eGFP against 
tdTomato.  Likewise  the  producer  cell  line  SMT_dneo(2)_24‐tdTomato  was  derived  from  the  master  cell  line 
SMT_dneo(2)_24.The master  cell  line  SMT_dneo(2)_24 was  used  for  the  integration  of  a  second  exchange  locus  
(PEF‐FRT13‐tdTomato‐FRT14‐Δpuro) to create the binary RMCE master cell lines TE3‐B4‐H1 (higher level of fluorescence 
for locus 2) and TE3‐B4‐L1.1 (lower level of fluorescence for locus 2) which therefore expressed tdTomato in their second 
exchange  locus.  The  binary  producer  cell  lines  TE3‐B4‐H1‐tdTomato/tdTomato‐C1  and 




The tdTomato expressing RMCE master and producer cell lines were analysed using 
genomic PCR to address several questions. Firstly, as already described in Section 4.1.5, 
genomic PCR was used to determine full integration of the exchange cassettes 
PEF-FRT3-eGFP-FRTwt-Δneo and PEF-FRT13-tdTomato-FRT14-Δpuro in the binary RMCE master 
cell lines TE3-B4-H1 and TE3-B4-L1.1.  
Secondly, genomic PCR was used to control the successful exchange of eGFP against 
tdTomato for the producer cell lines TE3-B4-L1.1-tdTomato/tdTomato-C1 and 
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BBA10-tdTomato-C1. The eGFP and/or tdTomato inserts in both loci were amplified using 
the forward oligonucleotide Insert-pEF-S with the reverse oligonucleotide Insert-dneo-AS 
or Insert-dpuro-AS (Figure 4-16). The amplified sequences showed the presence of either 
eGFP (1334 bp band), tdTomato (1896 bp band) or tdTomato with a downstream PGK 
promoter (2795 bp band), if eGFP was replaced against tdTomato using RMCE, in a given 
locus.  The successful exchange of eGFP against tdTomato in exchange locus 1 of the tested 
producer cell lines TE3-B4-L1.1-tdTomato/tdTomato-C1 and BBA10-tdTomato-C1 was 
demonstrated as seen in Figure 4-17. Both producer cell lines amplified the 2795 bp band 
specific for the integrated tdTomato gene with a downstream PGK promoter. As expected 
the binary master cell lines, which served as a control, amplified the 2795 bp band for eGFP 
in exchange locus 1 and the 1334 bp band for tdTomato (without downstream PGK 
promoter) in exchange locus 2. Moreover it was shown that no detectable cross-interaction 
between the two exchange loci occurred as this would have resulted in the larger 1896 bp 




amplification of  locus 1 before and after exchange of eGFP against  tdTomato via RMCE. Amplification of  the eGFP 
containing locus 1 (PEF‐FRT3‐eGFP‐FRTwt‐Δneo) with the oligonucleotide pair Insert‐pEF‐S/Insert‐dneo‐AS will result in 
an  1334  bp  amplicon  for  all  master  cell  lines.  The  same  locus  after  integration  of  tdTomato 
(PEF‐FRT3‐tdTomato‐PPGK‐ATG‐FRTwt‐Δneo)  will  yield  an  2795  bp  amplicon  for  producer  cell  lines 





























TE3‐B4‐H1  and  TE3‐B4‐L1.1  as  well  as  producer  cell  lines  TE3‐B4‐L1.1‐tdTomato/tdTomato‐C1  and 
BBA10‐tdTomato‐C1: The genomic amplification of either eGFP or tdTomato in locus 1 or locus 2 demonstrated the 
successful  exchange  of  eGFP  against  tdTomato  in  the  cell  lines  TE3‐B4‐L1.1‐tdTomato/tdTomato‐C1  and 
BBA10‐tdTomato‐C1. The amplification marked with a wildcard (*,left gel) did not work and was repeated (*,right gel). 
4.2.2 Quantification  of  tdTomato  expressing  RMCE  master  and 
producer cell lines by fluorescence with the Tecan MD 1000 plate 
reader 
To quantify the expression of tdTomato and determine eventual batch to batch variations 
that might occur; the tdTomato expressing cell lines TE3-B4-H1, TE3-B4-L1.1, 
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TE3-B4-L1.1-tdTomato/tdTomato-C1 and BBA10-tdTomato-C1 were cultured in triplicates 
using parallel batch cultures. To evaluate the kinetics of tdTomato expression at different 
timepoints, a specific cell number (3x106 cells) was withdrawn from the cultures 24 h 
(timepoint 1), 48 h (timepoint 2) and 72 h (timepoint 3) after expansion. Cell extracts were 
analysed with the Tecan MD 1000 plate reader as described in Section 3.8.4. The acquired 
values were compared with a tdTomato calibration curve (Figure A.2-1 in appendix) and 
subjected to statistical analysis. Figure 4-18 shows the average tdTomato protein 
concentrations obtained for cell extracts measured with the Tecan MD 1000 plate reader for 
each cell line including the standard deviation (SD). As expected the binary cell line 
TE3-B4-L1.1-tdTomato-tdTomato shows the highest level of tdTomato expression. The cell 
lines TE3-B4-H1, TE3-B4-L1.1 and BBA10-tdTomato, which express tdTomato in only one 
but different chromosomal locus for each cell line, show lower expression yields. While the 
cell line TE3-B4-L1.1 clearly shows the lowest level of tdTomato expression the cell lines 
TE3-B4-H1 and BBA10-tdTomato-C1 exhibit a similar level of expression which becomes 
clear when comparing the standard deviations. In conclusion chromosomal position of each 
locus exhibits specific, reproducible expression properties for each cell line.  
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To determine if a difference in tdTomato expression can be observed between batches or 
harvesting timepoints, the obtained yields (Table A.2-2 in the appendix) were subjected to 
an analysis of variance (ANOVA) according to Section 3.9.2. ANOVA is a statistical method 
which enables the comparison between sample means and determine if they belong into 
the same overall group. ANOVA showed that the values obtained for parallel batch 
cultures and different harvesting timepoints belong to the same group (Table A.2-3 in 
appendix). This means, that there is no significant difference in expression between batches 
nor harvesting time points. Thus the reproducibility of tdTomato expression was 
demonstrated between triplicate batch cultures as well as their independence of the 
harvesting timepoint (for a determined cell number). This confirms the robust and 
reproducible expression properties of the tested stable cell lines. Moreover, these properties 
were not influenced by their growth phase. 
To determine if the analysis of cell extracts obtained from a small number of cells 
(3x106 cells) will result in equivalent tdTomato yields as the analysis of purified tdTomato 
obtained from a larger number of cells (2x108 cells) both were compared.  Purified tdTomato 
obtained from triplicate batch cultures of the same cell lines (Section 4.2.3), was analysed 
with the Tecan MD 1000 plate reader. The tdTomato calibration curve is available in the 
appendix (Figure A.2-2). Figure 4-19 compares the average yields (calculated for 1x109 cells) 
of tdTomato obtained from cell extracts and purified tdTomato for each cell line including 
the SD for triplicate batch cultures. This confirms that the data obtained with the 
Tecan MD 1000 is consistent independent of the harvested cell number and therefore 
tdTomato concentration in the analysed sample as well as sample preparation (cell extract 
vs. purified protein). Particularly the similar expression level of the cell lines TE3-B4-H1 
and BBA10-tdTomato-C1, as discussed above, are visualized in Figure 4-19. The specific 
expression properties for each cell line described in this section as well as other tdTomato 
expressing cell lines are also described in Section 4.2.4. 
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Figure 4‐19: Comparison of protein yields obtained with the Tecan MD 1000 fluorescent plate reader for cell extracts 
of tdTomato expressing cell  lines and purified tdTomato. Comparison of average protein yields  for 1x109 cells  for 
triplicate  batches  of  tdTomato  expressing  cell  lines.  Protein  yields  for  tdTomato  expression were  either  obtained 
through the measurement of cell extracts or purified tdTomato using the Tecan MD 1000 fluorescent plate reader. Error 
bars for the standard deviation between triplicate batch cultures (black bars) are included.  
4.2.3 Quantification  and  comparison  of  tdTomato  expressing  RMCE 
master and producer cell lines after affinity chromatography 
To quantify tdTomato expression the cell lines TE3-B4-H1, TE3-B4-L1.1, 
TE3-B4-L1.1-tdTomato/tdTomato-C1 and BBA10-tdTomato-C1 were cultivated in 
triplicate batch cultures. Cell extracts obtained from 2x108 cells were purified using affinity 
chromatography (Ni-NTA). The spectrophotometrically obtained tdTomato yields for 
triplicate batch cultures are listed in Table 4-1. However, some unspecific background 
proteins co-purified with each sample raised the actual protein concentration 
un-proportionally for cell lines with lower expression of tdTomato as described in 
Section 4.2.5. The observed fragmentation of tdTomato caused by intramolecular nicking of 
tdTomato during SDS-PAGE (Figure 4-20) was previously described by Meyer, (2012). Full 
length tdTomato at 55 kDa as well as truncated fragments of tdTomato below 50 kDa and 
37 kDa could be observed and identified as tdTomato fragments by MALDI-TOF. 
Native-PAGE (Figure 4-21) shows tdTomato in its mostly non-truncated state just one lower 
band was detected. Compared to SDS-PAGE, Native-PAGE demonstrates a better 
visualization of expression strength for each cell line due to the lack of fragmentation. Thus 
the cell lines TE3-B4-L1.1-tdTomato/tdTomato-C1 and TE3-B4-L1.1, which express the 
highest and lowest level of tdTomato, can be clearly differentiated from the remaining two 
cell lines. A detailed discussion and comparison of all cell lines is available in Section 4.2.5. 
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TE3‐B4‐H1  0.7  0.8  0.7  0.7 ± 0.1 
TE3‐B4‐L1.1  0.5  0.5  0.4  0.5 ± 0.1 
TE3‐B4‐L1.1‐tdTomato/tdTomato‐C1  1.1  0.9  0.9  1.0 ± 0.1 


















TE3‐B4‐H1, TE3‐B4‐L1.1, TE3‐B4‐L1.1‐tdTomato/tdTomato‐C1 and BBA10‐tdTomato‐C1 were  cultivated  in  triplicate 
batch cultures. Cell extracts obtained  from 2x108 cells were used  to purify  tdTomato using Ni‐NTA. SDS‐PAGE and 
Western blot show tdTomato at 55 kDa and its truncated forms. 
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4.2.4 Flowcytometric  analysis of  tdTomato  expressing RMCE master 
and producer cell lines 
Flowcytometry was used to define the different level of tdTomato expression for the binary 
master cell lines TE3-B4-H1 and TE3-B4-L1.1 (Section 4.1.4) as well as the producer cell lines 
BBA10-tdTomato-C1, SMT_dneo2(24)-tdTomato-C1 and the binary producer cell lines 
TE3-B4-H1-tdTomato/tdTomato-C1 and TE3-B4-L1.1-tdTomato/tdTomato-C1 described 
below.  
To generate binary producer cell lines expressing tdTomato in two chromosomal loci the 
binary master cell lines TE3-B4-H1 and TE3-B4-L1.1 were used. These binary master cell 
lines already express tdTomato in exchange locus 2 (PEF-FRT13-tdTomato-FRT14-Δpuro). They 
were used to create the binary producer cell lines TE3-B4-H1-tdTomato/tdTomato-C1 
(Johannes Spehr, HZI) and TE3-B4-L1.1-tdTomato/tdTomato-C1 respectively through the 
exchange of eGFP in locus 1 (PEF-FRT3-eGFP-FRTwt-Δneo) against tdTomato using RMCE. 
Successful integration of tdTomato into locus 1 was demonstrated via flowcytometry. The 
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introduction of a second copy of the tdTomato gene, and the consequent increase in 
tdTomato expression, could be detected through the rise in fluorescence levels 
(Figure 4-22). Likewise tdTomato was integrated into the master cell lines SWI3_26 and 
SMT_dneo(2)_24 to generate the producer cell lines BBA10-tdTomato-C1 as previously 
described in Section 4.1.2 and SMT_dneo(2)_24-tdTomato-C1 (Johannes Spehr, HZI) 
respectively (Figure 4-23). 
 




(black  lines) and producer cell  line TE3‐B4‐L1.1‐tdTomato/tdTomato‐C1  (solid green or red). Both producer cell  lines 
were derived from their respective master cell lines through the exchange of eGFP against tdTomato in exchange locus 1 
(PEF‐FRT3‐eGFP‐FRTwt‐Δneo) via RMCE. Data demonstrates the successful exchange of eGFP against tdTomato in locus 1. 
The binary master cell lines TE3-B4-H1 and TE3-B4-L1.1 described in Section 4.1.4 contain 
only one exchange locus expressing tdTomato. Nonetheless, the integration of tdTomato at 
different chromosomal loci results in different expression level as shown previously 
(Section 4.1.4). 
Histogram overlays of all tdTomato expressing cell lines are shown in Figure 4-23. This 
visualizes and demonstrates the different level of tdTomato expression for each cell line. 
Figure 4-24 shows a direct comparison of mean fluorescence for the binary producer cell 
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lines TE3-B4-H1-tdTomato/tdTomato-C1 and TE3-B4-L1.1-tdTomato/tdTomato-C1 that 
express tdTomato in both exchange loci in comparison to appropriate cell lines that express 
tdTomato in one of either locus alone. Numeric values are available in Table A.2-1 in the 
appendix. In summary this data demonstrates a cumulative effect in tdTomato expression 
for the binary RMCE system proportional to the expression capabilities of each locus if both 
exchange loci express tdTomato. Furthermore it was shown that the integration at a 
chromosomal location with high expression capabilities can have the same effect as the 
introduction of several copy numbers of a GOI. For example the binary producer cell line 
TE3-B4-L1.1-tdTomato/tdTomato-C1 shows similar level of tdTomato expression as the 
cell line TE3-B4-H1 that only expresses tdTomato in one exchange cassette. Likewise the 
effects of chromosomal positioning are demonstrated by the cell lines that express 
tdTomato in only one exchange cassette at different chromosomal loci 




lines  TE3‐B4‐H1  (light  brown)  and  TE3‐B4‐L1.1  (light  red)  as  well  as  producer  cell  lines 
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Figure  4‐24: Mean  red  fluorescence  of  tdTomato  expressing  cell  lines  that  express  tdTomato  at  one  or  two 
chromosomal  loci:  (Top)  Comparison  of  red  fluorescence  level  in  the  binary  producer  cell  line  
TE3‐B4‐H1‐tdTomato/tdTomato‐C1 which expresses tdTomato in both exchange cassettes, to the red fluorescence level 
of SMT_dneo(2)_24‐tdTomato  and TE3‐B4‐H1 that express tdTomato in only one exchange cassette that refer to locus 1 
or  locus 2 of  the binary producer cell  line  respectively.  (Bottom) Comparison of  red  fluorescence  level  in  the binary 
producer cell line  TE3‐B4‐L1.1‐tdTomato/tdTomato‐C1 which expresses tdTomato in both exchange cassettes, to the 
red  fluorescence  level  of  SMT_dneo(2)_24‐tdTomato  and  TE3‐B4‐L1  that  express  tdTomato  in  only  one  exchange 
cassette that refer to locus 1 or locus 2 of the binary producer cell line respectively. 
4.2.5 Summary  and  conclusion  –  evaluation  of  tdTomato  expressing 
RMCE master and producer cell lines 
Expression level of tdTomato expressing RMCE master and producer cell lines were 
evaluated in Sections 4.2.2 - 4.2.4 using several methods. Quantitative yield obtained from 
fluorometric quantification with the Tecan MD-1000 plate reader (Section 4.2.2) and protein 
purification (Section 4.2.3) are summarised in Table 4-2. As described previously in 
Section 4.2.3 some unspecifically bound protein was co-purified during Ni-NTA which 
raised the obtained protein yields unproportionally for cell lines with lower tdTomato 













TE3‐B4‐H1  3.8   3.5  3.6 
TE3‐B4‐L1.1  1.4   1.1  2.4 
TE3‐B4‐L1.1‐tdTomato/tdTomato‐C1  4.5   4.5  4.8 
BBA10‐tdTomato‐C1  3.2  3.4  4.9 
 
In summary, tdTomato expressing cell lines that comprise tdTomato in only one but distinct 
exchange locus (TE3-B4-L1.1, TE3-B4-H1, SMT_dneo(2)_24-tdTomato-C1 and 
BBA10-tdTomato-C1) showed locus specific levels of tdTomato expression as described in 
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Sections 4.2.2 - 4.2.4. The binary producer cell lines TE3-B4-H1-tdTomato/tdTomato-C1 
and TE3-B4-L1.1-tdTomato/tdTomato-C1 that express tdTomato in two genomic loci 
showed cumulative level of expression which were proportional to the expression 
capabilities of each locus. This demonstrates that targeted integration into pre-characterised 
genomic loci in a binary RMCE system can be used to obtain stable producer cell lines with 
predictable expression properties. The use of chromosomal loci with high expression 
capabilities in both loci will be desirable for most targets. However, the use of binary RMCE 
cell lines that show different expression capabilities for each locus may proof useful for the 
co-expression of proteins that are required in a varying proportions. Monoclonal antibodies 
for example consist of heavy and light chain subunits in an equimolar ratio. However, it 
was show that an overproduction of the light chain improves overall productivity (Schlatter 
et al., 2005). Even the co-expression of accessory molecules which are required in only small 
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4.3 mGRP94 and mPRAT4A 
4.3.1 Cloning  of  mPRAT4A  and  mGRP94  into  pFlpBtM‐II_F13/F14 
vector 
Difficult to express protein targets such as TLRs can serve as a formidable challenge. The 
stable co-expression of accessory molecules is anticipated to improve their expression. To 
generate stable binary CHO Lec3.2.8.1 cell lines that co-express Toll–like receptors with 
their ER chaperones mPRAT4A or mGRP94, these chaperones were cloned into the 
exchange vector pFlpBtM-II_F13/F14 made in Section 4.1.6.  The commercially available 
plasmids pUNO1-mPRAT4A and pUNO1-mGRP94 (InvivoGen) were used to amplify full 
length murine PRAT4A and GRP94 constructs with N- and C-terminal FLAG-tags to test 
variances in expression using HEK293-6E before the stable integration into binary RMCE 
master cell lines (Section 4.3.2). Restriction sites NcoI and MluI were introduced for cloning 
of mPRAT4A constructs whereas ClaI and MluI sites were introduced for cloning of 
mGRP94 constructs as mGRP94 already contains internal NcoI restriction sites. For the 
ligation of mPRAT4A constructs, the pFlpBtM-II_F13/F14 vector was digested with NcoI 
and MluI restriction endonucleases. This resulted in the removal of the IgG secretion signal 
sequence, which was replaced by the native secretion signal sequence of mPRAT4A and 
the removal of the internal His- and Twin-Strep-tags, replacing those with a FLAG-tag. For 
the ligation of mGRP94 constructs, the pFlpBtM-II_F13/F14 vector was digested with BstBI 
and MluI restriction endonucleases. As before this resulted in the removal of the IgG 
secretion signal sequence, which was replaced by the native secretion signal sequence of 
mGRP94 and the removal of the internal His- and Twin-Strep-tags, replacing those with a 
FLAG-tag. The Shine-Dalgarno sequence which was also removed due to the use of the 
BstBI site needed to be replaced with the mGRP94 PCR fragments. The ligation of mGRP94 
PCR fragments with the vector backbone resulted in the destruction of the compatible 
BstBI/ClaI restriction sites. Cloning steps are described in Figure 4-25 and Figure 4-26. 
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Figure  4‐25: Cloning  of C‐  and N‐terminally  FLAG‐tagged mPRAT4A  constructs.  (A)  PCR  fragments  for N‐  and 
C‐terminally tagged mPRAT4A constructs were amplified using the commercial vector pUNO1‐mPRAT4A (InvivoGen) 
(red arrows). (B) A pFlpBtM‐II vector backbone (red line) was obtained through digestion with NcoI and MluI restriction 
endonucleases,  thus  removing  the  IgG  secretion  signal  sequence and  the  internal His‐ and Twin‐Strep‐tag.  (C) The 




 94  
 
Figure  4‐26:  Cloning  of  C‐  and N‐terminally  FLAG‐tagged mGRP94  constructs.  (A)  PCR  fragments  for N‐  and 
C‐terminally  tagged mGRP94  constructs were  amplified using  the  commercial  vector pUNO1‐mGRP94  (InvivoGen) 
(red arrows). (B) A pFlpBtM‐II vector backbone was obtained (red line) through digestion with BstBI and MluI restriction 
endonucleases, thus removing the Shine‐Dalgarno sequence, IgG secretion signal sequence and the  internal His‐ and 
Twin‐Strep‐tag.  (C)  The  ligation with  the  digested  (ClaI  and MluI) mGRP94  PCR  products, which  reintroduce  the 
Shine‐Dalgarno sequence and destroy  the BstBI/ClaI  restriction sites,  resulted    in  the  final exchange vectors  for  the 
N‐ terminally FLAG‐tagged (D)  and C‐terminally FLAG‐tagged mGRP94 constructs. 
4.3.2 Test expression of mPRAT4A and mGRP94 in HEK293‐6E 
To determine if the position of the FLAG-tag has an influence on the expression level of 
mPRAT4A or mGRP94; constructs with N- and C-terminal FLAG-tags were designed 
(Section 4.3.1) and transiently expressed in HEK293-6E using 250 mL batch cultures. 
mPRAT4A and mGRP94, obtained from cell extracts, were purified with FLAG magnetic 
beads and expression analysed using SDS-PAGE and Western blot. This demonstrated that 
C-terminally tagged constructs show better expression level for both mPRAT4A and 
mGRP94 (Figure 4-27). However, it is possible that the N-terminal FLAG-tag which was 
locatated upstream of the signal peptide was removed together with the signal peptide after 
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cellular sorting in the secretion pathway (Alberts, 2008). In that case mPRAT4A and 
mGRP94 might have been expressed, but could not be purified due to the loss of the 
FLAG-tags. Consequently, mPRAT4A and mGRP94 constructs with C-terminal FLAG-tags 
were used for small scale (6 mL) co-expression with mTLR1 and ssmTLR2 in HEK293-6E. 
These results were not conclusive but seemed to indicated improvement in TLR2 
expression level (data not shown). Thus C-terminally FLAG-tagged mPRAT4A and 
mGRP94 constructs were used for the stable co-expression with TLR ECD constructs  in 











Figure  4‐27:  12 %  SDS‐PAGE  and Western  blot  analysis  of  C‐  and N‐terminally  FLAG‐tagged mPRAT4A  and 
mGRP94 constructs expressed transiently in HEK293‐6E and purified with FLAG‐magnetic beads. (Top) SDS‐PAGE 
showing  fractions  of  magnetic  bead  purification  for  C‐terminally  FLAG‐tagged  mPRAT4A  (left)  and  N‐terminally 
FLAG‐tagged mPRAT4A (middle) with corresponding western blot (right). (Bottom) SDS‐PAGE showing fractions of 
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4.3.3 Expression of mPRAT4A and mGRP94  in binary RMCE cell  lines 
(CHO Lec3.2.8.1) 
The first step for the generation of binary TLR/chaperone producer cell lines required the 
introduction of mPRAT4A and mGRP94 into the second exchange locus 
(PEF-FRT13-tdTomato-FRT14-Δpuro) of the binary RMCE master cell line TE3-B4-H1 via 
RMCE. Previous efforts to introduce TLR and chaperones into both exchange loci 
simultaneously failed due to the low exchange rates realized by FLP recombinase. 
Consequently, the isolation of clones that successfully exchanged both cassettes and 
survived antibiotic selection against G418 and puromycin simultaneously could not be 
accomplished (data not shown).  Figure 4-28 and Figure 4-29 show flowcytometric data for 
the binary producer cell lines TE3-B4-H1-eGFP/mPRAT4A-1.1 and 
TE3-B4-H1-eGFP/mGRP94-C1 compared to the RMCE master cell line TE3-B4-H1 from 
which they were derived. The slight shift within the green channel reflects a minor overlap 
of the upper detection limit of the green channel (555 nm) and the lower range of the 
tdTomato emission spectrum (Section 1.5.1). The successful exchange of tdTomato against 











the  second  locus  (PEF‐FRT13‐tdTomato‐FRT14‐Δpuro)  against  mGRP94  and  the  binary  producer  cell  line 
TE3‐B4‐H1‐eGFP/mGRp94‐C1  (green or red solid). 
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To confirm the expression of mGRP94 and mPRAT4A, cell extracts were obtained from 1 L 
batch cultures of the producer cell lines TE3-B4-H1-ssmTLR2/mPRAT4A-C1 and 
TE3-B4-H1-ssmTLR2/mGRP94-C1 described in Section 4.4.2. Figure 4-30 shows SDS-PAGE 
and western blot analysis of concentrated mPRAT4A and mGRP94 eluates after one round 
of purification with Anti-FLAG® M2 affinity resin. While a strong background of 
unspecifically bound protein is still present, the expression of mPRAT4A and mGRP94 was 
confirmed by MALDI-TOF for the marked bands (red arrows). mPRAT4A, like tdTomato 
discussed in Section 4.2.3, seems to show some fragmentation under reducing conditions. 
mPRAT4A exhibits a strong band below the original 31.5 kDa band which can also be 
detected on Western blot analysis. In conclusion the expression of mGRP94 as well as 
mPRAT4A was confirmed. This result is valid for all generated binary producer cell lines 
co-expressing TLRs with chaperones in this work as these were all derived from the cell 
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4.4 Toll‐like receptors 
4.4.1 Cloning of TLR constructs 
TLR ECD and chimeric TLR-VLR ECD constructs are used in this work. They all encompass 
their own secretion signal sequence and comprise His-tags if cloned into the exchange 
vector pFlpBtM-I or Twin-Strep and His-tags separated by a protease cleavage site if cloned 







The vector pFlpBtM-ssmTLR2H8 (Figure 4-32) comprises a C-terminally His-tagged 
murine TLR2 ECD construct (amino acids 1-587) (Meyer et al., 2013). It was used for 
transient expression tests in HEK293-6E and stable genomic integration into (binary) RMCE 




Murine TLR1 constructs ranging from amino acids 1-408, 1-455 and 1-500 were previously 
reported to express solubly as chimera when fused C-terminally with a VLR fragment 
(amino acids 133-200) (Jin et al., 2007). Therefore, mTLR1 ECD with these specific lengths 
    RESULTS 
 99  
were amplifying from the vector pDUO_mTLR1_mTLR2 (InvivoGen) with the forward 
oligonucleotide TLR1_FWD_NcoI in combination with the reverse oligonucleotides 
TLR1_408_NheI_r, TLR1_455_NheI_r or TLR1_500_NheI_r. Restriction sites NcoI and NheI 
were introduced to enable the integration into a pFlpBtM-II(beta)-VLR-TEV-Strep-H8 
backbone containing the VLR fragment which was obtained from vector 
pFlpBtM-IIbeta-sshTLR5-1-198-VLR-TEV-Strep-H8 through the removal of the hTLR5 
insert with the same restriction endonucleases (Figure 4-33). After test expressions in 
HEK293-6E cells (Agarwal, 2012) construct mTLR1_1-455 was chosen for stable integration 
into the (binary) RMCE master cell lines SMT_dneo(2)_24 and TE3-B4-H1 as it showed the 
highest level of expression (Section 4.4.3). 
RESULTS 
 





removal  of  an  sshTLR5  insert  (red  line)  with  NcoI  and  NheI  restriction  sites  from  vector 
pFlpBtM‐II(beta)‐sshTLR5‐1‐198‐VLR‐TEV‐Strep‐H8 (Steffen Meyer, HZI). (C)   Ligation of the NcoI and NheI digested 
PCR  fragments  resulted  in  the  final  exchange  vectors  pFlpBtM‐II(beta)‐mTLR1_1‐408‐VLR‐TEV‐Strep‐H8  (D) 
pFlpBtM‐II(beta)‐mTLR1_1‐455‐VLR‐TEV‐Strep‐H8 and (E) pFlpBtM‐II(beta)‐mTLR1_1‐500‐VLR‐TEV‐Strep‐H8. 
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A human TLR5 construct was prepared as follows; oligonucleotides TLR5_1-391NheRev 
and BamHI-Nco-For were used for the amplification of an hTLR5 ECD ranging from amino 
acids 1-391 introducing restriction sites for NcoI and NheI. The PCR fragment was inserted 
into a pFlpBtM-II(beta)-VLR-TEV-Strep-H8 backbone containing a VLR fragment which 
was obtained from vector pFlpBtM-II(beta)-sshTLR5-1-198-VLR-TEV-Strep-H8 through the 




amino  acids  1‐391  including  NcoI  and  NheI  restriction  sites  was  amplified  (red  arrows)  using  the  vector 
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4.4.2 CHO Lec3.2.8.1 TLR2 producer cell lines 
To determine if the co-expression of mTLR2 with molecular chaperones improves the 
expression of mTLR2, stable CHO Lec3.2.8.1 cell lines that produce mTLR2 with or without 
their molecular chaperones mPRAT4A or mGRP94 were generated as described below. 
Furthermore, it should be tested weather the solubly expressed mTLR2 shows a similar 
level of expression when integrated into the RMCE master cell lines SWI3_26 and 
SMT_dneo(2)_24 as was shown for the intracellular protein tdTomato (Section 4.2). 
The mTLR2 ECD construct was introduced with the vector pFlpBtM-ssmTLR2H8 
(Section 4.4.1) into the master cell lines SWI3_26 and SMT_dneo(2)_24 using RMCE. Both 
cell lines only comprise one exchange locus (PEF-FRT3-eGFP-FRTwt-Δneo) and were 
previously described in Section 4.1. Figure 4-35 shows the successful exchange of eGFP 
against mTLR2 using flowcytometry for the producer cell lines BBA10-TLR2-C1 and 
SMT_dneo(2)_24-ssmTLR2-C7. Likewise binary producer cell lines were generated through 
the introduction of mTLR2 into locus 1 (PEF-FRT3-eGFP-FRTwt-Δneo) of the cell lines 
TE3-B4-H1-mPRAT4A-C1.1 and TE3-B4-H1-mGRP94-C1 (Section 4.3.3) which already 
contain chaperones in exchange locus 2 (PEF-FRT13-Chaperone-FRT14-Δpuro) as shown in 















The expression of mTLR2 for one or two clones of each producer cell line was tested in 
1 L - 1.5 L batch cultures in shake flasks. The cell line SMT_dneo(2)_24-ssmTLR2  was not 
tested in small scale batch culture due to time restrictions. Clones were either selected 
according to their flowcytometric profile alone (successful integration) or after screening of 
several clones using TCA precipitation of 1 mL culture supernatants as for BBA10-TLR2 
and SMT_dneo(2)_24-ssmTLR2 clones in combination with Western blot analysis 
(Figure 4-37). It should be noted that one false positive clone was found for 
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Lane  BBA10‐TLR2 (67.2 kDa)  Lane  SMT_dneo(2)_24‐ssmTLR2‐C1 (67.2 kDa) 
1  Precision Plus Protein All Blue (Bio‐Rad)  1  SMT_dneo(2)_24‐ssmTLR2‐C1 
2  BBA10‐TLR2‐C1  2  SMT_dneo(2)_24‐ssmTLR2‐C2 
3  BBA10‐TLR2‐C2  3  PageRuler Plus prestained (Thermo Scientific) 
4  BBA10‐TLR2‐C3  4  SMT_dneo(2)_24‐ssmTLR2‐C3 
5  BBA10‐TLR2‐C4  5  SMT_dneo(2)_24‐ssmTLR2‐C4 
6  BBA10‐TLR2‐C5  6  SMT_dneo(2)_24‐ssmTLR2‐C5 
7  BBA10‐TLR2‐C6  7  SMT_dneo(2)_24‐ssmTLR2‐C6 
8  BBA10‐TLR2‐C7  8  SMT_dneo(2)_24‐ssmTLR2‐C7 
9  BBA10‐TLR2‐C8  9  SMT_dneo(2)_24‐ssmTLR2‐C8 
10  BBA10‐TLR2‐C9  ‐  ‐ 
11  BBA10‐TLR2‐C10  ‐  ‐ 
12  Precision Plus Protein All Blue (Bio‐Rad)  ‐  ‐ 




Batch cultures of BBA10-ssmTLR2-C1 and BBA10-ssmTLR2-C7 in shaker flasks resulted in 
volumetric yields of 0.5 mg/L and 0.9 mg/L purified mTLR2 respectively. Figure 4-38 
shows SDS-PAGE analysis of mTLR2 purified using one round of Ni-IMAC from these cell 
lines. mTLR2 that was concentrated more than 5x using Vivaspin columns shows some 
unspecific background. Volumetric yields of 0.9 ± 0.3 mg/L were obtained with large scale 
expressions in 40 L perfusion reactors for BBA10-TLR2-C1. Figure 4-39 shows purified 
mTLR2 obtained from a perfusion reactor run after purification with Ni-IMAC. 
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Lane  BBA10‐TLR2‐C1 (67.2 kDa)  Lane  BBA10‐TLR2‐C7 (67.2 kDa) 
1  Precision Plus Protein unstained (Bio‐Rad)  1  Precision Plus Protein unstained (Bio‐Rad) 
2  Purified mTLR2 (Ni‐IMAC)   2  ‐  
3  ‐  3  Purified mTLR2 (Ni‐IMAC) – Run 1 
4  10x concentrated mTLR2  4  Purified mTLR2 (Ni‐IMAC) – Run 2 
5  5x concentrated mTLR2  5  Purified mTLR2 (Ni‐IMAC) – Run 1+2 















Figure  4‐39:  12  %  SDS‐PAGE  analysis  of  purified  mTLR2  expressed  in  a  perfusion  reactor  using  cell  line 
BBA10‐TLR2‐C1. Example of mTLR2 that was produced in a perfusion reactor and purified using Ni‐IMAC. Yields up to 
0.9 ± 0.3 mg/L were reached in a 40 L scale. 
However, it should be noted that the cell lines BBA10-ssmTLR2-C1 and 
BBA10-ssmTLR2-C7 were derived from the master cell line SWI3_26 (please see Figure 4-15 
in Section 4.2 for an overview of master cell lines used in this work). The binary master cell 
RESULTS 
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line used for the generation of mTLR2/mPRAT4A or mTLR2/mGRP94 producer cell lines 
on the contrary was derived from the master cell line SMT_dneo(2)_24. As described in 
Section 4.2, the cell lines BBA10-tdTomato-C1 and SMT_dneo(2)_24-tdTomato-C1 show 
similar expression yields for intracellular tdTomato. To determine if the yields of the 
solubly expressed mTLR2 are proportional for both cell lines as well, the cell line 
BBA10-ssmTLR2-C1 was compared to the cell line SMT_dneo(2)_24-ssmTLR2-C7. As 
described above the cell line BBA10-ssmTLR2-C1 expresses 0.9 ± 0.3 mg/L mTLR2 in 
bioreactor runs. Likewise the cell line SMT_dneo(2)_24-ssmTLR2-C7 was shown to express 
an average of  1.4 ± 0.1 mg/L mTLR2 in a bioreactor run as described below. Therefore it 
can be concluded that proteins, expressed intracellular or in soluble form, will exhibit a 
level of expression proportional to the expression capabilities of each exchange locus as 
described in Section 4.2. 
Expression of mTLR2 in the binary cell line TE3-B4-H1-ssmTLR2/mGRP94-C1 as well as in 
the binary cell lines TE3-B4-H1-ssmTLR2/mPRAT4A-C1 and 
TE3-B4-H1-ssmTLR2/mPRAT4A-C2 was confirmed through expression in 1 L batch 
cultures in shaker flasks (Figure 4-40 and Figure 4-41). However one round of purification 
using Ni-IMAC was not sufficient to obtain volumetric yields. Large scale expressions in a 
2.5 L bioreactors performed in batch mode were done by Nadine Konisch in duplicate for 
SMT_dneo(2)_24-ssmTLR2-C7 as well as for the binary cell lines  
TE3-B4-H1-ssmTLR2/mGRP94-C1 and SMT_dneo(2)_24-ssmTLR2/mPRAT4A-C1. Cell 
densities were adjusted to a similar level (between 3.8-6.0x106 cells/mL) to obtain 
comparable results. Subsequently, volumetric yields of mTLR2 expression were obtained 
for each cell line after purification with Ni-NTA. Figure A.2-3 - Figure A.2-5 in the appendix 
show examples for SDS-PAGE analysis of purified mTLR2 obtained from these reactor 
runs. Surprisingly the mTLR2 expression yields obtained for the cell line 
SMT_dneo(2)_24-ssmTLR2-C7 are the highest even though no chaperones were 
co-expressed. The co-expression of mPRAT4A or mGRP94 reduces the volumetric yields 
significantly as can be seen in Table 4-3.  
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TE3‐B4‐H1‐ssmTLR2/mGRP94‐C1.  mTLR2  was  produced  in  a  1  L  batch  culture  using  the  cell  line 
TE3‐B4‐H1‐ssmTLR2/mGRP94‐C1. Expression of mTLR2 was confirmed but no volumetric yields could be obtained for 
this  cell  line.  SDS‐PAGE  and Western  blot  (α‐His  antibody)  shows wash  and  eluate  fractions  after  one  round  of 
purification (Ni‐IMAC). 
       
Lane  TE3‐B4‐H1‐ssmTLR2/mPRAT4A‐C1  Lane  TE3_B4‐H1‐ssmTLR2/mPRAT4A‐C2 
1  PageRuler Plus prestained (Thermo Scientific)  1  PageRuler Plus prestained (Thermo Scientific) 
2  Diafiltrated/concentrated culture supernatant  2  Diafiltrated/concentrated culture supernatant 
3  Non‐binding fraction  3  Non‐binding fraction 
4  Wash 1  4  Wash 1 
5  Wash 2  5  Wash 2 
6  Eluate – mTLR2 (67.2 kDa)  6  Eluate – mTLR2 (67.2 kDa) 
7  PageRuler Plus prestained (Thermo Scientific)  7  PageRuler Plus prestained (Thermo Scientific) 
Figure 4‐41: 12 % SDS‐PAGE and Western blot analysis of mTLR2 expressed in batch cultures using the cell lines 
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Table 4‐3: Comparison of yields obtained for the expression of ssmTLR2 and its co‐expression with chaperons. 
Cell Line  Run  Yield [mg/L]  Yield [mg/1010 cells] 
SMT_dneo(2)_24‐ssmTLR2‐C7  1  1.5  2.3 
SMT_dneo(2)_24‐ssmTLR2‐C7  2  1.2  2.5 
TE3‐B4‐H1‐ssmTLR2/mPRAT4A‐C1  1  0.4  0.9 
TE3‐B4_H1‐ssmTLR2/mPRAT4A‐C1  2  0.5  1.0 
TE3 B4 H1 ssmTLR2/mGRP94‐C1  1  0.5  1.3 
TE3 B4 H1 ssmTLR2/mGRP94‐C1  2  0.7  1.4 
4.4.3 CHO Lec3.2.8.1 TLR1 producer cell lines 
To determine if the chaperone co-expression improves mTLR1 production stable 
CHO Lec3.2.8.1 cell lines that produce mTLR1 with or without their molecular chaperones 
mPRAT4A or mGRP94 were generated as described below. 
The mTLR1 ECD construct ranging from amino acids 1-455 was introduced with the vector 
pFlpBtM-II(beta)-mTLR1_1-455-VLR-TEV-Strep-H8 (Section 4.4.1) into the master cell line 
SMT_dneo(2)_24 using RMCE. To evaluate the effects of chaperone co-expression on 
mTLR1 yields, mTLR1 was also introduced into locus 1 (PEF-FRT3-eGFP-FRTwt-Δneo) of the 
binary cell lines TE3-B4-H1-eGFP/mPRAT4A-1.1 and TE3-B4-H1-eGFP/mGRP94-C1 
(Section 4.3.3). These cell lines already contain chaperones in exchange locus 2 
(PEF-FRT13-Chaperone-FRT14-Δpuro). Figure 4-42 shows the successful exchange of eGFP 
against mTLR1 using flowcytometry for two clones of the producer cell lines 
SMT_dneo(2)_24-mTLR1-455 as well as for the binary producer cell line 
TE3-B4-H1-mTLR1/mPRAT4A and for TE3-B4-H1-mTLR1/mGRP94-C1. 
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Figure  4‐42:  Generation  of  mTLR1  producer  cell  lines:  Histogram  overlays  obtained  with  the  Guava  easyCyte 
flowcytometer show the level of green fluorescence of the RMCE master cell line SMT_dneo(2)_24 (top) as well as the  
binary cell lines TE3‐B4‐H1‐eGFP/mPRAT4A‐1.1 (bottom, left) and TE3‐B4‐H1‐eGFP/mGRP94‐C1 (bottom, right) which 
contain  eGFP  in  locus  1  (solid  green).  The  thereof  derived  producer  cell  lines  SMT_dneo(2)_24‐mTLR1‐455, 
TE3‐B4‐H1‐mTLR1/mPRAT4A and TE3‐B4‐H1‐mTLR1/mGRP94‐C1 are shown in the same gate as black line for clone 1 
and red line for clone 2 after successful exchange of eGFP against mTLR1. 
Expression of mTLR1 was confirmed in 1 L - 1.5 L batch cultures in shaker flasks for the cell 
lines SMT_dneo(2)_24-mTLR1-455-C1 and SMT_dneo(2)_24-mTLR1-455-C2 as well as the 
binary cell lines TE3-B4-H1-mTLR1/mPRAT4A-C1 and 
TE3-B4-H1-mTLR1/mPRAT4A-C2. The expression of mTLR1 was shown through 
SDS-PAGE and Western blot analysis of mTLR1 purifications obtained using either 
Ni-IMAC or Strep purification (Figure 4-43 and Figure 4-44). As can be seen one round of 
Strep purification is superior to one round of Ni-IMAC and thus the mTLR1 band can 
already be identified on SDS-PAGE (Figure 4-44). Purification with Ni-IMAC however 
exhibits a strong background. To specifically identify mTLR1 different antibodies were 
used to detect mTLR1 on western blot analysis. The anti-strep antibody however showed a 
high level of cross-interaction if a strong background was present. Antibodies raised against 
the His-tag and a TLR1 specific antibody gave the most accurate results. (Figure 4-43). 
However, due to the very low yields quantification was not possible. Expression was not 
yet confirmed for TE3-B4-H1-mTLR1/mGRP94-C1.   
RESULTS 
 








Figure  4‐43:  12  %  SDS‐PAGE  and  Western  blot  analysis  of  mTLR1  expressed  in  cell  lines 
SMT_dneo(2)_24‐mTLR1‐C1 and SMT_dneo(2)_24‐mTLR1‐C2. mTLR1 was produced  in 1.5 L and 1 L batch cultures 
using the cell lines SMT_dneo(2)_24‐mTLR1‐C1 and ‐C2 respectively. SDS‐PAGE and Western blot shows mTLR1 after 










Figure  4‐44:  12  %  SDS‐PAGE  and  Western  blot  analysis  of  purified  TE3‐B4‐H1‐mTLR1/mPRAT4A‐C1  and 
TE3‐B4‐H1‐mTLR1/mPRAT4A‐C2.  mTLR1  was  produced  in  1  L  batch  cultures  using  the  cell  lines 
TE3‐B4‐H1‐mTLR1/mPRAT4A‐C1 and  ‐C2. SDS‐PAGE and Western blots show fractions of mTLR1 purifications done 
using Ni‐IMAC or Strep beads for cell lines TE3‐B4‐H1‐mTLR1/mPRAT4A‐C1 and ‐C2 respectively. Western blots were 
exposed  to anti‐Strep, anti‐His or anti‐TLR1 antibodies. Even  though purified mTLR1  could be obtained with Strep 
purification the achieved yields were below the detection limit of the used photometric methods. 
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4.4.4 CHO Lec3.2.8.1 TLR5 producer cell lines 
The hTLR5 ECD construct was introduced with the vector 
pFlpBtM-II(beta)-sshTLR5_1-391-VLR-TEV-STrEP-H8 (Section 4.4.1) into the master cell 
line SMT_dneo(2)_24 using RMCE. To evaluate the effects of chaperone co-expression 
hTLR5 was also integrated into locus 1 (PEF-FRT3-eGFP-FRTwt-Δneo) of the binary cell line 
TE3-B4-H1-eGFP/mPRAT4A-1.1 (Section 4.3.3). This cell line already contains mPRAT4A 
in exchange locus 2 (PEF-FRT13-mRAT4A-FRT14-Δpuro). Figure 4-45 shows the successful 
exchange of eGFP against hTLR5 using flowcytometry for two clones of the producer cell 





thereof derived producer  cell  lines SMT_dneo(2)_24‐mTLR1‐455‐C1 and  ‐C2  (black and  red  lines  respectively) after 
successful exchange of eGFP against hTLR5. (Right) Likewise the binary cell line TE3‐B4‐H1‐eGFP/mPRAT4A‐1.1 (green 
solid) and the thereof derived producer cell line TE3‐B4‐H1‐sshTLR5/mPRAT4A‐C1 (black line) are shown. 
Expression of hTLR5 was tested in 1.5 L batch cultures for the cell lines 
SMT_dneo(2)_24-sshTLR5-C1 and SMT_dneo(2)_24-sshTLR5-C2  using culture flasks, 
followed by one round of Ni-IMAC (Figure 4-46). The binary cell line 
TE3-B4-H1-sshTLR5/mPRAT4A-C1 was expressed in a 1 L batch culture and subjected to 
one round of Strep purification (Figure 4-47). No quantitative yields could be obtained for 
the binary cell line TE3-B4-H1-sshTLR5/mPRAT4A-C1 as expression could only be 
detected using Western blot analysis. While expression of hTLR5 could be detected for the 
cell lines SMT_dneo(2)_24-sshTLR5-C1 and SMT_dneo(2)_24-sshTLR5-C2 using 
SDS-PAGE (Figure 4-46) quantification was not possible due the co-purification of 
unspecifically bound protein. However, volumetric yield could be obtained for the cell line 
SMT_dneo(2)_24-sshTLR5-C1 expressed in a 20 L perfusion reactor. Following two rounds 
of Ni-IMAC and one round of Strep purification a volumetric yield of 0.07 mg/L was 
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obtained. However, two bands on SDS-PAGE in the non-binding fraction (lane 2) might 
indicate that hTLR5 did not fully bind to the column (Figure 4-48). A stronger band at 
~ 50 kDa and a weaker band right above it could fit the size of hTLR5 (57.5 kDa). If this is 
true the actual expression of hTLR5 would be higher than obtained from purification. 
Unfortunately no Western blot analysis nor MS-data is available for those two bands to 
confirm the identity of hTLR5. This suspicion was confirmed in a second perfusion reactor 
run performed in a 40 L scale with improved yields. Following one round of Ni-IMAC and 
one round of Strep purification volumetric a yield of 0.1 mg/L were obtained. No 
volumetric yields can be compared to determine if the co-expression of hTLR5 with 
mPRAT4A improved hTLR5 expression. However, as described for mTLR2 in Section 4.4.2, 
the co-expression of mPRAT4A seems to reduce hTLR5 yields. As described above hTLR5 
co-expressed with mPRAT4A in batch culture can only be detected using Western blot 
analysis whereas hTLR5 expressed alone can also be detected using SDS-PAGE which leads 














Figure  4‐46:  10  %  SDS‐PAGE  and  Western  blot  analysis  of  purified  SMT_dneo(2)_24‐sshTLR5‐C1  and 
SMT_dneo(2)_24‐sshTLR5‐C2.  hTLR5  was  produced  in  1.5  L  batch  cultures  using  the  cell  lines 
SMT_dneo(2)_24‐sshTLR5‐C1 and ‐C2. SDS‐PAGE and Western blots show fractions of sshTLR5 purifications done using 
Ni‐IMAC. However, as one round of purification was not sufficient to obtain volumetric yields, these were estimated 




















Figure  4‐48:  12  %  SDS‐PAGE  of  purified  hTLR5  from  expression  in  perfusion  reactor  using 
SMT_dneo(2)_24‐sshTLR5‐C1.  hTLR5  that  was  produced  in  a  30  L  perfusion  reactor  using  the  cell  line 
SMT_dneo(2)_24‐sshTLR5‐C1  and  purified  using  two  rounds  of  Ni‐IMAC  and  one  round  of  Strep  purification. 
Yield: 0.05 mg/L. 
4.4.5 Summary  –  expression  and  co‐expression  of  TLR  ECDs  and 
chaperones 
Table 4-4 summarises the results obtained for the expression of the TLR ECD constructs 
mTLR1, mTLR2 and hTLR5 as well as their co-expression with the molecular chaperones 
mPRAT4A or mGRP94 as described in Section 4.4.2 – Section 4.4.4. The co-expression of 
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chaperones was not shown to improve the expression of TLRs. In the contrary, it was 
demonstrated that mTLR2 yields were reduced up to ~ 67 %. Most likely the yields of 
mTLR1 and hTLR5 were similarly impacted. A detailed discussion about the reasons that 
might have led to this result are available in Section 5.4. 
Table 4‐4: Summary table TLR (co)‐expression 




BBA10‐TLR2‐C1  mTLR2  N/A  0.5  0.9 ± 0.3 
BBA10‐TLR2‐C7  mTLR2  N/A  0.9  ‐ 
SMT_dneo(2)_24‐ssmTLR2‐C7  mTLR2  N/A  WB  1.4 ± 0.1 
TE3‐B4‐H1‐ssmTLR2/mPRAT4A‐C1  mTLR2  mPRAT4A  SDS‐PAGE/WB  0.5 ± 0.1 
TE3‐B4‐H1‐ssmTLR2/mPRAT4A‐C2  mTLR2  mPRAT4A  SDS‐PAGE/WB  ‐ 
TE3‐B4‐H1‐ssmTLR2/mGRP94‐C1  mTLR2  mGRP94  SDS‐PAGE/WB  0.6 ± 0.1 
SMT_dneo(2)_24‐mTLR1‐455‐C1  mTLR1  N/A  SDS‐PAGE/WB  ‐ 
SMT_dneo(2)_24‐mTLR1‐455‐C2  mTLR1  N/A  SDS‐PAGE/WB  ‐ 
TE3‐B4‐H1‐mTLR1/mPRAT4A‐C1  mTLR1  mPRAT4A  SDS‐PAGE/WB  ‐ 
TE3‐B4‐H1‐mTLR1/mPRAT4A‐C2  mTLR1  mPRAT4A  SDS‐PAGE/WB  ‐ 
TE3‐B4‐H1‐mTLR1/mGRP94‐C1  mTLR1  mGRP94  TBD  ‐ 
SMT_dneo(2)_24‐sshTLR5‐C1  hTLR5  N/A  SDS‐PAGE  0.1 
SMT_dneo(2)_24‐sshTLR5‐C1  hTLR5  N/A  SDS‐PAGE  ‐ 
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5 Discussion 
5.1 Stable cell line development 
CHO cell lines are the most commonly used host for recombinant protein production in 
industrial applications (Datta et al., 2013). Their well-established safety profile eases the 
approval of biopharmaceuticals with regulatory agencies and extensively optimized 
processes are already in place (Estes et al., 2014). As a mammalian host PTMs are processed 
and can be modified to improve intrinsic properties such as plasma-half life, shield 
immunogenic epitopes or increase the uptake into target cells (Walsh et al., 2006). The time 
invested into the generation and isolation of stable isogenic producer cell lines is 
compensated with the prospect to scale up protein production in a reproducible and robust 
manner using bioreactors.  
Standard methods for stable cell line generation require the random integration of each 
target gene into the host genome. The identification of recombinant cells is based on the 
co-introduction of a selectable marker gene of choice. This marker can either result in the 
rescue or improvement of essential cellular processes as in the DHFR-system (Urlaub et al., 
1980) or the GS-system (Cockett et al., 1990) or introduce entirely new properties into 
recombinant cells. For example, the introduction of a bacterial antibiotic marker will 
introduce resistance to a specific antibiotic (Southern et al., 1982, Vara et al., 1986) whereas 
the introduction of fluorescent marker genes will enable the identification of recombinant 
cells via flowcytometric methods which are preferably used for HTP approaches (Shi 2011). 
As random integration of a transgene into the host genome will result in unpredictable 
expression properties due to the site of integration (position-effect) and the number of 
transgene integrations, extensive screening is required to isolate isogenic high producer cell 
lines for each protein target (Wurm, 2004). 
To simplify the generation of high producer cell lines the use of site specific recombinases 
for tag-and-target and tag-and-exchange strategies was introduced. Particularly Flp/FRT 
based methods are gaining popularity including: The Flp-in  system (O'Gorman et al., 1991, 
Invitrogen, 2010), the FLIRT system with its variations (Huang et al., 1997, Kaufman et al., 
2008, Wilke et al., 2010) and finally the RMCE system (Schlake et al., 1994). While the 
generation of isogenic high producer master cell lines follows the same pattern as for 
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conventional cell line development, this initial effort to isolate a suitable master cell line 
with a tagged genomic locus enables the comparatively quick generation of high producer 
cell lines containing a GOI. Multiplexing approaches which employ the use of different sets 
of heterospecific FRT sites were proposed (Turan et al., 2010).  
Numerous examples wherein the co-expression of proteins favour the expression or 
function of a target gene are described in the literature. The use of one expression cassette 
(monocistronic or polycistronic) or several expression cassettes within one or more 
expression vectors can be used for the co-expression of protein subunits, ligands or 
accessory molecules. For example: (i) Improved cell-surface expression level were obtained 
for a G-protein-coupled receptor (GPCR), called olfactory receptor, when co-expressed with 
Hsc70t in HEK293 cells which was otherwise retained within the ER (Neuhaus et al., 2006). 
(ii) The co-expression of farnesyltransferase heterodimer subunits in Sf9 improved 
functional activity of this enzyme (Chen et al., 1993). (iii) Functional cytokine expression 
and in vivo half-life were improved in CHO cells for an IL-15 variant when combined with 
its receptor (Han et al., 2011). Additional examples are reviewed elsewhere (Romier et al., 
2006, Kerrigan et al., 2011). Expression systems which enable the co-expression of several 
protein targets through site specific recombination using the Cre/loxP system were 
established in E.coli (Acembl) (Bieniossek et al., 2009) insect cells (MultiBac system) (Berger 
et al., 2004, Fitzgerald et al., 2007) and mammalian cells (MultiLabel) (Kriz et al., 2010) and 
put to use for the co-expression of several multi-protein complexes (Bieniossek et al., 2008).  
In this work a binary Flp/FRT based RMCE system was set up in the glycosylation deficient 
CHO Lec3.2.8.1 cell line (Section 4.1). This binary system enables the co-expression of target 
genes at different pre-defined genomic loci. The generation and evaluation of this system 
is discussed in Section 5.2 and Section 5.3 respectively. The co-expression of TLR ECD 
constructs together with their chaperones mPRAT4A and mGRP94 are discussed in 
Section 5.4).  
5.2 Generation  of  binary  CHO  Lec3.2.8.1  RMCE master  and 
producer cell lines 
Expression hosts capable of PTMs are favourable for protein expression and function of 
complex proteins. However heterogeneous glycosylation pattern do interfere in structural 
biology applications and thus the use of glycosylation inhibitors during protein expression 
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or the use of glycosylation deficient cell lines becomes necessary (Aricescu et al., 2006, 
Nettleship et al., 2010). CHO Lec3.2.8.1, a glycosylation deficient cell line which expresses a 
uniform GlcNAc2Man5 profile on the protein surface (Stanley, 1989), was used for the 
generation of the Flp/FRT based binary RMCE system described in this work.  
It was desired to establish a cell line which enables the independent integration of two 
transgenes at different genomic loci. The co-expression of proteins with accessory 
molecules or the co-expression of multi-protein complexes might be beneficial for difficult 
to express targets. For this purpose binary RMCE cell lines containing the exchange 
cassettes PEF-FRT3-eGFP-FRTwt-Δneo and PEF-FRT13-tdTomato-FRT14-Δpuro were generated 
(Section 4.1.4). Site specific recombination based on the Flp/FRT system was used to 
integrate transgenes at pre-defined chromosomal loci. The use of distinct sets of 
heterospecific FRT sites (FRT3/FRTwt and FRT13/FRT14) enabled the independent 
integration at either locus as described in Section 4.3 and Section 4.4.  
The fluorescent marker gene tdTomato present in exchange locus 2 
(PEF-FRT13-tdTomato-FRT14-Δpuro) was used for the isolation of binary RMCE master cell 
lines after the genomic tagging of two different RMCE master cell lines that already 
contained locus 1 (PEF-FRT3-eGFP-FRTwt-Δneo) in their genome. As the cell sorter used for 
this work were not operated under sterile conditions drawbacks from frequent 
contaminations resulted in the delayed generation of the binary master cell lines. The 
attempt to control contaminations through the addition of antibiotics penicillin, 
streptomycin and gentamicin were of limited success as they seemed to have an adverse 
effect on the sorted cells most likely due to the cellular stress that resulted in low cell 
vitalities. Cells sorted without antibiotics however could be isolated as pools (൒22.000 
positive cells derived from 1x107 sorted cells) if not contaminated. Attempts to isolate single 
cells or a small pools of up to 100 cell in multi-well formats failed. When sorting small cell 
numbers of 1 cell/well or 10 cells/well these did not proliferate either due to the statistical 
probability of having a living cell in one well or due to the small cell number of surviving 
cells in each well. When sorting 100 cells/well however the prolonged time required for 
sorting into 96-well plates in an open system resulted in the contamination of virtually all 
wells. While the isolation of single cells via FACS would have been favourable to isolate 
truly isogenic master cell lines, the use of limiting dilution or the use of a second round of 
FACS yielded virtually isogenic cell lines as described in Section 4.1.4. It should be noted 
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that binary master cell line selection was based entirely on the level of fluorescence as 
selection criteria. No antibiotic selection pressure was used as this was shown to result in 
heterogeneous expression and epigenetic silencing of the isolated cells after removal of 
selective pressure (Liu et al., 2006). Due to the problems confronted during FACS in this 
work the isolation of producer cell lines after RMCE was done using limiting dilution in 
combination with selective pressure. Even though the isolation of producer cell lines using 
limiting dilution can be time-consuming due to the varying amount of rounds required for 
the successful isolation of producer cell lines, the process was not slowed down due to 
contaminations and thus more predictable. 
The integrity of both exchange loci was confirmed through genomic PCR (Section 4.1.5). 
The number of integration sites for locus 1 (PEF-FRT3-eGFP-FRTwt-Δneo) was previously 
determined by Wilke et al., (2011) for the cell line SWI3_26 and by Sarah Maria Tokarski 
(HZI) for the cell line SMT_dneo(2)_24. Both cell lines comprise one exchange locus. To 
determine the number of integrated loci for the newly introduced locus 2 
(PEF-FRT13-tdTomato-FRT14-Δpuro) in the binary RMCE master cell lines Southern blots using 
digoxigenin (DIG)-labelling were done but yielded no results. Likewise no results using 
radioactive southern blots could yet be obtained. While this may leave doubts about the 
number of integration sites, the behaviour of the cell lines does not lead to the conclusion 
that more than one second locus was integrated. The exchange efficiency does not seem to 
be negatively influenced for locus 2. If more than one locus would be present within the 
binary RMCE cell lines it would be more difficult to obtain tdTomato negative clones as it 
would require the successful exchange in all integrated loci. Successful integration however 
is a rare event. As described in the next paragraph the simultaneous exchange of both 
exchange loci failed due to this very reason. If more than one second exchange locus would 
be present within the binary RMCE cell lines it would be very difficult to obtain tdTomato 
negative clones. Nonetheless, the number of integration sites still needs to be confirmed. 
An alternative or addition to Southern blot analysis would be whole genome sequencing of 
our binary RMCE master cell lines. This would not only confirm the number of integration 
loci but also the chromosomal integration site. 
The generation of binary producer cell lines was performed through sequential integration 
into each exchange locus at one time. Attempts to exchange both loci simultaneously were 
not successful. Even though the RMCE reaction is driven through the molecular excess of 
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the used exchange plasmids as described by Seibler et al., (1998) this does not necessary 
result in the exchange of both loci in the same cell. Although this event was observed 
microscopically in 100 mm cell culture dishes the isolation of these few cells was not 
possible. The application of selective pressure using both antibiotics (G418 and puromycin) 
to screen for double positive cells resulted in virtually total cell death of all present cells as 
the few that might have survived were not able to proliferate any further. A timeline for the 
generation of binary producer cell lines is shown in Figure 5-1. Each round of RMCE and 
producer cell line isolation takes 6-9 weeks thus at least 12-18 weeks are required for the 
generation of a binary producer cell line. This does not include expression analysis which 
would be required after each round of RMCE. Depending on the scale (40 mL – 1.5 L batch 
cultures) as well as the method of culture supernatant dialysis and concentration this will 
take another 1-3 weeks including sample purification and protein analysis. 3 months for the 
generation of a producer cell line with only one GOI is clearly an improvement to 
conventional cell line development which can take over 1 year (Wurm, 2004). The 
generation of a binary producer cell line with two GOIs does require approximately 
6 months. While this is still an improvement the generation of binary producer cell lines 
would greatly benefit if optimized for FACS under sterile conditions as timelines could be 






were  they are permitted  to grow  for 1 week. The most promising clones are subjected  to several  rounds of  limiting 
dilutions to obtain subclones of the desired producer cell line. This step can take up to 3 weeks and is the most labour 




Furthermore it could be clearly observed that the selection stringency of locus 1 
(PEF-FRT3-eGFP-FRTwt-Δneo) was significantly lower than that of locus 2 
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(PEF-FRT13-tdTomato-FRT14-Δpuro) and thus required additional rounds of limiting dilution 
to obtain the desired producer cell lines. This can be attributed to the apparent resistance of 
CHO Lec3.2.8.1 cells towards G418 which require higher concentrations of antibiotic 
(2 mg/mL) compared to puromycin which only requires low concentrations (15 µg/mL). 
The more gradual decrease observed in cell viability when using G418 compared to the 
more sharp decrease in cell viability when using puromycin while estimating appropriate 
titres supports this observation in the obtained kill-curves (Figure 4-1). Thus future 
CHO Lec3.2.8.1 master cell lines should relinquish Δneo as a selection trap and rather choose 
an alternative gene such as hyg which confers resistance towards hygromycin B and shows 
a similarly sharp decrease in cell viability as does puromycin in the obtained kill curve 
(Figure 4-1). However when producer cell line isolation could be optimized for FACS the 
leaky resistance against G418 would not present a challenge anymore as only GFP negative 
cells would be sorted. 
RMCE compared to other Flp/FRT based integration methods bears the advantage that no 
additional prokaryotic elements are co-introduced with the GOI which might induce 
epigenetic silencing (Schlake et al., 1994). The only prokaryotic elements introduced in the 
system are those present in the tagging vector. However, master cell lines are isolated 
according to their expression profile presented by the fluorescent marker in the integrated 
loci and observed over several weeks for uniform expression (Section 4.1.4). Thus it can be 
presumed that the site of exchange cassette integration was within the transcriptionally 
active euchromatin structure and that potential effects of epigenetic silencing can be 
disregarded for those loci. The system could be improved through the introduction of 
cis-regulatory elements such as S/MARs to oppose heterochromatin effects as it is 
occasionally done in conventional cell line development (Wurm, 2004). However instead of 
flanking the GOI which would unnecessarily increase the size of the insert and thus 
potentially reduce the integration efficiency of the RMCE reaction cis-regulatory elements 
could be designed to flank the entire exchange cassette before genomic tagging. 
5.3 Evaluation of binary RMCE cell lines expressing tdTomato 
To evaluate position and gene dose effects within the integrated exchange loci for several 
RMCE cell lines, the expression level of tdTomato which was transcribed in one or two loci 
within a given cell line was determined as described in Section 4.2. The obtained yields 
confirmed that the site of integration is directly correlated to the expression level of 
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tdTomato. Furthermore, the robustness of expression was shown when performed in 
triplicate which resulted in reproducible expression level for each cell line. The expression 
of tdTomato is dependent on the expression capabilities of each locus and shown to be 
cumulative. This allows the prediction of protein level if each locus express the same 
protein. In general, binary master cell lines with exchange loci integrated at genomic hot 
spots will be most desirable for difficult to express protein targets. 
However, the use of master cell lines containing stable loci with varying expression 
capabilities may be of advantage for the co-expression of subunits that are required in 
different ratios for optimal expression such as light and heavy chains of antibodies 
(Schlatter et al., 2005) or accessory molecules which are not required in abundance and 
therefore should not unnecessarily occupy the cellular transcription and translation 
machinery. 
5.4 Expression of TLR ECD constructs 
The information available about the expression of TLR ECD constructs is limited. Until 
today the production of TLRs still poses a formidable challenge. An overview regarding the 
current state for each TLR evaluated in this work (TLR2, TLR5 and TLR1) in position to the 
obtained outcomes is given in the following Sections.  
5.4.1 Expression of TLR2 ECD 
The expression of human and murine TLR2 ECD constructs fused to VLR fragments in High 
Five insect cells was reported by Jin et al., (2007) and Kang et al., (2009). While no specific 
yield for the human TLR2 ECD constructs were given a murine TLR2 ECD construct was 
reported to have an approximate volumetric yield of 100 µg/L by Kang et al., (2009).  Several 
TLR2 ECD hybrids fused with VLR fragments at their C- or N-terminus were screened for 
soluble expression (Jin et al., 2007). The longest murine TLR2 ECD hybrid that was 
C-terminally fused at its last LRR sequence (LRR19) with the VLR fragment was 
successfully used for co-crystallisation with mTLR6 upon binding to the di-acylated 
lipopeptide Pam2CSK4 (Kang et al., 2009). Likewise the longest human TLR2 ECD hybrid 
was co-crystallized with hTLR1 after binding to the tri-acylated lipopeptide ligand 
Pam3CSK4 (Jin et al., 2007).  
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In this work a murine TLR2 construct that comprises the complete ECD including its own 
signal peptide, all LRR sequences and it natural LRRCT capping motive was utilized. 
RMCE based integration into several CHO Lec3.2.8.1 producer cell lines yielded soluble 
protein with volumetric yields of up to 0.9 mg/L in batch cultures and up to 1.5 mg/L when 
cultivated in a bioreactor (Section 4.4.2). Compared to the transient expression in insect cells 
used in the published literature (Jin et al., 2007, Kang et al., 2009)  the production of mTLR2 
was improved when expressed stably in CHO Lec3.2.8.1. This was further supported by 
previous experiments performed within our own group in which the full mTLR2 ECD 
construct was expressed in insect cells. While similar quantities of the mTLR2 ECD (up to 
1 mg/L) were expressed these were only present in an insoluble form (Meyer, 2012) or 
showed strong batch to batch variations (personal communication Joop van den Heuvel, 
HZI). Likewise transient expression of mTLR2 in HEK293-6E cells yielded only insoluble 
protein (Meyer, 2012). In general higher protein yields can be obtained with transient 
expression systems due to the high copy-number of transgenes introduced into the 
transfected cells.  However the extensive overexpression of a target protein may also cause 
problems if the protein-folding machinery is overloaded. This can cause protein 
aggregation that results in the retention of the improperly folded protein within 
intracellular compartments thus limiting the amount of soluble protein (Ishiyama et al., 
2010, Halff et al., 2014).  Clearly the stable expression of a single-copy mTLR2 ECD in 
CHO Lec3.2.8.1 is favourable to transient expression in BEVS or HEK293-6E when soluble 
protein is required. Knowing this, it would be worthwhile to evaluate the stable expression 
of a chimeric mTLR2-VLR construct in CHO Lec3.2.8.1 as this might positively influence 
volumetric yields. However the screening of constructs in transient HEK396-6E would still 
face the problem of protein aggregation if performed under standard conditions. The 
reduction of total protein expression  as suggested by Halff et al., (2014) through the 
transfection with smaller amounts of the express vector could improve the soluble 
expression of mTLR2 constructs in HEK293-6E.  A different approach to improve the 
expression of the mTLR2 ECD was pursuit in this work. The co-expression of the mTLR2 
ECD with the molecular chaperones mPRAT4A and mGRP94. To do so binary producer 
cell lines in CHO Lec3.2.8.1 that stably co-express the mTLR2 ECD and either mPRAT4A or 
mGRP94 were generated (Section 4.4.2). Expression of mPRAT4A and mGRP94 was 
confirmed after integration into locus 2 (PEF-FRT13-tdTomato-FRT14-Δpuro) of the binary 
RMCE cell line TE3-B4-H1 (Section 4.3.3). Afterwards the mTLR2 ECD was integrated into 
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locus 1 (PEF-FRT3-eGFP-FRTwt-Δneo). The expression of mTLR2 in 2.5 L bioreactors yielded 
volumetric yield of 0.5 ± 0.1 mg/L and 0.6 ± 0.1 mg/L for the cell lines 
TE3-B4-H1-ssmTLR2/mPRAT4A-C1 and TE3-B4-H1-ssmTLR2/mGRP94-C1 respectively. 
Thus the expression of mTLR2 was clearly reduced when co-expressed with molecular 
chaperones. Reasons why the co-expression of TLR2 with mPRAT4A did not improve 
protein expression are discussed in Section 5.4.4. 
5.4.2 Expression of TLR5 ECD 
Yoon et al., (2012) attempted to produce TLR5 ectodomains form several organisms 
including human, mouse, frog, trout and zebrafish in High Five insect cells. The full ECD 
construct of zebrafish TLR5 was the only one to express. However the obtained volumetric 
yields of secreted soluble protein remained clearly below 50 µg/L. To obtain sufficient 
quantities for structural analysis the creation of dsTLR5-VLR hybrids was pursued. Crystal 
structures could be solved for dsTLR5 ECDs with C-terminally fused VLR fragments at 
LRR12 and LRR14 but no specific yield were described. The same group further improved 
the expression of the non-hybrid dsTLR5 ECD through the addition of the flagellin FliC 
during production thus increasing the volumetric yield to 0.4 mg/L for the complex. This 
approach however could not be transferred to human TLR5. The expression of human TLR5 
was aided through the generation of hTLR5-VLR hybrids. But only very short fragments 
could be expressed. The fusion of VLR fragments to the C-terminus at LRR4 or LRR6 
yielded ~0.3 mg/L. The fusion of VLR fragments to both termini even yielded 0.8 mg/L 
when fused to LRR11 and LRR14. Likewise the expression of dsTLR5-VLR hybrids could 
be improved for truncated dsTLR5 domains if VLR fragments were fused at one or both 
termini reaching yields up to 3.8 mg/L (Hong et al., 2012). However none of the short 
expressible hTLR5-VLR-hybrids was able to form a complex with FliC. 
In this work a human TLR5-VLR hybrid was used. The hTLR5 ECD was fused at its 
C-terminus with a VLR fragment at LRR16 to ease expression. Upon stable integration into 
CHO Lec3.2.8.1 cells volumetric yields of 0.1 mg/L were achieved when cultivated in a 
perfusion reactor (Section 4.4.4). Comparable constructs, with C-terminal VLR-fusions at 
LLR14 and LRR17, tested by Hong et al., (2012) in High Five insect cells did not yield any 
protein. As for the mTLR2 ECD discussed in Section 5.4.1 the over-expression of hTLR5 in 
insect cells appears to result in the intracellular accumulation of the protein as shown by 
Meyer, (2012) for several hTLR5 ECD constructs. The single-copy expression in stable 
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CHO Lec3.2.8.1 improves the soluble expression of hTLR5 compared to similar ECD 
constructs tested by Hong et al., (2012) in BEVS. While a volumetric yield of 0.1 mg/L 
soluble hTLR5 in CHO Lec3.2.8.1 leaves space for improvement it is the largest solubly 
expressible hTLR5 ECD construct reported so far. To improve the expression of hTLR5 in 
CHO Lec3.2.8.1 a binary producer cell that co-expresses hTLR5 and mPRAT4A was 
generated (Section 4.4.4). Expression of hTLR5 was confirmed via Western blot but no 
volumetric yields could be obtained. The effects of chaperone co-expression are discussed 
in Section 5.4.4.  
5.4.3 Expression of TLR1 ECD 
A human TLR1 ECD C-terminally fused at LRR17 with a VLR fragment was previously 
expressed in High Five insect cells to obtain sufficient quantities for crystallization but no 
specific yields were given. Additional human and murine TLR1-VLR hybrids that can be 
solubly expressed in High Five were reported (Jin et al., 2007). Three of these described 
soluble murine TLR1 constructs that were C-terminally fused at LRR14, LRR16 and LRR19 
were screened in HEK293-6E by Agarwal, (2012) for this work. The mTLR1 construct fused 
C-terminally at LRR16 with a VLR fragment was the only one to show expression in 
HEK293-6E and was chosen for stable integration into CHO Lec3.2.8.1 via RMCE 
(Section 4.4.3). While mTLR1 was expressed solubly in CHO Lec3.2.8.1 no volumetric yields 
could be obtained due to its low expression level. To improve the expression of mTLR1 
binary producer cell lines expressing mTLR1 with one chaperone, either mPRAT4A or 
mGRP94, were generated (Section 4.4.3). While the expression of mTLR1 in the binary 
producer cell line TE3-B4-H1-mTLR1/mGRP94-C1 could not yet be confirmed, the binary 
producer cell lines TE3-B4-H1-mTLR1/mPRAT4A-C1 and 
TE3-B4-H1-mTLR1/mPRAT4A-C2 do express mTLR1 but the volumetric yields are still too 
low for quantification. A more detailed discussion on the effects of chaperone co-expression 
can be found in Section 5.4.4. Like hTLR5 discussed in Section 5.4.2 mTLR1 shows a very 
low level of expression. Large scale cultivation in a perfusion reactor is likely to give 
quantifiable yields but will not reach those of hTLR5. The generation of mTLR1 ECD 
constructs N- and C-terminally fused to VLR fragments might improve expression as 
previously reported for dsTLR5 and hTLR5 by Hong et al., (2012). 
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5.4.4 Co‐expression of TLR ECDs with molecular chaperones 
The importance of the ER resident chaperone GRP94 for conformational maturation and 
cell surface trafficking of TLR1, TLR2 and TLR5 was demonstrated by Randow et al., (2001)  
and Yang et al., (2006). Likewise the role of the ER resident chaperone PRAT4A for cell 
surface expression of TLR1, TLR2 and TLR5 was shown by Takahashi et al., (2007) and 
Shibata et al., (2012). 
The binary RMCE system established during this work (Section 4.1) was used to generate 
several binary producer cell lines co-expressing one TLR ECD construct (mTLR1, mTLR2 
or hTLR5) together with one molecular chaperone (mGRP94 or mPRAT4A) (Section 4.3 and 
Section 4.4). It was anticipated that the over-expression of the molecular chaperones will 
support the soluble expression of the TLR ECDs. However this could not be confirmed for 
any of the generated binary producer cell lines as described in Section 5.4.1–Section 5.4.3. 
In the contrary the expression level of mTLR2 were even reduced when co-expressed with 
molecular chaperones. On reason why the co-expression of mPRAT4A or mGRP94 did not 
improve TLR ECD expression could be that the overexpression of only one chaperone is 
not sufficient to significantly aid the expression of the tested TLR constructs. A publication 
by Liu et al., (2010) demonstrated that at least TLR9, present in endosomal compartments, 
does require both PRAT4A and GRP94 for maturation. PRAT4A was shown to serves as 
co-chaperone of GRP94 in a tri-molecular complex with TLR9. It cannot be excluded that 
TLR1, TLR2 or TLR5 also require both chaperones in a 1:1 ratio for successful maturation. 
If only one chaperone is overexpressed this balance would not be given.  A different reason, 
why the co-expression of mPRAT4A or mGRP94 negatively influenced TLR expression 
could be the design of the construct itself. Both chaperones were designed with a C-terminal 
FLAG-tag downstream of the ER retention signals KDEL or PDEL. These retention signals 
are required for the regulation of ER-retrieval of ER resident proteins from the Golgi 
apparatus. The ER-retention signals are recognized by KDEL-receptors and trafficked back 
to the ER (Alberts, 2008). If the C-terminal FLAG tag should impair recognition of the 
chaperones by the KDEL receptor these would not be shuttled back to the ER and gradually 
lost over time. If the molecular chaperones are lost from the ER they can no longer aid the 
TLR folding process. Furthermore, if improperly folded TLRs are still associated with the 
chaperones when they are lost from the ER they might be targeted for proteasomal 
degradation which would explain the reduced TLR yields. Thus the FLAG tag should be 
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located upstream before the KDEL or PDEL sequence or left out altogether. As the isolation 
and purification of mGRP94 and mPRAT4A are not necessarily required the FLAG tag 
could be omitted and target specific antibodies could be used to detect the overexpression 
of both using Western blot analysis. Moreover, the overexpression of mPRAT4A and 
mGRP94 might have occupied significant portions of the cellular transcription and 
transcription machinery or even imitated an unfolded protein responses (UPR) that might 
have resulted in the downregulation of cellular protein synthesis (Reid et al., 2014). The 
integration of mPRAT4A and mGRP94 into a binary RMCE master cell line with an 
exchange locus that exhibits low expression capabilities might be favourable.   
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6 Outlook 
A binary RMCE system in CHO Lec3.2.8.1 cells was established. Thus the stable integration 
of transgenes into predefined chromosomal loci via RMCE, based on the Flp/FRT system, 
enables the co-expression of different target proteins for structural biology applications. 
The binary RMCE system was shown to yield predictable expression pattern for each locus 
and therefore allows the reproducible production of recombinant proteins after the 
generation of stable producer cell lines. This system expands the Multi-Host system (Meyer 
et al., 2013) developed in our group. The use of the binary RMCE system could be adapted 
for other mammalian cell lines including CHO-K1 or HEK293 when native glycosylation 
profiles are required. Likewise compatible RMCE as well as binary RMCE approaches 
could be established in insect and yeast platforms. 
The use of targeted integration already reduces the time necessary for the isolation of stable 
high producer cell lines. However, isolation of master and producer cell lines would benefit 
immensely when adapted for FACS under sterile conditions. Limiting dilution, which was 
used for the clonal isolation of producer cell lines in this work, is cumbersome labour- and 
time-intensive. Therefore the reduction of limiting dilution steps would be favourable. 
Moreover, the number of cell lines that could be processed in parallel could be expanded 
as each cell line would require less attention from the operator. FACS based methods for 
the isolation of RMCE master and producer cell lines derived from CHO-K1 are used by 
the Rentschler Biotechnologie GmbH for the generation TurboCellTM lines. These cut their 
timelines by 50 % compared to random integration based cell line development (Rehberger 
et al., 2013). 
The expression properties of the TLR ECDs discussed in Section 5.4 showed intracellular 
accumulation in Insect and HEK293-6E cells (Meyer, 2012) whereas the soluble expression 
in CHO Lec3.2.8.1 cells was clearly improved. Recently Croset et al., (2012) raised awareness 
that while there are only minor differences in glycosylation and glycoprotein isoform patter 
between different HEK cell lines (HEK293-EBNA and HEK293-6E were compared) major 
differences could be observed between HEK and CHO-S cells which might result in 
non-comparable results when switching from HEK to CHO systems. This may be a concern 
that should be addressed for the system used in this work. Currently HEK293-6E are used 
for transient screening to identify constructs that express solubly. Those constructs with the 
highest potential than are used for the generation of stable producer cell lines in 
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glycosylation mutant CHO Lec3.2.8.1. If differences in the glycoprotein isoform patter 
between HEK and CHO-S can be considered problematic (Croset et al., 2012) this problem 
will reflect even more on glycosylation mutant CHO Lec3.2.8.1. Therefore the establishment 
of a transient CHO Lec3.2.8.1 platform might be of advantage when screening for solubly 
expressible constructs designated for stable integration in CHO Lec3.2.8.1. Examples for 
transient EBNA-1 based systems in CHO cell were described in the literature (Kunaparaju 
et al., 2005, Goepfert et al., 2010, Durocher et al., 2011, Daramola et al., 2014).  
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Tissue culture flat tubes  10 cm2   91253  TPP 
96‐well plate  untreated, straight w/Lid  260860  Nunc / Thermo 
Scientific 




























































Cryogenic vials  Nalgene® cryoware cryogenic vials (2 mL)  5000‐0020  Thermo Scientific/ 
Nalgene 
Cryogenic vials  CryoTubeTM Vials  375418  Thermo Scientific/ 
Nunc 


























BBA10‐tdTomato‐C1  99 %  3.6  3.9  3.5 
SMT_dneo(2)_24‐tdTomato‐C1  99 %  3.5  3.7  3.4 
TE3‐B4‐H1  98 %  5.0  5.6  5.5 
TE3‐B4‐H1‐tdTomato/tdTomato‐C1  99 %  9.9  10.6  9.7 
TE3‐B4‐L1.1  98 %  1.8  1.9  1.8 












































Culture 1  5.60  6.56  4.85 
Culture 2  6.69  4.74  6.81 







Culture 1  2.43  1.44  2.20 
Culture 2  2.01  1.94  1.96 









Culture 1  5.99  5.61  8.04 
Culture 2  7.44  5.47  7.75 







Culture 1  5.91  3.70  4.82 
Culture 2  5.46  3.65  4.97 
Culture 3  4.52  4.33  5.75 
Table A.2‐3: ANOVA analysis of tdTomato yields for triplicate batch cultures at 3 timepoints. 
TE3‐B4‐H1  F  P‐value  Fcrit 
Cultures  0.04  0.97  6.94 
Timepoints  0.30  0.76  6.94 
TE3‐B4‐L1.1  F  P‐value  Fcrit 
Cultures  4.58  0.09  6.94 
Timepoints  2.02  0.25  6.94 
TE3‐B4‐L1.1‐
tdTomato/tdTomato‐C1  F  P‐value  Fcrit 
Cultures  3.67  0.12  6.94 
Timepoints  0.15  0.86  6.94 
BBA10‐tdTomato‐C1  F  P‐value  Fcrit 
Cultures  4.16  0.12  6.94 
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Lane  SMT_dneo(2)_24‐ssmTLR2‐C7     
1  Precision Plus unstained (BioRad)     
2  Permeate of dialysis     
3  Filtrate of dialysis     
4  Flowthrough     
5‐10  Wash fractions     






Lane  SMT_dneo(2)_24‐ssmTLR2/mPRAT4A‐C1     
1  Precision Plus unstained (BioRad)     
2‐17  Eluate fractions – mTLR2 (67.2 kDa)     
Figure A.2‐4:  12 % SDS‐PAGE analysis of purified mTLR2 from expression in perfusion reactor using the cell line 
SMT_dneo(2)_24  ssmTLR2/mPRAT4A‐C1. mTLR2 was produced  in duplicate  in 5 L perfusion  reactors and purified 
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Lane  TE3‐B4‐H1‐ssmTLR2/mGRP94‐C1     
1  Precision Plus unstained (BioRad)     
2‐3  Wash fractions     
4‐18  Eluate fractions – mTLR2 (67.2 kDa)     
Figure A.2‐5: 12 % SDS‐PAGE analysis of purified mTLR2 from expression in perfusion reactor using the cell line 





Protein  Size  Length  A280 correction  Emission/Excitation 
tdTomato  55.0 kDa  482 aa  0.79 mg/mL  554 nm/ 581 nm 
eGFP (gb ADD98904.1)  28.0 kDa  248 aa  1.40 mg/mL  488 nm/ 507 nm 
ssmTLR2_1‐587 (UniProt Q9QUN7)  67.2 kDa  594 aa  1.28 mg/mL  ‐ 
sshTLR5 _1‐391 (UniProt O60602)  57.5 kDa  511 aa  0.94 mg/mL  ‐ 
ssmTLR1_1‐408 (UniProt Q9EPQ1)  59.8 kDa  529 aa  1.06 mg/mL  ‐ 
ssmTLR1_1‐455 (UniProt Q9EPQ1)  64.9 kDa  576 aa  1.02 mg/mL  ‐ 
ssmTLR1_1‐500 (UniProt Q9EPQ1)  69.7 kDa  621 aa  1.09 mg/mL  ‐ 
mPRAT4A (UniProt Q9DAU1)  31.5 kDa  284 aa  0.97 mg/mL  ‐ 
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